{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:09:11Z","timestamp":1790554151388,"version":"4.1.0"},"reference-count":1296,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L025752\/1"],"award-info":[{"award-number":["BB\/L025752\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["08\/IN.1\/B2083, 12\/RC\/2272"],"award-info":[{"award-number":["08\/IN.1\/B2083, 12\/RC\/2272"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2016.00060","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T06:23:12Z","timestamp":1480918992000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["A Dormant Microbial Component in the Development of Preeclampsia"],"prefix":"10.3389","volume":"3","author":[{"given":"Douglas B.","family":"Kell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise C.","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7827-7-70","article-title":"Potential markers of preeclampsia \u2013 a review","volume":"7","author":"Grill","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"d1875","DOI":"10.1136\/bmj.d1875","article-title":"Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort","volume":"342","author":"North","year":"2011","journal-title":"BMJ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/VHRM.S20181","article-title":"Pre-eclampsia: pathophysiology, diagnosis, and management","volume":"7","author":"Uzan","year":"2011","journal-title":"Vasc Health Risk Manag"},{"issue":"12","key":"B5","first-page":"14","article-title":"Improving diagnosis and clinical management of pre-eclampsia","volume":"44","author":"Kenny","year":"2012","journal-title":"MLO Med Lab Obs"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.5005\/jp\/books\/11866","volume-title":"Obstetric Vasculopathies","author":"Desai","year":"2013"},{"key":"B7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1161\/HYPERTENSIONAHA.114.03578","article-title":"Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the screening for pregnancy endpoints (SCOPE) international cohort study","volume":"64","author":"Kenny","year":"2014","journal-title":"Hypertension"},{"key":"B9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MNH.0000000000000105","article-title":"Pathogenesis of preeclampsia","volume":"24","author":"Sircar","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin Perinatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"issue":"Suppl 1","key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1471-0528.12629","article-title":"Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health","volume":"121","author":"Abalos","year":"2014","journal-title":"BJOG"},{"key":"B15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.110.157297","article-title":"Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers","volume":"56","author":"Kenny","year":"2010","journal-title":"Hypertension"},{"key":"B16","doi-asserted-by":"publisher","first-page":"i1753","DOI":"10.1136\/bmj.i1753","article-title":"Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies","volume":"353","author":"Bartsch","year":"2016","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.115.05024","article-title":"Preeclampsia and pregnancy-related hypertensive disorders","volume":"67","author":"Karumanchi","year":"2016","journal-title":"Hypertension"},{"key":"B18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"Br Med J"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1201\/b13484","volume-title":"Obstetrics by Ten Teachers","author":"Baker","year":"2011"},{"key":"B20","doi-asserted-by":"publisher","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980\u20132010: age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3109\/10641955.2013.858745","article-title":"Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase\u20091","volume":"33","author":"Bdolah","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/0002-9378(90)91176-D","article-title":"Epidemiology of preeclampsia and eclampsia in the United-States, 1979-1986","volume":"163","author":"Saftlas","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/oxfordjournals.epirev.a017954","article-title":"Epidemiology of pregnancy-induced hypertension","volume":"19","author":"Zhang","year":"1997","journal-title":"Epidemiol Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2393-12-47","article-title":"Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008","volume":"12","author":"Lamminp\u00e4\u00e4","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"key":"B25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.midw.2012.04.001","article-title":"Maternal age >= 45 years and maternal and perinatal outcomes: a review of the evidence","volume":"29","author":"Carolan","year":"2013","journal-title":"Midwifery"},{"key":"B26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bpobgyn.2011.01.007","article-title":"Pre-eclampsia: risk factors and causal models","volume":"25","author":"Trogstad","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0029-7844(95)00049-W","article-title":"Risk-factors for preeclampsia in twin pregnancies \u2013 a population-based cohort study","volume":"85","author":"Coonrod","year":"1995","journal-title":"Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/10641959909016193","article-title":"Preeclampsia in twin pregnancies: incidence and outcome","volume":"18","author":"Campbell","year":"1999","journal-title":"Hypertens Pregnancy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"428.e1","DOI":"10.1016\/j.ajog.2007.10.783","article-title":"Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?","volume":"198","author":"Bdolah","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/aje\/kwi334","article-title":"Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia","volume":"162","author":"Bodnar","year":"2005","journal-title":"Am J Epidemiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.preghy.2010.10.013","article-title":"The role of obesity in preeclampsia","volume":"1","author":"Roberts","year":"2011","journal-title":"Pregnancy Hypertens"},{"key":"B32","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1111\/nure.12055","article-title":"Epidemiology of preeclampsia: impact of obesity","volume":"71","author":"Jeyabalan","year":"2013","journal-title":"Nutr Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajog.2013.10.014","article-title":"Effect of obesity on incidence of preeclampsia","volume":"210","author":"Sugerman","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1471-0528.1999.tb08326.x","article-title":"Twin mothers, pregnancy hypertension and pre-eclampsia","author":"Thornton","year":"1999","journal-title":"Brit J Obstet Gynaecol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/(SICI)1096-8628(20000410)91:4256::AID-AJMG33.0.CO;2-T","article-title":"Genetic effects on the liability of developing pre-eclampsia and gestational hypertension","volume":"91","author":"Ros","year":"2000","journal-title":"Am J Med Genet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bpobgyn.2011.02.007","article-title":"The genetics of pre-eclampsia and other hypertensive disorders of pregnancy","volume":"25","author":"Williams","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"632732","DOI":"10.1155\/2012\/632732","article-title":"Pathogenesis of preeclampsia: the genetic component","volume":"2012","author":"Valenzuela","year":"2012","journal-title":"J Pregnancy"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1093\/aje\/kwt189","article-title":"Associations of personal and family preeclampsia history with the risk of early-, intermediate- and late-onset preeclampsia","volume":"178","author":"Boyd","year":"2013","journal-title":"Am J Epidemiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12884-015-0754-2","article-title":"The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes","volume":"15","author":"Roten","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"B40","first-page":"12","article-title":"The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome \u2013 molecular mimicry?","volume":"27","author":"Asherson","year":"2000","journal-title":"J Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/ard.62.5.388","article-title":"Antiphospholipid antibodies and infections","volume":"62","author":"Asherson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1023\/B:JOCI.0000018058.28764.ce","article-title":"Antiphospholipid syndrome infectious origin","volume":"24","author":"Blank","year":"2004","journal-title":"J Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.imbio.2005.10.004","article-title":"The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity","volume":"210","author":"Harel","year":"2005","journal-title":"Immunobiology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11926-007-0035-9","article-title":"Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?","volume":"9","author":"Clark","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"B46","first-page":"923","article-title":"Catastrophic antiphospholipid syndrome and sepsis. A common link?","volume":"34","author":"Espinosa","year":"2007","journal-title":"J Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2007.10.001","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and infections","volume":"7","author":"S\u00e8ne","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1177\/0961203309345738","article-title":"Common infectious agents prevalence in antiphospholipid syndrome","volume":"18","author":"Zinger","year":"2009","journal-title":"Lupus"},{"key":"B49","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/Gco.0000000000000086","article-title":"Antiphospholipid antibody syndrome and reproduction","volume":"26","author":"Kutteh","year":"2014","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ogc.2013.10.004","article-title":"Antiphospholipid antibody syndrome","volume":"41","author":"Kutteh","year":"2014","journal-title":"Obstet Gyn Clin N Am"},{"key":"B51","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2105\/Ajph.84.3.405","article-title":"Urinary-tract infection during pregnancy \u2013 its association with maternal morbidity and perinatal outcome","volume":"84","author":"Schieve","year":"1994","journal-title":"Am J Public Health"},{"key":"B53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajog.2007.07.040","article-title":"Maternal infection and risk of preeclampsia: systematic review and metaanalysis","volume":"198","author":"Conde-Agudelo","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10995-007-0224-1","article-title":"Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies","volume":"12","author":"Rustveld","year":"2008","journal-title":"Matern Child Health J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/bmj.323.7323.1213","article-title":"Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study","volume":"323","author":"Irgens","year":"2001","journal-title":"BMJ"},{"key":"B56","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","article-title":"Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis","volume":"335","author":"Bellamy","year":"2007","journal-title":"BMJ"},{"key":"B57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2217\/17455057.4.2.133","article-title":"Pre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular disease","volume":"4","author":"Craici","year":"2008","journal-title":"Womens Health (Lond Engl)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.110.943407","article-title":"Hypertension in pregnancy and later cardiovascular risk: common antecedents?","volume":"122","author":"Romundstad","year":"2010","journal-title":"Circulation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e7677","DOI":"10.1136\/bmj.e7677","article-title":"Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study","volume":"345","author":"Skjaerven","year":"2012","journal-title":"BMJ"},{"key":"B61","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/1471-0528.12215","article-title":"Pre-eclampsia and cardiovascular disease: more questions than answers?","volume":"120","author":"Ananth","year":"2013","journal-title":"BJOG"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/micc.12079","article-title":"Vascular dysfunction in preeclampsia","volume":"21","author":"Brennan","year":"2014","journal-title":"Microcirculation"},{"key":"B63","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cvr\/cvu018","article-title":"Pre-eclampsia and cardiovascular disease","volume":"101","author":"Chen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0142538","DOI":"10.1371\/journal.pone.0142538","article-title":"Syncytiotrophoblast extracellular vesicles from pre-eclampsia placentas differentially affect platelet function","volume":"10","author":"Tannetta","year":"2015","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1212\/01.wnl.0000228277.84760.a2","article-title":"Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome","volume":"67","author":"Bateman","year":"2006","journal-title":"Neurology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/STROKEAHA.108.538025","article-title":"Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study","volume":"40","author":"Kajantie","year":"2009","journal-title":"Stroke"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1161\/STROKEAHA.108.540880","article-title":"Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan","volume":"40","author":"Tang","year":"2009","journal-title":"Stroke"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.berh.2007.09.005","article-title":"Antiphospholipid syndrome (APS): where does it come from?","volume":"21","author":"Sherer","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ajog.2005.08.065","article-title":"Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease","volume":"194","author":"Mignini","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"057356","DOI":"10.1101\/057356","article-title":"A dormant microbial component in the development of pre-eclampsia. BioRxiv preprint","author":"Kell","year":"2016","journal-title":"bioRxiv"},{"key":"B72","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","article-title":"Current topic: pre-eclampsia and the placenta","volume":"12","author":"Redman","year":"1991","journal-title":"Placenta"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00404-011-1865-2","article-title":"Evaluation of oxidative stress markers in first trimester for assessment of preeclampsia risk","volume":"284","author":"Genc","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jsgi.2004.03.003","article-title":"Placental oxidative stress: from miscarriage to preeclampsia","volume":"11","author":"Burton","year":"2004","journal-title":"J Soc Gynecol Investig"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2013.05.003","article-title":"If we know so much about preeclampsia, why haven\u2019t we cured the disease?","volume":"99","author":"Roberts","year":"2013","journal-title":"J Reprod Immunol"},{"issue":"Suppl","key":"B77","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia \u2013 two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"key":"B78","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/aje\/155.3.203","article-title":"Impact of preeclampsia and gestational hypertension on birth weight by gestational age","volume":"155","author":"Xiong","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"Suppl A","key":"B79","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"key":"B80","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.preghy.2014.04.020","article-title":"The six stages of pre-eclampsia","volume":"4","author":"Redman","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"B81","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"Sacks","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl A","key":"B82","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1053\/plac.2002.0930","article-title":"Pre-eclampsia, the placenta and the maternal systemic inflammatory response \u2013 a review","volume":"24","author":"Redman","year":"2003","journal-title":"Placenta"},{"key":"B83","first-page":"164","article-title":"Dyslipidemia and pre-eclampsia","volume-title":"Pre-Eclampsia-Aetiology and Clinical Practice","author":"Hubel","year":"2006"},{"key":"B84","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00204-010-0577-x","article-title":"Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson\u2019s, Huntington\u2019s, Alzheimer\u2019s, prions, bactericides, chemical toxicology and others as examples","volume":"577","author":"Kell","year":"2010","journal-title":"Arch Toxicol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev.med.59.110106.214058","article-title":"Preeclampsia and angiogenic imbalance","volume":"59","author":"Maynard","year":"2008","journal-title":"Annu Rev Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/pd.4554","article-title":"Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia","volume":"35","author":"Palomaki","year":"2015","journal-title":"Prenat Diagn"},{"key":"B90","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/0002-9378(83)90804-9","article-title":"Clinical applications of the altered iron kinetics of toxemia of pregnancy","volume":"146","author":"Entman","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"B91","first-page":"189","article-title":"Human fetal borreliosis, toxemia of pregnancy, and fetal death","volume":"263","author":"MacDonald","year":"1986","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"key":"B92","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1471-0528.1991.tb13505.x","article-title":"Some historical aspects of toxaemia of pregnancy. A review","volume":"98","author":"Loudon","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2353\/ajpath.2006.051304","article-title":"Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility","volume":"169","author":"Meziani","year":"2006","journal-title":"Am J Pathol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1210\/jc.2005-0532","article-title":"Decrease and senescence of endothelial progenitor cells in patients with preeclampsia","volume":"90","author":"Sugawara","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B95","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0143-4004(98)90018-2","article-title":"Placental mitochondria as a source of oxidative stress in pre-eclampsia","volume":"19","author":"Wang","year":"1998","journal-title":"Placenta"},{"key":"B96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4419-8997-0_5","article-title":"Current paradigms in cellular oxygen sensing","volume":"543","author":"Schumacker","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B97","first-page":"295","article-title":"Environment and disease: association or causation?","volume":"58","author":"Bradford Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e14424","DOI":"10.7554\/eLife.14424","article-title":"Biological causal links on physiological and evolutionary time scales","volume":"5","author":"Karmon","year":"2016","journal-title":"Elife"},{"key":"B99","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1742-4658.2006.05136.x","article-title":"Metabolomics, modelling and machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor B\u00fccher lecture","volume":"273","author":"Kell","year":"2006","journal-title":"FEBS J"},{"key":"B100","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.micinf.2014.08.012","article-title":"A spirit of scientific rigour: Koch\u2019s postulates in twentieth-century medicine","volume":"16","author":"Gradmann","year":"2014","journal-title":"Microbes Infect"},{"issue":"Suppl 2","key":"B101","doi-asserted-by":"publisher","first-page":"S274","DOI":"10.1093\/cid\/10.Supplement_2.S274","article-title":"Molecular Koch\u2019s postulates applied to microbial pathogenicity","volume":"10","author":"Falkow","year":"1988","journal-title":"Rev Infect Dis"},{"key":"B102","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/CMR.9.1.18","article-title":"Sequence-based identification of microbial pathogens \u2013 a reconsideration of Koch\u2019s postulates","volume":"9","author":"Fredricks","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrmicro799","article-title":"Molecular Koch\u2019s postulates applied to bacterial pathogenicity \u2013 a personal recollection 15 years later","volume":"2","author":"Falkow","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1473-3099(08)70257-3","article-title":"Causality and gastrointestinal infections: Koch, Hill, and Crohn\u2019s","volume":"8","author":"Lowe","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.surg.2010.03.008","article-title":"The molecular Koch\u2019s postulates and surgical infection: a view forward","volume":"147","author":"Seal","year":"2010","journal-title":"Surgery"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1038\/jid.2013.260","article-title":"What does it take to satisfy Koch\u2019s postulates two centuries later? Microbial genomics and Propionibacteria acnes","volume":"133","author":"Segre","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1126\/science.aad6753","article-title":"Adapting Koch\u2019s postulates","volume":"351","author":"Byrd","year":"2016","journal-title":"Science"},{"key":"B108","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/S0140525X00057046","article-title":"Explanatory coherence","volume":"12","author":"Thagard","year":"1989","journal-title":"Behav Brain Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1207\/s15516709cog2201_1","article-title":"Coherence as constraint satisfaction","volume":"22","author":"Thagard","year":"1998","journal-title":"Cogn Sci"},{"key":"B110","doi-asserted-by":"crossref","DOI":"10.1515\/9780691187303","volume-title":"How Scientists Explain Disease","author":"Thagard","year":"1999"},{"key":"B111","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1086\/520941","article-title":"Coherence, truth, and the development of scientific knowledge","volume":"74","author":"Thagard","year":"2007","journal-title":"Philos Sci"},{"key":"B112","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/CBO9780511814273.026","article-title":"Explanatory coherence","volume-title":"Reasoning: Studies of Human Inference and Its Foundations","author":"Thagard","year":"2008"},{"key":"B113","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dmm.008516","article-title":"Preeclampsia: multiple approaches for a multifactorial disease","volume":"5","author":"Pennington","year":"2012","journal-title":"Dis Model Mech"},{"key":"B114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"Magee","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000097926","article-title":"Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes","volume":"63","author":"Goddard","year":"2007","journal-title":"Hum Hered"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.bbadis.2012.08.004","article-title":"Molecular genetics of preeclampsia and HELLP syndrome \u2013 a review","volume":"1822","author":"Jebbink","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B117","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/aje\/kwu151","article-title":"Maternal genotype and severe preeclampsia: a HuGE review","volume":"180","author":"Fong","year":"2014","journal-title":"Am J Epidemiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cyto.2014.11.017","article-title":"Activin signalling and pre-eclampsia: from genetic risk to pre-symptomatic biomarker","volume":"71","author":"Williamson","year":"2015","journal-title":"Cytokine"},{"key":"B119","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/456018a","article-title":"The case of the missing heritability","volume":"456","author":"Maher","year":"2008","journal-title":"Nature"},{"key":"B120","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1073\/pnas.1119675109","article-title":"The mystery of missing heritability: genetic interactions create phantom heritability","volume":"109","author":"Zuk","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B122","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1034\/j.1600-0897.2002.01076.x","article-title":"Preeclampsia: a multifactorial disease resulting from the interaction of the feto-maternal HLA genotype and HCMV infection","volume":"48","author":"Carreiras","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/aji.12526","article-title":"Immunostimulatory role of mitochondrial DAMPs: alarming for pre-eclampsia?","volume":"76","author":"McCarthy","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1042\/CS20160103","article-title":"Mitochondrial [dys]function; culprit in pre-eclampsia?","volume":"130","author":"McCarthy","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1755-8794-2-2","article-title":"Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases","volume":"2","author":"Kell","year":"2009","journal-title":"BMC Med Genomics"},{"key":"B126","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum ferritin is an important disease marker, and is mainly a leakage product from damaged cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"key":"B127","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1039\/c4ib00025k","article-title":"Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases","volume":"6","author":"Pretorius","year":"2014","journal-title":"Integr Biol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1039\/c4ib00173g","article-title":"The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen)","volume":"7","author":"Kell","year":"2015","journal-title":"Integr Biol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MBC.0b013e3283468a0d","article-title":"Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes","volume":"22","author":"Pretorius","year":"2011","journal-title":"Blood Coagul Fibrinol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1097\/MBC.0b013e32834bdb32","article-title":"Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients","volume":"22","author":"Pretorius","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11239-010-0538-5","article-title":"A descriptive investigation of the ultrastructure of fibrin networks in thrombo-embolic ischemic stroke","volume":"31","author":"Pretorius","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00296-013-2817-x","article-title":"An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus","volume":"34","author":"Pretorius","year":"2014","journal-title":"Rheumatol Int"},{"key":"B133","doi-asserted-by":"publisher","first-page":"788","DOI":"10.18632\/aging.100695","article-title":"Eryptosis as a marker of Parkinson\u2019s disease","volume":"6","author":"Pretorius","year":"2014","journal-title":"Aging"},{"key":"B134","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12933-015-0192-5","article-title":"Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics","volume":"13","author":"Pretorius","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"00088","DOI":"10.3389\/fnagi.2013.00088","article-title":"High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer\u2019s disease","volume":"5","author":"Bester","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e85271","DOI":"10.1371\/journal.pone.0085271","article-title":"Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents","volume":"9","author":"Pretorius","year":"2014","journal-title":"PLoS One"},{"key":"B137","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.blre.2016.01.001","article-title":"Erythrocytes and their role as health indicator: using structure in a patient-orientated precision medicine approach","volume":"30","author":"Pretorius","year":"2016","journal-title":"Blood Rev"},{"key":"B138","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1586\/17474108.2.6.735","article-title":"Preeclampsia as an infectious disease","volume":"2","author":"Todros","year":"2007","journal-title":"Exp Rev Obstet Gynecol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"179","DOI":"10.12688\/f1000research.6709.1","article-title":"Individuality, phenotypic differentiation, dormancy and \u2018persistence\u2019 in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology","volume":"4","author":"Kell","year":"2015","journal-title":"F1000Research"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1039\/C5IB00158G","article-title":"On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death","volume":"7","author":"Kell","year":"2015","journal-title":"Integr Biol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/femsre\/fuv013","article-title":"The dormant blood microbiome in chronic, inflammatory diseases","volume":"39","author":"Potgieter","year":"2015","journal-title":"FEMS Microbiol Rev"},{"key":"B142","article-title":"Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability","author":"Pretorius","year":"Forthcoming 2016","journal-title":"Exp Biol Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3233\/JAD-160318","article-title":"A bacterial component to Alzheimer-type dementia seen via a systems biology approach that links iron dysregulation and inflammagen shedding to disease","volume":"53","author":"Pretorius","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"B144","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/BOR.0b013e32835cedbf","article-title":"The human microbiome and autoimmunity","volume":"25","author":"Proal","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00011-014-0755-z","article-title":"Inflammation and vitamin D: the infection connection","volume":"63","author":"Mangin","year":"2014","journal-title":"Inflamm Res"},{"key":"B146","first-page":"257","article-title":"Inflammatory disease and the human microbiome","volume":"17","author":"Proal","year":"2014","journal-title":"Discov Med"},{"key":"B147","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3233\/JAD-160152","article-title":"Microbes and Alzheimer\u2019s disease","volume":"51","author":"Itzhaki","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"B148","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1084\/jem.193.3.393","article-title":"Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus","volume":"193","author":"Morath","year":"2001","journal-title":"J Exp Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2911(08)60248-9","article-title":"Viability measurements and the survival of microbes under minimum stress","volume":"1","author":"Postgate","year":"1967","journal-title":"Adv Micro Physiol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0580-9517(08)70149-1","article-title":"Viable counts and viability","volume":"1","author":"Postgate","year":"1969","journal-title":"Methods Microbiol"},{"key":"B151","first-page":"1","article-title":"Death in microbes and macrobes","volume-title":"In the Survival of Vegetative Microbes","author":"Postgate","year":"1976"},{"key":"B152","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.mi.39.100185.001541","article-title":"Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats","volume":"39","author":"Staley","year":"1985","journal-title":"Annu Rev Microbiol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1128\/AEM.02741-14","article-title":"A hidden pitfall in the preparation of agar media undermines microorganism cultivability","volume":"80","author":"Tanaka","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1128\/AEM.01754-09","article-title":"Use of ichip for high-throughput in situ cultivation of \u201cuncultivable\u201d microbial species","volume":"76","author":"Nichols","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature17645","article-title":"Culturing of \u2018unculturable\u2019 human microbiota reveals novel taxa and extensive sporulation","volume":"533","author":"Browne","year":"2016","journal-title":"Nature"},{"key":"B156","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1574-6968.1993.tb05871.x","article-title":"Dormancy in non-sporulating bacteria","volume":"10","author":"Kaprelyants","year":"1993","journal-title":"FEMS Microbiol Rev"},{"key":"B157","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1023\/A:1000664013047","article-title":"Viability and activity in readily culturable bacteria: a review and discussion of the practical issues","volume":"73","author":"Kell","year":"1998","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B158","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/JCM.14.6.623-627.1981","article-title":"Comparison of liquid growth media for Legionella pneumophila","volume":"14","author":"Saito","year":"1981","journal-title":"J Clin Microbiol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/clinids\/5.2.258","article-title":"Legionella infections \u2013 a review of 5 years of research","volume":"5","author":"Meyer","year":"1983","journal-title":"Rev Infect Dis"},{"key":"B160","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1099\/00222615-22-2-97","article-title":"Factors affecting growth of Legionella pneumophila in liquid media","volume":"22","author":"Barker","year":"1986","journal-title":"J Med Microbiol"},{"key":"B161","first-page":"556","article-title":"Legionella and human disease: part 1: a path of scientific and community discovery","volume":"18","author":"Molinari","year":"1997","journal-title":"Compend Contin Educ Dent"},{"key":"B162","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AEM.64.2.760-762.1998","article-title":"Environmental occurrence of the Whipple\u2019s disease bacterium (Tropheryma whippelii)","volume":"64","author":"Maiwald","year":"1998","journal-title":"Appl Environ Microbiol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1086\/318512","article-title":"Whipple\u2019s disease and Tropheryma whippelii: secrets slowly revealed","volume":"32","author":"Maiwald","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B164","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1073\/pnas.0812074106","article-title":"Host cell-free growth of the Q fever bacterium Coxiella burnetii","volume":"106","author":"Omsland","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B165","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-94-007-4315-1_11","article-title":"Axenic growth of Coxiella burnetii","volume":"984","author":"Omsland","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"B166","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/9781555818005.ch3","article-title":"One hundred years of discovery and rediscovery of Helicobacter pylori and its association with peptic ulcer disease","volume-title":"Helicobacter pylori: Physiology and Genetics","author":"Marshall","year":"2001"},{"key":"B167","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/cmdc.200600153","article-title":"Helicobacter connections","volume":"1","author":"Marshall","year":"2006","journal-title":"ChemMedChem"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"B169","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","article-title":"Attempt to fulfil Koch\u2019s postulates for pyloric Campylobacter","volume":"142","author":"Marshall","year":"1985","journal-title":"Med J Aust"},{"key":"B170","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/AEM.59.10.3187-3196.1993","article-title":"Dormancy in stationary-phase cultures of Micrococcus luteus: flow cytometric analysis of starvation and resuscitation","volume":"59","author":"Kaprelyants","year":"1993","journal-title":"Appl Environ Microbiol"},{"key":"B171","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1574-6968.1994.tb06662.x","article-title":"Estimation of dormant Micrococcus luteus cells by penicillin lysis and by resuscitation in cell-free spent medium at high dilution","volume":"115","author":"Kaprelyants","year":"1994","journal-title":"FEMS Microbiol Lett"},{"key":"B172","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/BF02111491","article-title":"Dormancy of Mycobacterium tuberculosis and latency of disease","volume":"13","author":"Wayne","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B173","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2958.2007.06078.x","article-title":"The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro","volume":"67","author":"Kana","year":"2008","journal-title":"Mol Microbiol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"B175","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1590\/S1517-838246320140507","article-title":"Dormancy models for Mycobacterium tuberculosis: a minireview","volume":"46","author":"Alnimr","year":"2015","journal-title":"Braz J Microbiol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.micpath.2014.11.016","article-title":"Reactivation of dormant \u201cnon-culturable\u201d Mycobacterium tuberculosis developed in vitro after injection in mice: both the dormancy depth and host genetics influence the outcome","volume":"78","author":"Shleeva","year":"2015","journal-title":"Microb Pathog"},{"key":"B177","doi-asserted-by":"publisher","first-page":"8916","DOI":"10.1073\/pnas.95.15.8916","article-title":"A bacterial cytokine","volume":"95","author":"Mukamolova","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B178","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2958.2002.03183.x","article-title":"The rpf gene of Micrococcus luteus encodes an essential secreted growth factor","volume":"46","author":"Mukamolova","year":"2002","journal-title":"Mol Microbiol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1046\/j.1365-2958.2002.03184.x","article-title":"A family of autocrine growth factors in Mycobacterium tuberculosis","volume":"46","author":"Mukamolova","year":"2002","journal-title":"Mol Microbiol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2958.2005.04930.x","article-title":"Muralytic activity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation","volume":"59","author":"Mukamolova","year":"2006","journal-title":"Mol Microbiol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1164\/rccm.200905-0661OC","article-title":"Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum","volume":"181","author":"Mukamolova","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B182","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1128\/IAI.71.8.4789-4794.2003","article-title":"Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice","volume":"71","author":"Yeremeev","year":"2003","journal-title":"Infect Immun"},{"key":"B183","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-1-18","article-title":"Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses","volume":"1","author":"Zvi","year":"2008","journal-title":"BMC Med Genomics"},{"key":"B184","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Global burden of tuberculosis \u2013 estimated incidence, prevalence, and mortality by country","volume":"282","author":"Dye","year":"1999","journal-title":"JAMA"},{"key":"B185","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1128\/IAI.69.7.4195-4201.2001","article-title":"Tuberculosis: latency and reactivation","volume":"69","author":"Flynn","year":"2001","journal-title":"Infect Immun"},{"key":"B186","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.micro.55.1.139","article-title":"Nonreplicating persistence of Mycobacterium tuberculosis","volume":"55","author":"Wayne","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tube.2003.08.003","article-title":"M. tuberculosis persistence, latency, and drug tolerance","volume":"84","author":"Gomez","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"key":"B188","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1053\/j.gastro.2007.11.009","article-title":"Host-bacterial interactions in Helicobacter pylori infection","volume":"134","author":"Amieva","year":"2008","journal-title":"Gastroenterology"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1053\/j.gastro.2009.01.073","article-title":"Helicobacter pylori in health and disease","volume":"136","author":"Cover","year":"2009","journal-title":"Gastroenterology"},{"key":"B190","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/CMR.10.2.320","article-title":"Bacterial persistence and expression of disease","volume":"10","author":"Domingue","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"B191","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nrmicro1919","article-title":"Systems biology of persistent infection: tuberculosis as a case study","volume":"6","author":"Young","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev.micro.112408.134306","article-title":"Persister cells","volume":"64","author":"Lewis","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/Fmicb.2014.00070","article-title":"The role of metabolism in bacterial persistence","volume":"5","author":"Amato","year":"2014","journal-title":"Front Microbiol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/bies.201400080","article-title":"Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells: an investigation of persister cells, their formation and their role in S. aureus disease","volume":"36","author":"Conlon","year":"2014","journal-title":"Bioessays"},{"key":"B195","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/10409238.2013.869543","article-title":"Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria","volume":"49","author":"Kester","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mib.2014.06.016","article-title":"Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics","volume":"21","author":"Levin","year":"2014","journal-title":"Curr Opin Microbiol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cell.2014.02.050","article-title":"Molecular mechanisms underlying bacterial persisters","volume":"157","author":"Maisonneuve","year":"2014","journal-title":"Cell"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1128\/IAI.01244-13","article-title":"Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection","volume":"82","author":"Rank","year":"2014","journal-title":"Infect Immun"},{"key":"B199","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1126\/science.1262033","article-title":"Persisters unmasked","volume":"347","author":"Holden","year":"2015","journal-title":"Science"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780471729259.mc1709s36","article-title":"Aminoglycoside-enabled elucidation of bacterial persister metabolism","volume":"36","author":"Orman","year":"2015","journal-title":"Curr Protoc Microbiol"},{"key":"B201","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1111\/mec.13127","article-title":"Fitness trade-offs explain low levels of persister cells in the opportunistic pathogen Pseudomonas aeruginosa","volume":"24","author":"Stepanyan","year":"2015","journal-title":"Mol Ecol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature18442","article-title":"Pumping persisters","volume":"534","author":"Gerdes","year":"2016","journal-title":"Nature"},{"key":"B203","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.molcel.2016.03.035","article-title":"Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells","volume":"62","author":"Pu","year":"2016","journal-title":"Mol Cell"},{"key":"B204","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1574-6976.2012.00336.x","article-title":"Persistent intracellular pathogens","volume":"36","author":"Dehio","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nat Med"},{"key":"B206","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd2438","article-title":"Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?","volume":"7","author":"Dobson","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"B207","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.drudis.2011.05.010","article-title":"Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only","volume":"16","author":"Kell","year":"2011","journal-title":"Drug Discov Today"},{"key":"B208","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.drudis.2012.11.008","article-title":"The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so","volume":"18","author":"Kell","year":"2013","journal-title":"Drug Discov Today"},{"key":"B209","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphar.2014.00231","article-title":"How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion","volume":"5","author":"Kell","year":"2014","journal-title":"Front Pharmacol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrmicro2508","article-title":"Are bloodstream leukocytes Trojan horses for the metastasis of Staphylococcus aureus?","volume":"9","author":"Thwaites","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1078\/1438-4221-00167","article-title":"Bacterial persistence within erythrocytes: a unique pathogenic strategy of Bartonella spp","volume":"291","author":"Seubert","year":"2002","journal-title":"Int J Med Microbiol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"14170","DOI":"10.1073\/pnas.0602136103","article-title":"Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract","volume":"103","author":"Mysorekar","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1128\/AAC.00014-10","article-title":"Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics","volume":"54","author":"Blango","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"B214","doi-asserted-by":"publisher","first-page":"184ra160","DOI":"10.1126\/scitranslmed.3005497","article-title":"Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection","volume":"5","author":"Chen","year":"2013","journal-title":"Sci Transl Med"},{"key":"B215","doi-asserted-by":"publisher","first-page":"e00356","DOI":"10.1128\/mBio.00356-15","article-title":"Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity","volume":"6","author":"Goneau","year":"2015","journal-title":"MBio"},{"key":"B216","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1574-6976.2011.00305.x","article-title":"Mechanisms of Toxoplasma gondii persistence and latency","volume":"36","author":"Sullivan","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1126\/science.288.5471.1651","article-title":"Lack of a role for iron in the Lyme disease pathogen","volume":"288","author":"Posey","year":"2000","journal-title":"Science"},{"key":"B218","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.1074\/jbc.M112.433540","article-title":"A manganese-rich environment supports superoxide dismutase activity in a Lyme disease pathogen, Borrelia burgdorferi","volume":"288","author":"Aguirre","year":"2013","journal-title":"J Biol Chem"},{"key":"B219","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.1975.03240130021018","article-title":"Nutritional immunity. Host\u2019s attempt to withold iron from microbial invaders","volume":"231","author":"Weinberg","year":"1975","journal-title":"JAMA"},{"key":"B220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1152\/physrev.1984.64.1.65","article-title":"Iron withholding: a defense against infection and neoplasia","volume":"64","author":"Weinberg","year":"1984","journal-title":"Physiol Rev"},{"key":"B221","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/beha.2002.0001","article-title":"Iron and infection: competition between host and microbes for a precious element","volume":"15","author":"Marx","year":"2002","journal-title":"Best Pract Res Clin Haematol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nchembio771","article-title":"How pathogenic bacteria evade mammalian sabotage in the battle for iron","volume":"2","author":"Fischbach","year":"2006","journal-title":"Nat Chem Biol"},{"key":"B223","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3233\/JAD-2008-13409","article-title":"Iron withholding: a defense against disease","volume":"13","author":"Weinberg","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"B224","doi-asserted-by":"publisher","first-page":"L795","DOI":"10.1152\/ajplung.00132.2009","article-title":"Role of lung iron in determining the bacterial and host struggle in cystic fibrosis","volume":"297","author":"Reid","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.bbagen.2008.07.002","article-title":"Iron availability and infection","volume":"1790","author":"Weinberg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B226","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10534-010-9361-x","article-title":"Siderophore uptake in bacteria and the battle for iron with the host; a bird\u2019s eye view","volume":"23","author":"Chu","year":"2010","journal-title":"Biometals"},{"key":"B227","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/j.1462-5822.2010.01529.x","article-title":"The struggle for iron \u2013 a metal at the host-pathogen interface","volume":"12","author":"Nairz","year":"2010","journal-title":"Cell Microbiol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"e1000949","DOI":"10.1371\/journal.ppat.1000949","article-title":"The battle for iron between bacterial pathogens and their vertebrate hosts","volume":"6","author":"Skaar","year":"2010","journal-title":"PLoS Pathog"},{"key":"B229","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nrmicro2836","article-title":"Nutritional immunity: transition metals at the pathogen-host interface","volume":"10","author":"Hood","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chom.2013.04.010","article-title":"Iron in infection and immunity","volume":"13","author":"Cassat","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B231","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.chom.2013.06.007","article-title":"Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron","volume":"14","author":"Deriu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B232","doi-asserted-by":"publisher","first-page":"e1003436","DOI":"10.1371\/journal.ppat.1003436","article-title":"Targeting iron acquisition blocks infection with the fungal pathogens Aspergillus fumigatus and Fusarium oxysporum","volume":"9","author":"Leal","year":"2013","journal-title":"PLoS Pathog"},{"key":"B233","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fcimb.2013.00096","article-title":"Iron in intracellular infection: to provide or to deprive?","volume":"3","author":"Silva-Gomes","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1126\/science.aaa2468","article-title":"The battle for iron","volume":"346","author":"Armitage","year":"2014","journal-title":"Science"},{"key":"B235","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/1574-6976.12087","article-title":"Metal limitation and toxicity at the interface between host and pathogen","volume":"38","author":"Becker","year":"2014","journal-title":"FEMS Microbiol Rev"},{"key":"B236","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcimb.2014.00002","article-title":"Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis","volume":"4","author":"Diaz-Ochoa","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"B237","doi-asserted-by":"publisher","first-page":"e1003910","DOI":"10.1371\/journal.ppat.1003910","article-title":"Conflicting interests in the pathogen-host tug of war: fungal micronutrient scavenging versus mammalian nutritional immunity","volume":"10","author":"Potrykus","year":"2014","journal-title":"PLoS Pathog"},{"key":"B238","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.tig.2015.09.001","article-title":"Buried treasure: evolutionary perspectives on microbial iron piracy","volume":"31","author":"Barber","year":"2015","journal-title":"Trends Genet"},{"key":"B239","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.chom.2015.06.017","article-title":"Iron regulatory proteins mediate host resistance to Salmonella infection","volume":"18","author":"Nairz","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B240","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1021\/acs.accounts.5b00301","article-title":"Coordination chemistry of microbial iron transport","volume":"48","author":"Raymond","year":"2015","journal-title":"Acc Chem Res"},{"key":"B241","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1039\/c4mt00329b","article-title":"Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection","volume":"7","author":"Subashchandrabose","year":"2015","journal-title":"Metallomics"},{"key":"B242","doi-asserted-by":"publisher","first-page":"18984","DOI":"10.1074\/jbc.R115.643973","article-title":"Nramp1 and other transporters involved in metal withholding during infection","volume":"290","author":"Wessling-Resnick","year":"2015","journal-title":"J Biol Chem"},{"key":"B243","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mehy.2016.01.018","article-title":"Therapeutic iron restriction in sepsis","volume":"89","author":"Xia","year":"2016","journal-title":"Med Hypotheses"},{"key":"B244","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9378(82)90247-2","article-title":"Elevated serum ferritin in the altered ferrokinetics of toxemia of pregnancy","volume":"144","author":"Entman","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"B245","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0002-9378(87)80037-6","article-title":"The origin of increased serum iron in pregnancy-induced hypertension","volume":"157","author":"Samuels","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"B246","first-page":"65","article-title":"Hyperferritinemia in pregnancy induced hypertension and eclampsia","volume":"38","author":"Raman","year":"1992","journal-title":"J Postgrad Med"},{"key":"B247","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1053\/ob.1996.v175.a74252","article-title":"Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress","volume":"175","author":"Hubel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"B248","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/humrep\/15.8.1843","article-title":"Third trimester iron status and pregnancy outcome in non-anaemic women; pregnancy unfavourably affected by maternal iron excess","volume":"15","author":"Lao","year":"2000","journal-title":"Hum Reprod"},{"key":"B249","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1067\/mob.2002.123895","article-title":"Abnormal iron parameters in the pregnancy syndrome preeclampsia","volume":"187","author":"Rayman","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"B250","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/cbf.1235","article-title":"Serum iron and copper status and oxidative stress in severe and mild preeclampsia","volume":"24","author":"Serdar","year":"2006","journal-title":"Cell Biochem Funct"},{"key":"B251","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1471-0528.2007.01490.x","article-title":"Iron, pre-eclampsia and hypoxia-inducible factor","volume":"114","author":"Smith","year":"2007","journal-title":"BJOG"},{"key":"B252","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1447-0756.2008.00972.x","article-title":"Comparison of effect of daily versus weekly iron supplementation during pregnancy on lipid peroxidation","volume":"35","author":"Bhatla","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"B253","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00404-010-1728-2","article-title":"Iron status parameters in preeclamptic women","volume":"284","author":"Siddiqui","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"B254","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3329\/fmcj.v8i1.16892","article-title":"Serum ferritin in preeclampsia and eclampsia: a case control study","volume":"8","author":"Fatima","year":"2013","journal-title":"Faridpur Med Coll J"},{"key":"B255","doi-asserted-by":"publisher","first-page":"121","DOI":"10.12691\/ajmbr-2-6-1","article-title":"Pre eclampsia and iron status: a review","volume":"2","author":"Kandi","year":"2014","journal-title":"Am J Med Biol Res"},{"key":"B256","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cbi.2013.11.010","article-title":"Association of oxidative DNA damage, protein oxidation and antioxidant function with oxidative stress induced cellular injury in pre-eclamptic\/eclamptic mothers during fetal circulation","volume":"208","author":"Negi","year":"2014","journal-title":"Chem Biol Interact"},{"key":"B257","doi-asserted-by":"publisher","first-page":"35284","DOI":"10.18632\/oncotarget.6074","article-title":"Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)","volume":"6","author":"Bester","year":"2015","journal-title":"Oncotarget"},{"key":"B258","doi-asserted-by":"publisher","first-page":"053538","DOI":"10.1101\/053538","article-title":"Acute induction of anomalous blood clotting by highly substoichiometric levels of bacterial lipopolysaccharide (LPS)","author":"Pretorius","year":"2016","journal-title":"bioRxiv"},{"key":"B259","doi-asserted-by":"publisher","first-page":"20160539","DOI":"10.1098\/rsif.2016.0539","article-title":"Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide","volume":"123","author":"Pretorius","year":"2016","journal-title":"J R Soc Interface"},{"key":"B260","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1126\/science.1195639","article-title":"Endotoxin-induced structural transformations in liquid crystalline droplets","volume":"332","author":"Lin","year":"2011","journal-title":"Science"},{"key":"B261","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1039\/C2SM26811F","article-title":"Influence of droplet size, pH and ionic strength on endotoxin-triggered ordering transitions in liquid crystalline droplets","volume":"9","author":"Miller","year":"2013","journal-title":"Soft Matter"},{"key":"B262","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3945\/ajcn.115.107896","article-title":"Maternal anemia and risk of adverse birth and health outcomes in low- and middle-income countries: systematic review and meta-analysis","volume":"103","author":"Rahman","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"B263","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0265-928X(85)85005-7","article-title":"The estimation of microbial biomass","volume":"1","author":"Harris","year":"1985","journal-title":"Biosensors"},{"key":"B264","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0966-842X(96)10035-4","article-title":"Do bacteria need to communicate with each other for growth?","volume":"4","author":"Kaprelyants","year":"1996","journal-title":"Trends Microbiol"},{"key":"B265","first-page":"19","article-title":"Electron dense cytoplasmic particles and chronic infection \u2013 a bacterial pleomorphy hypothesis","volume":"11","author":"Domingue","year":"1995","journal-title":"Endocytobiosis Cell Res"},{"key":"B266","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00042307-199801000-00009","article-title":"Cryptic bacterial infection in chronic prostatitis: diagnostic and therapeutic implications","volume":"8","author":"Domingue","year":"1998","journal-title":"Curr Opin Urol"},{"key":"B267","volume-title":"Cell Wall Deficient Forms: Stealth Pathogens","author":"Mattman","year":"2001","edition":"3rd ed"},{"key":"B268","first-page":"234","article-title":"Demystifying pleomorphic forms in persistence and expression of disease: are they bacteria, and is peptidoglycan the solution?","volume":"10","author":"Domingue","year":"2010","journal-title":"Discov Med"},{"key":"B269","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1128\/MMBR.60.4.641-696.1996","article-title":"Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analysis","volume":"60","author":"Davey","year":"1996","journal-title":"Microbiol Rev"},{"key":"B270","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2672.1992.tb01854.x","article-title":"Rapid assessment of bacterial viability and vitality using rhodamine 123 and flow cytometry","volume":"72","author":"Kaprelyants","year":"1992","journal-title":"J Appl Bacteriol"},{"key":"B271","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1099\/00222615-39-2-147","article-title":"The application of flow cytometry to the study of bacterial responses to antibiotics","volume":"39","author":"Gant","year":"1993","journal-title":"J Med Microbiol"},{"key":"B272","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/AEM.64.7.2681-2685.1998","article-title":"A fluorescent Gram stain for flow cytometry and epifluorescence microscopy","volume":"64","author":"Mason","year":"1998","journal-title":"Appl Environ Microbiol"},{"key":"B273","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0167-7012(00)00181-0","article-title":"Analysis of bacterial function by multi-colour fluorescence flow cytometry and single cell sorting","volume":"42","author":"Nebe-Von-Caron","year":"2000","journal-title":"J Microbiol Methods"},{"key":"B274","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1385\/1-59259-773-4:033","article-title":"Multiparameter flow cytometry of bacteria","volume":"263","author":"Shapiro","year":"2004","journal-title":"Methods Mol Biol"},{"key":"B275","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1574-6976.2010.00214.x","article-title":"Functional single-cell analyses: flow cytometry and cell sorting of microbial populations and communities","volume":"34","author":"M\u00fcller","year":"2010","journal-title":"FEMS Microbiol Rev"},{"key":"B276","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1128\/AEM.00744-11","article-title":"Life, death, and in-between: meanings and methods in microbiology","volume":"77","author":"Davey","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"B277","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1462-2920.2010.02317.x","article-title":"Red but not dead? Membranes of stressed Saccharomyces cerevisiae are permeable to propidium iodide","volume":"13","author":"Davey","year":"2011","journal-title":"Environ Microbiol"},{"key":"B278","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0165-9936(90)87042-K","article-title":"Real-time monitoring of cellular biomass: methods and applications","volume":"9","author":"Kell","year":"1990","journal-title":"Trends Anal Chem"},{"key":"B279","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0167-7799(00)89006-X","article-title":"GMP \u2013 good modelling practice: an essential component of good manufacturing practice","volume":"13","author":"Kell","year":"1995","journal-title":"Trends Biotechnol"},{"key":"B280","volume-title":"Impedance Microbiology","author":"Firstenberg-Eden","year":"1984"},{"key":"B281","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0141-0229(87)90075-5","article-title":"The dielectric permittivity of microbial suspensions at radio frequencies: a novel method for the estimation of microbial biomass","volume":"9","author":"Harris","year":"1987","journal-title":"Enzyme Microbiol Technol"},{"key":"B282","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oso\/9780199630462.003.0005","article-title":"Conductimetric and impedimetric devices","volume-title":"Biosensors: A Practical Approach","author":"Kell","year":"1990"},{"key":"B283","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1073\/pnas.74.11.5088","article-title":"Phylogenetic structure of the prokaryotic domain: the primary kingdoms","volume":"74","author":"Woese","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B284","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1086\/512818","article-title":"Detection and identification of microorganisms by gene amplification and sequencing","volume":"44","author":"Petti","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B285","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1515\/CCLM.2008.157","article-title":"Rapid methods for diagnosis of bloodstream infections","volume":"46","author":"Klouche","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"B286","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1469-0691.2008.02070.x","article-title":"Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories","volume":"14","author":"Woo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"B287","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.mimet.2009.09.014","article-title":"Development and validation of a modified broad-range 16S rDNA PCR for diagnostic purposes in clinical microbiology","volume":"79","author":"Cherkaoui","year":"2009","journal-title":"J Microbiol Methods"},{"issue":"Suppl 1","key":"B288","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1073\/pnas.1000080107","article-title":"Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample","volume":"108","author":"Caporaso","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B289","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1128\/JCM.01018-11","article-title":"Novel sensitive real-time PCR for quantification of bacterial 16S rRNA genes in plasma of HIV-infected patients as a marker for microbial translocation","volume":"49","author":"Kramski","year":"2011","journal-title":"J Clin Microbiol"},{"key":"B290","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10482-011-9660-4","article-title":"Systematics of prokaryotes: the state of the art","volume":"101","author":"K\u00e4mpfer","year":"2012","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B291","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000334655","article-title":"Diagnosis of neonatal sepsis by broad-range 16S real-time polymerase chain reaction","volume":"101","author":"Ohlin","year":"2012","journal-title":"Neonatology"},{"key":"B292","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","article-title":"Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences","volume":"31","author":"Langille","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B293","doi-asserted-by":"publisher","first-page":"e53608","DOI":"10.1371\/journal.pone.0053608","article-title":"Taxonomic classification of bacterial 16S rRNA genes using short sequencing reads: evaluation of effective study designs","volume":"8","author":"Mizrahi-Man","year":"2013","journal-title":"PLoS One"},{"key":"B294","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2217\/fmb.14.8","article-title":"Nonculture techniques for the detection of bacteremia and fungemia","volume":"9","author":"Valencia-Shelton","year":"2014","journal-title":"Future Microbiol"},{"key":"B295","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrmicro3330","article-title":"Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences","volume":"12","author":"Yarza","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"B296","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S1473-3099(14)70827-8","article-title":"Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections \u2013 needs, advances, and future prospects","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B297","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12864-015-2194-9","article-title":"A comprehensive benchmarking study of protocols and sequencing platforms for 16S rRNA community profiling","volume":"17","author":"D\u2019Amore","year":"2016","journal-title":"BMC Genomics"},{"key":"B298","doi-asserted-by":"crossref","DOI":"10.1128\/9781555816728","volume-title":"Manual of Clinical Microbiology","author":"Versalovic","year":"2011","edition":"10th ed"},{"key":"B299","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1128\/JCM.39.5.1956-1959.2001","article-title":"Does blood of healthy subjects contain bacterial ribosomal DNA?","volume":"39","author":"Nikkari","year":"2001","journal-title":"J Clin Microbiol"},{"key":"B300","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1128\/JCM.40.12.4771-4775.2002","article-title":"Are there naturally occurring pleomorphic bacteria in the blood of healthy humans?","volume":"40","author":"McLaughlin","year":"2002","journal-title":"J Clin Microbiol"},{"key":"B301","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1348-0421.2008.00048.x","article-title":"Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood","volume":"52","author":"Moriyama","year":"2008","journal-title":"Microbiol Immunol"},{"key":"B302","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1007\/s00125-011-2329-8","article-title":"Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept","volume":"54","author":"Amar","year":"2011","journal-title":"Diabetologia"},{"key":"B303","doi-asserted-by":"publisher","first-page":"264651","DOI":"10.1155\/2013\/264651","article-title":"Development of a broad-range 23S rDNA real-time PCR assay for the detection and quantification of pathogenic bacteria in human whole blood and plasma specimens","volume":"2013","author":"Gaibani","year":"2013","journal-title":"Biomed Res Int"},{"key":"B304","doi-asserted-by":"publisher","first-page":"e105221","DOI":"10.1371\/journal.pone.0105221","article-title":"Elevated levels of circulating DNA in cardiovascular disease patients: metagenomic profiling of microbiome in the circulation","volume":"9","author":"Dinakaran","year":"2014","journal-title":"PLoS One"},{"key":"B305","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.2337\/dc13-2817","article-title":"Gut dysbiosis and detection of \u201clive gut bacteria\u201d in blood of Japanese patients with type 2 diabetes","volume":"37","author":"Sato","year":"2014","journal-title":"Diabetes Care"},{"key":"B306","doi-asserted-by":"publisher","first-page":"e0120826","DOI":"10.1371\/journal.pone.0120826","article-title":"Viable bacteria associated with red blood cells and plasma in freshly drawn blood donations","volume":"10","author":"Damgaard","year":"2015","journal-title":"PLoS One"},{"key":"B307","doi-asserted-by":"publisher","first-page":"e0135756","DOI":"10.1371\/journal.pone.0135756","article-title":"Bacterial landscape of bloodstream infections in neutropenic patients via high throughput sequencing","volume":"10","author":"Gyarmati","year":"2015","journal-title":"PLoS One"},{"key":"B308","doi-asserted-by":"publisher","first-page":"23532","DOI":"10.1038\/srep23532","article-title":"Metagenomic analysis of bloodstream infections in patients with acute leukemia and therapy-induced neutropenia","volume":"6","author":"Gyarmati","year":"2016","journal-title":"Sci Rep"},{"key":"B309","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/trf.13477","article-title":"Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing","volume":"56","author":"Pa\u00efss\u00e9","year":"2016","journal-title":"Transfusion"},{"key":"B310","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1128\/IAI.15.2.621-627.1977","article-title":"Novel bacterial structures in human blood: cultural isolation","volume":"15","author":"Domingue","year":"1977","journal-title":"Infect Immun"},{"key":"B311","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1128\/IAI.01036-10","article-title":"The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes","volume":"79","author":"Belstr\u00f8m","year":"2011","journal-title":"Infect Immun"},{"key":"B312","volume-title":"Focal Infection","author":"Billings","year":"1915"},{"key":"B313","volume-title":"Dental Infections Oral and Systemic, Being a Contribution to the Pathology of Dental Infections, Focal Infections and the Degenerative Diseases, Parts I and II","author":"Price","year":"1923"},{"key":"B314","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neurobiolaging.2005.01.018","article-title":"Beta-amyloid deposition and Alzheimer\u2019s type changes induced by Borrelia spirochetes","volume":"27","author":"Miklossy","year":"2006","journal-title":"Neurobiol Aging"},{"key":"B315","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3233\/JAD-2008-13404","article-title":"Chronic inflammation and amyloidogenesis in Alzheimer\u2019s disease \u2013 role of spirochetes","volume":"13","author":"Miklossy","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"B316","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12026-008-8021-5","article-title":"Outsmarting the host: bacteria modulating the immune response","volume":"41","author":"Woolard","year":"2008","journal-title":"Immunol Res"},{"key":"B317","first-page":"20","article-title":"Role of chronic bacterial and viral infections in neurodegenerative, neurobehavioural, psychiatric, autoimmune and fatiguing illnesses: part 1","volume":"2","author":"Nicolson","year":"2009","journal-title":"Br J Med Pract"},{"key":"B318","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.autrev.2009.02.016","article-title":"Autoimmune disease in the era of the metagenome","volume":"8","author":"Proal","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B319","first-page":"301","article-title":"Role of chronic bacterial and viral infections in neurodegenerative, neurobehavioural, psychiatric, autoimmune and fatiguing illnesses: part 2","volume":"3","author":"Nicolson","year":"2010","journal-title":"Br J Med Pract"},{"key":"B320","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-2094-8-90","article-title":"Alzheimer\u2019s disease \u2013 a neurospirochetosis. Analysis of the evidence following Koch\u2019s and Hill\u2019s criteria","volume":"8","author":"Miklossy","year":"2011","journal-title":"J Neuroinflammation"},{"key":"B321","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/cmi.2010.77","article-title":"Immunostimulation in the era of the metagenome","volume":"8","author":"Proal","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"B322","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1128\/CMR.18.1.195-204.2005","article-title":"Bacterial contamination of blood components","volume":"18","author":"Brecher","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"B323","volume-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"2006","edition":"4th ed"},{"key":"B324","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.1070633","article-title":"Isolating \u201cuncultivable\u201d microorganisms in pure culture in a simulated natural environment","volume":"296","author":"Kaeberlein","year":"2002","journal-title":"Science"},{"key":"B325","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1128\/AEM.01309-07","article-title":"Incubation of environmental samples in a diffusion chamber increases the diversity of recovered isolates","volume":"73","author":"Bollmann","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"B326","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.chembiol.2010.02.010","article-title":"Siderophores from neighboring organisms promote the growth of uncultured bacteria","volume":"17","author":"D\u2019Onofrio","year":"2010","journal-title":"Chem Biol"},{"key":"B327","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ja.2010.87","article-title":"Uncultured microorganisms as a source of secondary metabolites","volume":"63","author":"Lewis","year":"2010","journal-title":"J Antibiot (Tokyo)"},{"key":"B328","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","volume":"517","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"B329","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/omi.12070","article-title":"The role of adipokines in periodontal infection and healing","volume":"29","author":"Deschner","year":"2014","journal-title":"Mol Oral Microbiol"},{"key":"B330","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1054\/mehy.2001.1378","article-title":"Is infection a major risk factor for preeclampsia?","volume":"57","author":"Herrera","year":"2001","journal-title":"Med Hypotheses"},{"key":"B331","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1590\/S0100-879X2001001000001","article-title":"Preeclampsia: from epidemiological observations to molecular mechanisms","volume":"34","author":"L\u00f3pez-Jaramillo","year":"2001","journal-title":"Braz J Med Biol Res"},{"key":"B332","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1034\/j.1600-0412.2002.810710.x","article-title":"Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?","volume":"81","author":"Von Dadelszen","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B333","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s102380200021","article-title":"Helicobacter pylori: 20 years on","volume":"2","author":"Marshall","year":"2002","journal-title":"Clin Med"},{"key":"B334","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1532\/IJH97.06180","article-title":"Overview: Helicobacter pylori and extragastric disease","volume":"84","author":"Suzuki","year":"2006","journal-title":"Int J Hematol"},{"key":"B335","first-page":"575","article-title":"Extragastric manifestations of Helicobacter pylori infection","volume":"111","author":"Prelipcean","year":"2007","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"Suppl 1","key":"B336","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1523-5378.2009.00699.x","article-title":"Helicobacters and extragastric diseases","volume":"14","author":"Pellicano","year":"2009","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"B337","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1523-5378.2010.00778.x","article-title":"Extragastric manifestations of Helicobacter pylori infection","volume":"15","author":"Figura","year":"2010","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"B338","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1523-5378.2012.00983.x","article-title":"Extragastric manifestations of Helicobacter pylori infection","volume":"17","author":"Bani\u0107","year":"2012","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"B339","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/hel.12077","article-title":"Extragastric diseases and Helicobacter pylori","volume":"18","author":"Roubaud Baudron","year":"2013","journal-title":"Helicobacter"},{"issue":"Suppl 1","key":"B340","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/hel.12159","article-title":"Helicobacter pylori and extragastric diseases","volume":"19","author":"Franceschi","year":"2014","journal-title":"Helicobacter"},{"key":"B341","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrgastro.2013.243","article-title":"Clinical effects of Helicobacter pylori outside the stomach","volume":"11","author":"Franceschi","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B342","doi-asserted-by":"publisher","first-page":"12781","DOI":"10.3748\/wjg.v20.i36.12781","article-title":"Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment","volume":"20","author":"Testerman","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B343","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1097\/HJH.0b013e3280109e8c","article-title":"Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy","volume":"24","author":"Ponzetto","year":"2006","journal-title":"J Hypertens"},{"key":"B344","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1523-5378.2012.00966.x","article-title":"Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia?","volume":"17","author":"Franceschi","year":"2012","journal-title":"Helicobacter"},{"key":"B345","doi-asserted-by":"publisher","first-page":"18346","DOI":"10.1038\/srep18346","article-title":"Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA","volume":"6","author":"Shimoda","year":"2016","journal-title":"Sci Rep"},{"key":"B346","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000354200","article-title":"Cytokines as key players in the pathophysiology of preeclampsia","volume":"22","author":"Raghupathy","year":"2013","journal-title":"Med Princ Pract"},{"key":"B347","doi-asserted-by":"publisher","first-page":"767694","DOI":"10.1155\/2012\/767694","article-title":"Extracellular vesicles and their convergence with viral pathways","volume":"2012","author":"Wurdinger","year":"2012","journal-title":"Adv Virol"},{"key":"B348","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/MMBR.00063-15","article-title":"Extracellular vesicles exploit viral entry routes for cargo delivery","volume":"80","author":"van Dongen","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"B349","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3109\/10641950903242642","article-title":"Chlamydia pneumoniae infection in preeclampsia","volume":"29","author":"Xie","year":"2010","journal-title":"Hypertens Pregnancy"},{"key":"B350","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0029-7844(02)02591-7","article-title":"Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia","volume":"101","author":"Heine","year":"2003","journal-title":"Obstet Gynecol"},{"key":"B351","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijgo.2010.11.014","article-title":"Impact of seroconversion and antichlamydial treatment on the rate of pre-eclampsia among Egyptian primigravidae","volume":"113","author":"El-Shourbagy","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"B352","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.preghy.2013.03.002","article-title":"Prenatal Chlamydia trachomatis infection increases the risk of preeclampsia","volume":"3","author":"Haggerty","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"B353","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.preghy.2012.09.002","article-title":"Chlamydia trachomatis infection may increase the risk of preeclampsia","volume":"3","author":"Haggerty","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"B354","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3109\/00016349.2010.499449","article-title":"An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis","volume":"89","author":"Xie","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B355","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/aji.12199","article-title":"CMV infection, TLR-2 and -4 expression, and cytokine profiles in early-onset preeclampsia with HELLP syndrome","volume":"71","author":"Xie","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B356","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1097\/HJH.0b013e3280113638","article-title":"Pre-eclampsia associated with Helicobacter pylori seropositivity","volume":"24","author":"Panarelli","year":"2006","journal-title":"J Hypertens"},{"key":"B357","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3109\/14767058.2015.1056146","article-title":"Helicobacter pylori, Chlamydiae pneumoniae and trachomatis as probable etiological agents of preeclampsia","volume":"29","author":"Mosbah","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B358","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2014.00484","article-title":"Insights into the role of Helicobacter pylori infection in preeclampsia: from the bench to the bedside","volume":"5","author":"Tersigni","year":"2014","journal-title":"Front Immunol"},{"key":"B359","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3109\/14767050903121456","article-title":"Association of Helicobacter pylori infection with systemic inflammation in preeclampsia","volume":"23","author":"\u00dcst\u00fcn","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B360","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/jcla.20330","article-title":"Helicobacter pylori seropositivity and its relationship with serum malondialdehyde and lipid profile in preeclampsia","volume":"23","author":"Aksoy","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"B361","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3748\/wjg.v20.i3.654","article-title":"Helicobacter pylori and pregnancy-related disorders","volume":"20","author":"Cardaropoli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B362","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/cbf.1503","article-title":"Interleukin-18 and gestosis: correlation with Helicobacter pylori seropositivity","volume":"26","author":"Pugliese","year":"2008","journal-title":"Cell Biochem Funct"},{"key":"B363","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jri.2015.02.004","article-title":"Helicobacter pylori seropositivity and pregnancy-related diseases: a prospective cohort study","volume":"109","author":"Cardaropoli","year":"2015","journal-title":"J Reprod Immunol"},{"key":"B364","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.3748\/wjg.v17.i47.5156","article-title":"Helicobacter pylori\u2019s virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation","volume":"17","author":"Cardaropoli","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"138","key":"B365","doi-asserted-by":"publisher","first-page":"138.e1","DOI":"10.1016\/j.ajog.2013.09.040","article-title":"High risk human papillomavirus at entry to prenatal care and risk of preeclampsia","volume":"210","author":"McDonnold","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B366","first-page":"529","article-title":"Frequency of asymptomatic bacteriuria in preeclampsia","volume":"67","author":"Hill","year":"1986","journal-title":"Obstet Gynecol"},{"key":"B367","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0020-7292(95)02373-K","article-title":"Urogenital infection in preeclampsia","volume":"49","author":"Hsu","year":"1995","journal-title":"Int J Gynaecol Obstet"},{"key":"B368","first-page":"491","article-title":"Preeclampsia. A nested, case-control study of risk factors and their interactions","volume":"41","author":"Mittendorf","year":"1996","journal-title":"J Reprod Med"},{"key":"B369","doi-asserted-by":"publisher","first-page":"387.e1","DOI":"10.1016\/j.ajog.2015.09.101","article-title":"Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia","volume":"214","author":"Easter","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"B370","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/14767050802488246","article-title":"Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?","volume":"22","author":"Mazor-Dray","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B371","doi-asserted-by":"publisher","first-page":"e73047","DOI":"10.1371\/journal.pone.0073047","article-title":"Acute maternal infection and risk of pre-eclampsia: a population-based case-control study","volume":"8","author":"Minassian","year":"2013","journal-title":"PLoS One"},{"key":"B372","doi-asserted-by":"publisher","first-page":"235","DOI":"10.5539\/gjhs.v8n7p235","article-title":"Association between asymptomatic bacteriuria and pre-eclampsia","volume":"8","author":"Rezavand","year":"2016","journal-title":"Glob J Health Sci"},{"key":"B373","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00404-008-0643-2","article-title":"The relationship between urinary tract infection during pregnancy and preeclampsia: causal, confounded or spurious?","volume":"277","author":"Karmon","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"B374","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ajog.2005.10.813","article-title":"Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?","volume":"194","author":"Villar","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"B375","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/00365540601087566","article-title":"Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments","volume":"39","author":"B\u00e1nhidy","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"B376","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/MJT.0b013e318164c149","article-title":"Subclinical infection as a cause of inflammation in preeclampsia","volume":"15","author":"L\u00f3pez-Jaramillo","year":"2008","journal-title":"Am J Ther"},{"key":"B377","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1902\/jop.2013.134009","article-title":"Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes \u2013 systematic review","volume":"84","author":"Ide","year":"2013","journal-title":"J Periodontol"},{"key":"B378","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/ANC.0000000000000218","article-title":"Maternal microbiome and pregnancy outcomes that impact infant health: a review","volume":"15","author":"Dunlop","year":"2015","journal-title":"Adv Neonatal Care"},{"key":"B379","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.healthplace.2014.12.003","article-title":"Association of anemia, pre-eclampsia and eclampsia with seasonality: a realist systematic review","volume":"31","author":"Hlimi","year":"2015","journal-title":"Health Place"},{"key":"B380","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2004.09.006","article-title":"Placental malaria and pre-eclampsia through the looking glass backwards?","volume":"65","author":"Brabin","year":"2005","journal-title":"J Reprod Immunol"},{"key":"B381","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4269\/ajtmh.2004.70.510","article-title":"Seasonal variation in the risk and causes of maternal death in the Gambia: malaria appears to be an important factor","volume":"70","author":"Anya","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"B382","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(96)90321-9","article-title":"Malaria associated pre-eclampsia in Senegal","volume":"347","author":"Sartelet","year":"1996","journal-title":"Lancet"},{"key":"B383","first-page":"262","article-title":"Infection in the pathogenesis of preterm labor","volume":"12","author":"Romero","year":"1988","journal-title":"Semin Perinatol"},{"key":"B384","first-page":"723","article-title":"The role of infection in the etiology of preterm birth","volume":"71","author":"Toth","year":"1988","journal-title":"Obstet Gynecol"},{"key":"B385","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1128\/CMR.6.1.69","article-title":"Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns","volume":"6","author":"Cassell","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"B386","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0002-9378(94)70098-2","article-title":"Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream","volume":"170","author":"McGregor","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"B387","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJM200005183422007","article-title":"Intrauterine infection and preterm delivery","volume":"342","author":"Goldenberg","year":"2000","journal-title":"N Engl J Med"},{"key":"B388","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mrdd.10008","article-title":"Intrauterine infection and prematurity","volume":"8","author":"Gon\u00e7alves","year":"2002","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"B389","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1086\/368205","article-title":"Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery","volume":"187","author":"Gerber","year":"2003","journal-title":"J Infect Dis"},{"key":"B390","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1055\/s-2004-831884","article-title":"Identification and sequencing of bacterial rDNAs in culture-negative amniotic fluid from women in premature labor","volume":"21","author":"Gardella","year":"2004","journal-title":"Am J Perinatol"},{"key":"B391","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ajog.2005.11.050","article-title":"Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery","volume":"194","author":"Espinoza","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"B392","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"B393","first-page":"252","article-title":"A practical approach to the prevention of miscarriage. Part 4 \u2013 role of infection","volume":"37","author":"Check","year":"2010","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B394","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clp.2011.06.003","article-title":"The role of inflammation and infection in preterm birth","volume":"38","author":"Bastek","year":"2011","journal-title":"Clin Perinatol"},{"key":"B395","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/OLQ.0b013e3181f2e85f","article-title":"Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics","volume":"38","author":"Johnson","year":"2011","journal-title":"Sex Transm Dis"},{"key":"B396","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10654-011-9586-1","article-title":"Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study","volume":"26","author":"Rours","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"B397","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-394381-1.00001-5","article-title":"The bacterial etiology of preterm birth","volume":"80","author":"Jefferson","year":"2012","journal-title":"Adv Appl Microbiol"},{"key":"B398","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/14767058.2011.579208","article-title":"Histological chorioamnionitis \u2013 implication for bacterial colonization, laboratory markers of infection, and early onset sepsis in very-low-birth-weight neonates","volume":"25","author":"Lee","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B399","doi-asserted-by":"publisher","first-page":"157159","DOI":"10.1155\/2012\/157159","article-title":"Antimicrobials for preterm birth prevention: an overview","volume":"2012","author":"Subramaniam","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"B400","doi-asserted-by":"publisher","first-page":"237ra265","DOI":"10.1126\/scitranslmed.3008599","article-title":"The placenta harbors a unique microbiome","volume":"6","author":"Aagaard","year":"2014","journal-title":"Sci Transl Med"},{"key":"B401","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1517\/14656566.2014.950225","article-title":"The early use of appropriate prophylactic antibiotics in susceptible women for the prevention of preterm birth of infectious etiology","volume":"15","author":"Joergensen","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"B402","doi-asserted-by":"publisher","first-page":"779.e1","DOI":"10.1016\/j.ajog.2015.01.032","article-title":"Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection","volume":"212","author":"Allen-Daniels","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B403","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/aji.12326","article-title":"Microorganisms in the female genital tract during pregnancy: tolerance versus pathogenesis","volume":"73","author":"de Andrade Ramos","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"B404","doi-asserted-by":"publisher","first-page":"e0126884","DOI":"10.1371\/journal.pone.0126884","article-title":"Cervical microbiota in women with preterm prelabor rupture of membranes","volume":"10","author":"Kacerovsky","year":"2015","journal-title":"PLoS One"},{"key":"B405","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fimmu.2015.00566","article-title":"Advances in the prevention of infection-related preterm birth","volume":"6","author":"Lamont","year":"2015","journal-title":"Front Immunol"},{"key":"B406","doi-asserted-by":"publisher","first-page":"e0129032","DOI":"10.1371\/journal.pone.0129032","article-title":"Eukaryote-made thermostable DNA polymerase enables rapid PCR-based detection of mycoplasma, ureaplasma and other bacteria in the amniotic fluid of preterm labor cases","volume":"10","author":"Ueno","year":"2015","journal-title":"PLoS One"},{"key":"B407","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.siny.2015.12.011","article-title":"The epidemiology, etiology, and costs of preterm birth","volume":"21","author":"Frey","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"B408","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.siny.2015.12.008","article-title":"Infection and preterm birth","volume":"21","author":"Nadeau","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"B409","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.siny.2016.02.004","article-title":"Maternal microbiome \u2013 a pathway to preterm birth","volume":"21","author":"Vinturache","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"B410","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/aji.12484","article-title":"Antibiotic therapy increases the risk of preterm birth in preterm labor without intra-amniotic microbes, but may prolong the gestation period in preterm labor with microbes, evaluated by rapid and high-sensitive PCR system","volume":"75","author":"Yoneda","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B411","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3109\/01443615.2013.842963","article-title":"Infection and antibiotics in the aetiology, prediction and prevention of preterm birth","volume":"33","author":"Oliver","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"B412","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1177\/1933719113503415","article-title":"Proteomic biomarkers for spontaneous preterm birth: a systematic review of the literature","volume":"21","author":"Kacerovsky","year":"2014","journal-title":"Reprod Sci"},{"key":"B413","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.siny.2009.02.003","article-title":"Infection and stillbirth","volume":"14","author":"McClure","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"issue":"Suppl 1","key":"B414","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1471-2393-9-S1-S4","article-title":"Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy","volume":"9","author":"Menezes","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"B415","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3109\/14767058.2010.547963","article-title":"Role of the infections in recurrent spontaneous abortion","volume":"24","author":"Nigro","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B416","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/humupd\/dmv041","article-title":"The role of infection in miscarriage","volume":"22","author":"Giakoumelou","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B417","first-page":"243","article-title":"Outcome of subsequent pregnancies following antibiotic therapy after primary or multiple spontaneous abortions","volume":"163","author":"Toth","year":"1986","journal-title":"Surg Gynecol Obstet"},{"key":"B418","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40168-016-0172-3","article-title":"Comparison of placenta samples with contamination controls does not provide evidence for a distinct placenta microbiota","volume":"4","author":"Lauder","year":"2016","journal-title":"Microbiome"},{"issue":"110","key":"B419","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.ajog.2007.05.044","article-title":"Detection of bacteria in placental tissues obtained from extremely low gestational age neonates","volume":"198","author":"Onderdonk","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B420","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1472-765X.2008.02475.x","article-title":"Bifidobacterium and Lactobacillus DNA in the human placenta","volume":"48","author":"Satokari","year":"2009","journal-title":"Lett Appl Microbiol"},{"issue":"226","key":"B421","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.ajog.2013.01.018","article-title":"Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations","volume":"208","author":"Stout","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"B422","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.placenta.2013.12.007","article-title":"Intracellular bacteria in placental basal plate localize to extravillous trophoblasts","volume":"35","author":"Cao","year":"2014","journal-title":"Placenta"},{"key":"B423","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1542\/neo.15-12-e537","article-title":"Placental microbiome and its role in preterm birth","volume":"15","author":"Cao","year":"2014","journal-title":"Neoreviews"},{"key":"B424","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.placenta.2014.10.007","article-title":"Term and preterm labour are associated with distinct microbial community structures in placental membranes which are independent of mode of delivery","volume":"35","author":"Doyle","year":"2014","journal-title":"Placenta"},{"key":"B425","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1055\/s-0033-1361830","article-title":"Microbiome in parturition and preterm birth","volume":"32","author":"Mysorekar","year":"2014","journal-title":"Semin Reprod Med"},{"key":"B426","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/pr.2014.165","article-title":"Gut microbiota and allergy: the importance of the pregnancy period","volume":"77","author":"Abrahamsson","year":"2015","journal-title":"Pediatr Res"},{"key":"B427","doi-asserted-by":"publisher","first-page":"653.e651","DOI":"10.1016\/j.ajog.2014.12.041","article-title":"The preterm placental microbiome varies in association with excess maternal gestational weight gain","volume":"212","author":"Antony","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B428","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000441518","article-title":"Correlation between clinical, placental histology and microbiological findings in spontaneous preterm births","volume":"40","author":"Garmi","year":"2015","journal-title":"Fetal Diagn Ther"},{"key":"B429","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.3390\/nu7085315","article-title":"The placental microbiome varies in association with low birth weight in full-term neonates","volume":"7","author":"Zheng","year":"2015","journal-title":"Nutrients"},{"key":"B430","doi-asserted-by":"publisher","first-page":"23129","DOI":"10.1038\/srep23129","article-title":"Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid","volume":"6","author":"Collado","year":"2016","journal-title":"Sci Rep"},{"key":"B431","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12916-016-0636-0","article-title":"Antibiotic use during pregnancy: how bad is it?","volume":"14","author":"Kuperman","year":"2016","journal-title":"BMC Med"},{"key":"B432","doi-asserted-by":"publisher","first-page":"627.e1","DOI":"10.1016\/j.ajog.2016.01.193","article-title":"The placental microbiome is altered among subjects with spontaneous preterm birth with and without chorioamnionitis","volume":"214","author":"Prince","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"B433","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/humupd\/5.4.373","article-title":"Hypothesis on the role of sub-clinical bacteria of the endometrium (bacteria endometrialis) in gynaecological and obstetric enigmas","volume":"5","author":"Viniker","year":"1999","journal-title":"Hum Reprod Update"},{"key":"B434","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/j.1471-0528.2006.01087.x","article-title":"Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections","volume":"113","author":"Svare","year":"2006","journal-title":"BJOG"},{"issue":"Suppl 1","key":"B435","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0897.2011.01034.x","article-title":"Innate immunity in the human endometrium and ovary","volume":"66","author":"Sheldon","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"B436","doi-asserted-by":"publisher","first-page":"e36466","DOI":"10.1371\/journal.pone.0036466","article-title":"A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy","volume":"7","author":"Aagaard","year":"2012","journal-title":"PLoS One"},{"key":"B437","doi-asserted-by":"publisher","first-page":"e98514","DOI":"10.1371\/journal.pone.0098514","article-title":"Pregnancy\u2019s stronghold on the vaginal microbiome","volume":"9","author":"Walther-Ant\u00f3nio","year":"2014","journal-title":"PLoS One"},{"key":"B438","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00248-014-0487-1","article-title":"Homogeneity of the vaginal microbiome at the cervix, posterior fornix, and vaginal canal in pregnant Chinese women","volume":"69","author":"Huang","year":"2015","journal-title":"Microb Ecol"},{"key":"B439","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/1471-0528.13115","article-title":"The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth","author":"Witkin","year":"2015","journal-title":"BJOG"},{"key":"B440","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.anaerobe.2016.09.001","article-title":"The role of the bacterial microbiota on reproductive and pregnancy health","volume":"42","author":"Nelson","year":"2016","journal-title":"Anaerobe"},{"key":"B441","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fimmu.2014.00595","article-title":"Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome","volume":"5","author":"Payne","year":"2014","journal-title":"Front Immunol"},{"key":"B442","doi-asserted-by":"publisher","first-page":"e1602","DOI":"10.7717\/peerj.1602","article-title":"Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene","volume":"4","author":"Verstraelen","year":"2016","journal-title":"PeerJ"},{"key":"B443","first-page":"175","article-title":"A microbiologic and clinical study of placental inflammation at term","volume":"70","author":"Dong","year":"1987","journal-title":"Obstet Gynecol"},{"key":"B444","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1471-0528.2002.01349.x","article-title":"Possible association between amniotic fluid micro-organism infection and microflora in the mouth","volume":"109","author":"Bearfield","year":"2002","journal-title":"BJOG"},{"key":"B445","doi-asserted-by":"publisher","first-page":"125.e1","DOI":"10.1016\/j.ajog.2013.11.032","article-title":"Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes","volume":"210","author":"Combs","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B446","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/lam.12334","article-title":"Is a foetus developing in a sterile environment?","volume":"59","author":"Wassenaar","year":"2014","journal-title":"Lett Appl Microbiol"},{"key":"B447","doi-asserted-by":"publisher","first-page":"482.e481","DOI":"10.1016\/j.ajog.2015.02.007","article-title":"Detection of microbial invasion of the amniotic cavity by analysis of cervicovaginal proteins in women with preterm labor and intact membranes","volume":"212","author":"Combs","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B448","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/bdrc.21117","article-title":"Microbial programming of health and disease starts during fetal life","volume":"105","author":"Koleva","year":"2015","journal-title":"Birth Defects Res C Embryo Today"},{"key":"B449","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/humrep\/der108","article-title":"Microbial colonization of follicular fluid: alterations in cytokine expression and adverse assisted reproduction technology outcomes","volume":"26","author":"Pelzer","year":"2011","journal-title":"Hum Reprod"},{"key":"B450","doi-asserted-by":"publisher","first-page":"e59062","DOI":"10.1371\/journal.pone.0059062","article-title":"Microorganisms within human follicular fluid: effects on IVF","volume":"8","author":"Pelzer","year":"2013","journal-title":"PLoS One"},{"key":"B451","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1902\/jop.2007.060362","article-title":"Evidence of periopathogenic microorganisms in placentas of women with preeclampsia","volume":"78","author":"Barak","year":"2007","journal-title":"J Periodontol"},{"key":"B452","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1086\/422330","article-title":"Viral and bacterial pathogens at the maternal-fetal interface","volume":"190","author":"McDonagh","year":"2004","journal-title":"J Infect Dis"},{"key":"B453","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/jog.12619","article-title":"Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia","volume":"41","author":"Amarasekara","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"B454","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1371\/journal.pmed.0030446","article-title":"Hypertension and maternal-fetal conflict during placental malaria","volume":"3","author":"Muehlenbachs","year":"2006","journal-title":"PLoS Med"},{"key":"B455","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1017\/S0031182007000170","article-title":"Plasmodium in the placenta: parasites, parity, protection, prevention and possibly preeclampsia","volume":"134","author":"Duffy","year":"2007","journal-title":"Parasitology"},{"key":"B456","doi-asserted-by":"publisher","first-page":"e0146157","DOI":"10.1371\/journal.pone.0146157","article-title":"Porphyromonas gingivalis within placental villous mesenchyme and umbilical cord stroma is associated with adverse pregnancy outcome","volume":"11","author":"Vanterpool","year":"2016","journal-title":"PLoS One"},{"key":"B457","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/jre.12074","article-title":"Porphyromonas gingivalis, Treponema denticola and toll-like receptor 2 are associated with hypertensive disorders in placental tissue: a case-control study","volume":"48","author":"Chaparro","year":"2013","journal-title":"J Periodontal Res"},{"key":"B458","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.autrev.2009.10.006","article-title":"Rheumatoid arthritis, proteus, anti-CCP antibodies and Karl Popper","volume":"9","author":"Ebringer","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B459","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-85729-950-5","volume-title":"Rheumatoid Arthritis and Proteus","author":"Ebringer","year":"2012"},{"key":"B460","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/apm.12154","article-title":"Rheumatoid arthritis is caused by a Proteus urinary tract infection","volume":"122","author":"Ebringer","year":"2014","journal-title":"APMIS"},{"key":"B461","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.cell.2016.04.007","article-title":"Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans","volume":"165","author":"Vatanen","year":"2016","journal-title":"Cell"},{"key":"B462","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0016-5085(03)01057-6","article-title":"Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice","volume":"125","author":"Ferrier","year":"2003","journal-title":"Gastroenterology"},{"key":"B463","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-020711-074937","article-title":"The microbiome in infectious disease and inflammation","volume":"30","author":"Honda","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B464","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.tim.2012.09.001","article-title":"Microbial translocation, immune activation, and HIV disease","volume":"21","author":"Klatt","year":"2013","journal-title":"Trends Microbiol"},{"key":"B465","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/ajcn\/87.5.1219","article-title":"Energy intake is associated with endotoxemia in apparently healthy men","volume":"87","author":"Amar","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"B466","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2337\/dc10-2197","article-title":"Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation","volume":"34","author":"Lassenius","year":"2011","journal-title":"Diabetes Care"},{"key":"B467","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1210\/JC.2015-2518","article-title":"Postprandial endotoxemia linked with chylomicrons and lipopolysaccharides handling in obese versus lean men: a lipid dose-effect trial","volume":"100","author":"Vors","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B468","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.mehy.2014.08.001","article-title":"Pre-eclampsia renamed and reframed: intra-abdominal hypertension in pregnancy","volume":"83","author":"Sawchuck","year":"2014","journal-title":"Med Hypotheses"},{"key":"B469","doi-asserted-by":"publisher","first-page":"e724","DOI":"10.1542\/peds.2006-1649","article-title":"Bacterial imprinting of the neonatal immune system: lessons from maternal cells?","volume":"119","author":"Perez","year":"2007","journal-title":"Pediatrics"},{"key":"B470","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.aad9378","article-title":"How colonization by microbiota in early life shapes the immune system","volume":"352","author":"Gensollen","year":"2016","journal-title":"Science"},{"key":"B471","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/AOG.0b013e3181c15b40","article-title":"Treatment of periodontal disease during pregnancy: a randomized controlled trial","volume":"114","author":"Newnham","year":"2009","journal-title":"Obstet Gynecol"},{"key":"B472","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11596-014-1343-8","article-title":"Maternal periodontal disease and risk of preeclampsia: a meta-analysis","volume":"34","author":"Huang","year":"2014","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B473","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1097\/00006454-198611010-00007","article-title":"Bacteriuria due to ureaplasmas and other fastidious organisms during pregnancy: prevalence and significance","volume":"5","author":"Gilbert","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"B474","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/jcpe.12281","article-title":"Association between periodontitis and preeclampsia in never-smokers: a prospective study","volume":"41","author":"Ha","year":"2014","journal-title":"J Clin Periodontol"},{"key":"B475","doi-asserted-by":"publisher","first-page":"e71387","DOI":"10.1371\/journal.pone.0071387","article-title":"Relationship between periodontitis and pre-eclampsia: a meta-analysis","volume":"8","author":"Sgolastra","year":"2013","journal-title":"PLoS One"},{"key":"B476","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1007\/s10995-006-0095-x","article-title":"Oral health in women during preconception and pregnancy: implications for birth outcomes and infant oral health","volume":"10","author":"Boggess","year":"2006","journal-title":"Matern Child Health J"},{"key":"B477","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1902\/jop.2012.120079","article-title":"Severe preeclampsia and maternal self-report of oral health, hygiene, and dental care","volume":"84","author":"Boggess","year":"2013","journal-title":"J Periodontol"},{"key":"B478","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-0757.2011.00396.x","article-title":"Bi-directional relationship between pregnancy and periodontal disease","volume":"61","author":"Armitage","year":"2013","journal-title":"Periodontol 2000"},{"key":"B479","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1902\/jop.2012.110256","article-title":"Periodontitis as a risk factor for preeclampsia","volume":"83","author":"Moura da Silva","year":"2012","journal-title":"J Periodontol"},{"key":"B480","doi-asserted-by":"publisher","first-page":"e18908","DOI":"10.17795\/whb-18908","article-title":"Periodontal disease as a risk factor for preeclampsia","volume":"1","author":"Jahromi","year":"2014","journal-title":"Womens Health Bull"},{"key":"B481","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/JPN.0b013e31821072e4","article-title":"Periodontal disease in pregnancy: review of the evidence and prevention strategies","volume":"25","author":"Lachat","year":"2011","journal-title":"J Perinat Neonatal Nurs"},{"key":"B482","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1600-0765.2011.01368.x","article-title":"Correlation between periodontal disease, inflammatory alterations and pre-eclampsia","volume":"46","author":"Politano","year":"2011","journal-title":"J Periodontal Res"},{"key":"B483","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1600-051X.2009.01503.x","article-title":"Maternal periodontitis and the causes of preterm birth: the case-control Epipap study","volume":"37","author":"Nabet","year":"2010","journal-title":"J Clin Periodontol"},{"key":"B484","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1902\/jop.2013.1340015","article-title":"Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms","volume":"84","author":"Madianos","year":"2013","journal-title":"J Periodontol"},{"issue":"Suppl","key":"B485","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.14219\/jada.archive.2006.0403","article-title":"Exploring the relationship between periodontal disease and pregnancy complications","volume":"137","author":"Bobetsis","year":"2006","journal-title":"J Am Dent Assoc"},{"key":"B486","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1097\/HJH.0b013e3281139ea9","article-title":"Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia","volume":"25","author":"Herrera","year":"2007","journal-title":"J Hypertens"},{"key":"B487","doi-asserted-by":"publisher","first-page":"389.e1","DOI":"10.1016\/j.ajog.2007.12.002","article-title":"Maternal periodontal disease, systemic inflammation, and risk for preeclampsia","volume":"198","author":"Ruma","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B488","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1902\/jop.2012.120264","article-title":"Periodontal disease and pregnancy hypertension: a clinical correlation","volume":"84","author":"Pralhad","year":"2013","journal-title":"J Periodontol"},{"key":"B489","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fpubh.2014.00290","article-title":"Mechanisms involved in the association between periodontitis and complications in pregnancy","volume":"2","author":"Zi","year":"2014","journal-title":"Front Public Health"},{"key":"B490","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00404-011-2012-9","article-title":"Simultaneous detection of periodontal pathogens in subgingival plaque and placenta of women with hypertension in pregnancy","volume":"285","author":"Swati","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"B491","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/14767050600797749","article-title":"Periodontal disease and adverse pregnancy outcomes","volume":"19","author":"Shub","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B492","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1471-0528.2005.00827.x","article-title":"Periodontal disease and adverse pregnancy outcomes: a systematic review","volume":"113","author":"Xiong","year":"2006","journal-title":"BJOG"},{"key":"B493","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1902\/jop.2011.110035","article-title":"Oral health behaviors, periodontal disease, and pathogens in preeclampsia: a case-control study in Korea","volume":"82","author":"Ha","year":"2011","journal-title":"J Periodontol"},{"key":"B494","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.placenta.2014.10.015","article-title":"Porphyromonas gingivalis lipopolysaccharide inhibits trophoblast invasion in the presence of nicotine","volume":"36","author":"Komine-Aizawa","year":"2015","journal-title":"Placenta"},{"key":"B495","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1902\/jop.2006.050020","article-title":"Periodontitis is associated with preeclampsia in pregnant women","volume":"77","author":"Contreras","year":"2006","journal-title":"J Periodontol"},{"key":"B496","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1902\/jop.2005.76.1.134","article-title":"Severe pregnancy complication (preeclampsia) is associated with greater periodontal destruction","volume":"76","author":"Oettinger-Barak","year":"2005","journal-title":"J Periodontol"},{"key":"B497","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2105\/AJPH.80.3.331","article-title":"Recurring urinary tract infection: incidence and risk factors","volume":"80","author":"Foxman","year":"1990","journal-title":"Am J Public Health"},{"issue":"Suppl 1A","key":"B498","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am J Med"},{"key":"B499","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.femsle.2005.08.028","article-title":"Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?","volume":"252","author":"Marrs","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"B500","doi-asserted-by":"publisher","first-page":"e1001042","DOI":"10.1371\/journal.ppat.1001042","article-title":"Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection","volume":"6","author":"Hannan","year":"2010","journal-title":"PLoS Pathog"},{"key":"B501","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev.micro.112408.134258","article-title":"Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli","volume":"64","author":"Hunstad","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"B502","first-page":"B4187","article-title":"Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli","volume":"58","author":"Ejrnaes","year":"2011","journal-title":"Dan Med Bull"},{"key":"B503","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1574-6976.2012.00339.x","article-title":"Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection","volume":"36","author":"Hannan","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"B504","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect Dis Clin North Am"},{"key":"B505","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1073\/pnas.0308125100","article-title":"Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis","volume":"101","author":"Justice","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B506","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-0854.2004.00251.x","article-title":"Covert operations of uropathogenic Escherichia coli within the urinary tract","volume":"6","author":"Bower","year":"2005","journal-title":"Traffic"},{"key":"B507","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1371\/journal.pmed.0040329","article-title":"Detection of intracellular bacterial communities in human urinary tract infection","volume":"4","author":"Rosen","year":"2007","journal-title":"PLoS Med"},{"issue":"Suppl 2","key":"B508","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-2362.2008.01986.x","article-title":"Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli","volume":"38","author":"Dhakal","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"B509","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/IAI.05339-11","article-title":"Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection","volume":"79","author":"Schwartz","year":"2011","journal-title":"Infect Immun"},{"key":"B510","first-page":"318","article-title":"Urinary Escherichia coli causing recurrent infections \u2013 a prospective follow-up of biochemical phenotypes","volume":"38","author":"Brauner","year":"1992","journal-title":"Clin Nephrol"},{"key":"B511","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/infdis\/172.2.440","article-title":"Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women","volume":"172","author":"Russo","year":"1995","journal-title":"J Infect Dis"},{"key":"B512","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/clinids\/22.1.91","article-title":"Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women","volume":"22","author":"Ik\u00e4heimo","year":"1996","journal-title":"Clin Infect Dis"},{"key":"B513","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1128\/IAI.00090-08","article-title":"Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression","volume":"76","author":"Rosen","year":"2008","journal-title":"Infect Immun"},{"key":"B514","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1128\/JCM.02086-12","article-title":"Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection","volume":"50","author":"Luo","year":"2012","journal-title":"J Clin Microbiol"},{"key":"B515","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.mehy.2012.08.002","article-title":"Preeclampsia: is it because of the asymptomatic, unrecognized renal scars caused by urinary tract infections in childhood that become symptomatic with pregnancy?","volume":"79","author":"\u00d6zl\u00fc","year":"2012","journal-title":"Med Hypotheses"},{"key":"B516","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0140-6736(65)90001-2","article-title":"Bacteriuria in pregnancy","volume":"1","author":"Kincaid-Smith","year":"1965","journal-title":"Lancet"},{"key":"B517","first-page":"54","article-title":"Urinary tract infections in pregnancy","volume":"2","author":"Loh","year":"2007","journal-title":"Malays Fam Physician"},{"key":"B518","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ucl.2006.10.010","article-title":"Asymptomatic bacteriuria and symptomatic urinary tract infections during pregnancy","volume":"34","author":"Macejko","year":"2007","journal-title":"Urol Clin North Am"},{"issue":"Suppl 2","key":"B519","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2362.2008.02009.x","article-title":"Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy","volume":"38","author":"Schnarr","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"B520","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4297\/najms.2010.2263","article-title":"Asymptomatic bacteriuria among pregnant women","volume":"2","author":"Imade","year":"2010","journal-title":"N Am J Med Sci"},{"key":"B521","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7453\/gahmj.2013.061","article-title":"Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action","volume":"2","author":"Gilbert","year":"2013","journal-title":"Glob Adv Health Med"},{"key":"B522","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ucl.2015.05.004","article-title":"Urinary tract infection and bacteriuria in pregnancy","volume":"42","author":"Glaser","year":"2015","journal-title":"Urol Clin North Am"},{"key":"B523","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.4049\/jimmunol.178.9.5949","article-title":"Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles","volume":"178","author":"Germain","year":"2007","journal-title":"J Immunol"},{"issue":"Suppl A","key":"B524","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.placenta.2007.11.016","article-title":"Circulating microparticles in normal pregnancy and pre-eclampsia","volume":"29","author":"Redman","year":"2008","journal-title":"Placenta"},{"issue":"Suppl","key":"B525","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.placenta.2010.06.018","article-title":"Cell-free nucleic acids as potential markers for preeclampsia","volume":"32","author":"Hahn","year":"2011","journal-title":"Placenta"},{"key":"B526","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/10641951003599571","article-title":"Placental microparticles, DNA, and RNA in preeclampsia","volume":"30","author":"Rusterholz","year":"2011","journal-title":"Hypertens Pregnancy"},{"issue":"Suppl","key":"B527","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.placenta.2011.12.006","article-title":"Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia","volume":"33","author":"Redman","year":"2012","journal-title":"Placenta"},{"key":"B528","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molmed.2014.11.009","article-title":"Molecular mechanisms of maternal vascular dysfunction in preeclampsia","volume":"21","author":"Goulopoulou","year":"2015","journal-title":"Trends Mol Med"},{"key":"B529","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-0035-1549850","article-title":"Microparticles: bridging the gap between autoimmunity and thrombosis","volume":"41","author":"Niccolai","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"B530","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ki.2015.26","article-title":"Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI","volume":"87","author":"Souza","year":"2015","journal-title":"Kidney Int"},{"key":"B531","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1016\/j.ajog.2015.07.001","article-title":"Placental exosomes in normal and complicated pregnancy","volume":"213","author":"Mitchell","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B532","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/pds.3492","article-title":"Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study","volume":"23","author":"de Jonge","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B533","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/phar.1649","article-title":"A review of antibiotic use in pregnancy","volume":"35","author":"Bookstaver","year":"2015","journal-title":"Pharmacotherapy"},{"key":"B534","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","article-title":"The most commonly dispensed prescription medications among pregnant women enrolled in the U.S. Medicaid program","volume":"126","author":"Palmsten","year":"2015","journal-title":"Obstet Gynecol"},{"key":"B535","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(03)12359-8","article-title":"Effects of antiretroviral therapy on occurrence of pre-eclampsia","volume":"361","author":"Mawson","year":"2003","journal-title":"Lancet"},{"key":"B536","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.aids.0000198090.70325.bd","article-title":"Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy","volume":"20","author":"Suy","year":"2006","journal-title":"AIDS"},{"key":"B537","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet"},{"key":"B538","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jri.2007.04.005","article-title":"Is pre-eclampsia less common in patients with HIV\/AIDS?","volume":"76","author":"Hall","year":"2007","journal-title":"J Reprod Immunol"},{"key":"B539","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijgo.2015.08.007","article-title":"A systematic review of the effect of HIV infection and antiretroviral therapy on the risk of pre-eclampsia","volume":"133","author":"Adams","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"B540","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-2125.2005.02572.x","article-title":"Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for Toxoplasma infection","volume":"61","author":"Todros","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"B541","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/1756-3305-7-167","article-title":"Lack of association between Toxoplasma gondii infection and hypertensive disorders in pregnancy: a case-control study in a Northern Mexican population","volume":"7","author":"Alvarado-Esquivel","year":"2014","journal-title":"Parasit Vectors"},{"key":"B542","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.preghy.2013.11.008","article-title":"Pre-eclampsia and gestational hypertension are less common in HIV infected women","volume":"4","author":"Hall","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"B543","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.placenta.2011.03.010","article-title":"Animal models of preeclampsia; uses and limitations","volume":"32","author":"McCarthy","year":"2011","journal-title":"Placenta"},{"key":"B544","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1073\/pnas.1018164108","article-title":"Preeclampsia: animal models for a human cure","volume":"108","author":"Aubuchon","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B545","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B546","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0002-9378(94)90463-4","article-title":"A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats","volume":"171","author":"Faas","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"B547","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0002-9378(00)70223-7","article-title":"Activation of peripheral leukocytes in rat pregnancy and experimental preeclampsia","volume":"182","author":"Faas","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"B548","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1097\/00000542-200012000-00017","article-title":"Evaluation of low-dose endotoxin administration during pregnancy as a model of preeclampsia","volume":"93","author":"Sakawi","year":"2000","journal-title":"Anesthesiology"},{"key":"B549","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.reprotox.2012.09.009","article-title":"Treatment of lipoxin A4 and its analogue on low-dose endotoxin induced preeclampsia in rat and possible mechanisms","volume":"34","author":"Lin","year":"2012","journal-title":"Reprod Toxicol"},{"key":"B550","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1084\/jem.20130295","article-title":"Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia","volume":"211","author":"Cotechini","year":"2014","journal-title":"J Exp Med"},{"key":"B551","doi-asserted-by":"publisher","first-page":"e0124001","DOI":"10.1371\/journal.pone.0124001","article-title":"Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia","volume":"10","author":"Xue","year":"2015","journal-title":"PLoS One"},{"key":"B552","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.2353\/ajpath.2010.100475","article-title":"Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay","volume":"177","author":"Kalkunte","year":"2010","journal-title":"Am J Pathol"},{"key":"B553","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2337\/dc09-0467","article-title":"Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes","volume":"32","author":"Nymark","year":"2009","journal-title":"Diabetes Care"},{"key":"B554","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1475-2840-8-20","article-title":"Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies","volume":"8","author":"Al-Attas","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"B555","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1038\/nutd.2013.24","article-title":"Evidence for metabolic endotoxemia in obese and diabetic Gambian women","volume":"3","author":"Hawkesworth","year":"2013","journal-title":"Nutr Diabetes"},{"key":"B556","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0976-9668.149098","article-title":"Relationship between postprandial endotoxemia in nonobese postmenopausal women and diabetic nonobese postmenopausal women","volume":"6","author":"Zaman","year":"2015","journal-title":"J Nat Sci Biol Med"},{"key":"B557","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00281-007-0071-6","article-title":"Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia","volume":"29","author":"Rusterholz","year":"2007","journal-title":"Semin Immunopathol"},{"key":"B558","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0897.2009.00745.x","article-title":"Toll-like receptor signaling and pre-eclampsia","volume":"63","author":"Xie","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"B559","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/humrep\/der362","article-title":"Lipopolysaccharide induces cytokine production and decreases extravillous trophoblast invasion through a mitogen-activated protein kinase-mediated pathway: possible mechanisms of first trimester placental dysfunction","volume":"27","author":"Anton","year":"2012","journal-title":"Hum Reprod"},{"key":"B560","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1600-0897.2010.00913.x","article-title":"Immunologic characteristics of preeclampsia, a comprehensive review","volume":"65","author":"Ahn","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"B561","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.arcmed.2011.08.003","article-title":"Expression of toll-like receptor TLR-2, TLR-3, TLR-4 and TLR-9 is increased in placentas from patients with preeclampsia","volume":"42","author":"Pineda","year":"2011","journal-title":"Arch Med Res"},{"key":"B562","doi-asserted-by":"publisher","first-page":"e41884","DOI":"10.1371\/journal.pone.0041884","article-title":"Placental toll-like receptor 3 and toll-like receptor 7\/8 activation contributes to preeclampsia in humans and mice","volume":"7","author":"Chatterjee","year":"2012","journal-title":"PLoS One"},{"key":"B563","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.immuni.2015.06.002","article-title":"Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity","volume":"42","author":"Gallo","year":"2015","journal-title":"Immunity"},{"key":"B564","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/IAI.02370-14","article-title":"Toll-like receptor 2 and NLRP3 cooperate to recognize a functional bacterial amyloid, curli","volume":"83","author":"Rapsinski","year":"2015","journal-title":"Infect Immun"},{"key":"B565","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chom.2015.06.013","article-title":"Fueling the fire with fibers: bacterial amyloids promote inflammatory disorders","volume":"18","author":"Spaulding","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B566","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1172\/JCI14235","article-title":"Mechanisms for the induction of autoimmunity by infectious agents","volume":"108","author":"Wucherpfennig","year":"2001","journal-title":"J Clin Invest"},{"key":"B567","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/jaut.2000.0499","article-title":"Structural basis of molecular mimicry","volume":"16","author":"Wucherpfennig","year":"2001","journal-title":"J Autoimmun"},{"key":"B568","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0966-842X(03)00006-4","article-title":"Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology","volume":"11","author":"Kohm","year":"2003","journal-title":"Trends Microbiol"},{"key":"B569","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mehy.2015.12.011","article-title":"Microbes, molecular mimicry and molecules of mood and motivation","volume":"87","author":"Morris","year":"2016","journal-title":"Med Hypotheses"},{"key":"B570","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1006\/bbrc.2000.2871","article-title":"Structural basis of functional mimicry between carbohydrate and peptide ligands of con A","volume":"272","author":"Jain","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B571","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.4049\/jimmunol.173.12.7358","article-title":"Plasticity within the antigen-combining site may manifest as molecular mimicry in the humoral immune response","volume":"173","author":"Goel","year":"2004","journal-title":"J Immunol"},{"issue":"317","key":"B572","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1016\/j.ajog.2008.06.091","article-title":"Lipopolysaccharide stimulation of trophoblasts induces corticotropin-releasing hormone expression through MyD88","volume":"199","author":"Uh","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B573","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.placenta.2009.06.008","article-title":"Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women?","volume":"30","author":"Chen","year":"2009","journal-title":"Placenta"},{"key":"B574","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.placenta.2012.07.019","article-title":"Antiphospholipid antibodies prolong the activation of endothelial cells induced by necrotic trophoblastic debris: implications for the pathogenesis of preeclampsia","volume":"33","author":"Chen","year":"2012","journal-title":"Placenta"},{"key":"B575","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jri.2012.03.487","article-title":"Transcriptomic analysis of placenta affected by antiphospholipid antibodies: following the TRAIL of trophoblast death","volume":"94","author":"Pantham","year":"2012","journal-title":"J Reprod Immunol"},{"key":"B576","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/humupd\/dmu049","article-title":"Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment","volume":"21","author":"Tong","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B577","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1161\/01.CIR.101.20.2382","article-title":"AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor","volume":"101","author":"Dechend","year":"2000","journal-title":"Circulation"},{"key":"B578","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1161\/01.CIR.101.20.2335","article-title":"Angiotensin-1 receptor autoantibodies: a role in the pathogenesis of preeclampsia?","volume":"101","author":"Roberts","year":"2000","journal-title":"Circulation"},{"key":"B579","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1139\/y02-160","article-title":"Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia","volume":"81","author":"Wallukat","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"B580","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.semnephrol.2004.07.006","article-title":"AT1 receptor agonistic antibodies, hypertension, and preeclampsia","volume":"24","author":"Dechend","year":"2004","journal-title":"Semin Nephrol"},{"key":"B581","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jsgi.2005.11.006","article-title":"Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia","volume":"13","author":"Dechend","year":"2006","journal-title":"J Soc Gynecol Investig"},{"key":"B582","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/01.HYP.0000256565.20983.d4","article-title":"Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia","volume":"49","author":"Hubel","year":"2007","journal-title":"Hypertension"},{"key":"B583","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11886-008-0070-9","article-title":"Are we getting closer to a nobel prize for unraveling preeclampsia?","volume":"10","author":"Dechend","year":"2008","journal-title":"Curr Cardiol Rep"},{"key":"B584","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00109-008-0332-4","article-title":"AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia","volume":"86","author":"Herse","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"B585","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nm.1856","article-title":"Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice","volume":"14","author":"Zhou","year":"2008","journal-title":"Nat Med"},{"key":"B586","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1179\/acb.2010.051","article-title":"Aetiology and physiopathology of preeclampsia and related forms","volume":"65","author":"Lorquet","year":"2010","journal-title":"Acta Clin Belg"},{"key":"B587","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/ajh.2010.70","article-title":"The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy","volume":"23","author":"Parrish","year":"2010","journal-title":"Am J Hypertens"},{"key":"B588","doi-asserted-by":"publisher","first-page":"375; author reply 376","DOI":"10.1038\/ajh.2010.249","article-title":"AT1-receptor autoantibody: a true causal factor of pre-eclampsia or only a marker of poor placentation?","volume":"24","author":"Carbillon","year":"2011","journal-title":"Am J Hypertens"},{"key":"B589","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/aji.12072","article-title":"Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension","volume":"69","author":"Herse","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"B590","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/HYPERTENSIONAHA.111.00157","article-title":"Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia","volume":"61","author":"Siddiqui","year":"2013","journal-title":"Hypertension"},{"key":"B591","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1159\/000299502","article-title":"Smooth muscle antibodies in pre-eclampsia of pregnancy","volume":"13","author":"Pietarinen","year":"1982","journal-title":"Gynecol Obstet Invest"},{"key":"B592","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/00016348409155540","article-title":"Serum IgE and smooth muscle antibodies in pre-eclampsia","volume":"63","author":"Alanen","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B593","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/01.CIR.0000140265.21608.8E","article-title":"Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation","volume":"110","author":"Fliser","year":"2004","journal-title":"Circulation"},{"key":"B594","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1592\/phco.2005.25.9.1213","article-title":"Protective effects of angiotensin II interruption: evidence for antiinflammatory actions","volume":"25","author":"Dagenais","year":"2005","journal-title":"Pharmacotherapy"},{"key":"B595","doi-asserted-by":"publisher","first-page":"14948","DOI":"10.1073\/pnas.0903958106","article-title":"Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity","volume":"106","author":"Platten","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B596","doi-asserted-by":"publisher","first-page":"e57983","DOI":"10.1371\/journal.pone.0057983","article-title":"Association between the presence of autoantibodies against adrenoreceptors and severe pre-eclampsia: a pilot study","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"B597","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/1479-5876-11-285","article-title":"Association of autoantibodies against the M2-muscarinic receptor with perinatal outcomes in women with severe preeclampsia","volume":"11","author":"Li","year":"2013","journal-title":"J Transl Med"},{"key":"B598","first-page":"243","article-title":"TH17- and IL-17-mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia","volume":"66","author":"Cornelius","year":"2014","journal-title":"Minerva Ginecol"},{"key":"B599","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jri.2012.01.006","article-title":"The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia","volume":"93","author":"Darmochwa\u0142-Kolarz","year":"2012","journal-title":"J Reprod Immunol"},{"key":"B600","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/HYPERTENSIONAHA.111.171348","article-title":"Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats","volume":"58","author":"Wenzel","year":"2011","journal-title":"Hypertension"},{"key":"B601","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jri.2006.08.084","article-title":"Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor?","volume":"73","author":"Stepan","year":"2007","journal-title":"J Reprod Immunol"},{"key":"B602","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/HYPERTENSIONAHA.110.150540","article-title":"Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling","volume":"55","author":"Irani","year":"2010","journal-title":"Hypertension"},{"key":"B603","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.semnephrol.2010.10.005","article-title":"Renin angiotensin signaling in normal pregnancy and preeclampsia","volume":"31","author":"Irani","year":"2011","journal-title":"Semin Nephrol"},{"key":"B604","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.placenta.2012.11.027","article-title":"The placental renin-angiotensin system and oxidative stress in pre-eclampsia","volume":"34","author":"Mistry","year":"2013","journal-title":"Placenta"},{"key":"B605","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/CS20130455","article-title":"The renin-angiotensin-aldosterone system in pre-eclampsia: the delicate balance between good and bad","volume":"126","author":"Verdonk","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"B606","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.coi.2008.09.003","article-title":"Cytokines that regulate autoimmunity","volume":"20","author":"Diveu","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B607","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1600-065X.2008.00709.x","article-title":"Regulation and pro-inflammatory function of interleukin-17 family cytokines","volume":"226","author":"Dong","year":"2008","journal-title":"Immunol Rev"},{"key":"B608","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"B609","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B610","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/eji.201344184","article-title":"Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis","volume":"44","author":"Benedetti","year":"2014","journal-title":"Eur J Immunol"},{"key":"B611","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.smim.2007.10.009","article-title":"Th17 cells and mucosal host defense","volume":"19","author":"Aujla","year":"2007","journal-title":"Semin Immunol"},{"key":"B612","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.smim.2007.10.011","article-title":"Transcriptional regulation of Th17 cell differentiation","volume":"19","author":"Ivanov","year":"2007","journal-title":"Semin Immunol"},{"key":"B613","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.smim.2007.10.008","article-title":"Th17 T cells: linking innate and adaptive immunity","volume":"19","author":"Stockinger","year":"2007","journal-title":"Semin Immunol"},{"key":"B614","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/intimm\/dxn106","article-title":"The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation","volume":"20","author":"Annunziato","year":"2008","journal-title":"Int Immunol"},{"key":"B615","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"B616","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"B617","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2008.10.031","article-title":"IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response","volume":"123","author":"Eyerich","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B618","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/mi.2009.100","article-title":"Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa","volume":"2","author":"Khader","year":"2009","journal-title":"Mucosal Immunol"},{"key":"B619","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/eji.201242605","article-title":"Immunity to infection in IL-17-deficient mice and humans","volume":"42","author":"Cypowyj","year":"2012","journal-title":"Eur J Immunol"},{"key":"B620","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.it.2012.01.003","article-title":"Innate IL-17 and IL-22 responses to enteric bacterial pathogens","volume":"33","author":"Rubino","year":"2012","journal-title":"Trends Immunol"},{"key":"B621","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/cei.12414","article-title":"Bacteria and their cell wall components uniformly co-activate interleukin-17-producing thymocytes","volume":"178","author":"Weber","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B622","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in chronic inflammation: from discovery to targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol Med"},{"key":"B623","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.immuni.2016.02.007","article-title":"Intestinal interleukin-17 receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation","volume":"44","author":"Kumar","year":"2016","journal-title":"Immunity"},{"key":"B624","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1586\/eci.11.49","article-title":"Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology","volume":"7","author":"Saito","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"B625","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/cmi.2014.54","article-title":"TH17 cells in human recurrent pregnancy loss and pre-eclampsia","volume":"11","author":"Fu","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"B626","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3109\/14767058.2013.861415","article-title":"Plasma IL-17, IL-35, interferon-gamma, SOCS3 and TGF-beta levels in pregnant women with preeclampsia, and their relation with severity of disease","volume":"27","author":"Ozkan","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B627","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.4049\/jimmunol.0901154","article-title":"Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia","volume":"183","author":"Santner-Nanan","year":"2009","journal-title":"J Immunol"},{"key":"B628","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1600-0897.2009.00763.x","article-title":"Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia","volume":"63","author":"Jianjun","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"B629","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/icb.2010.68","article-title":"Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia","volume":"88","author":"Saito","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"B630","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0897.2011.00987.x","article-title":"Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia","volume":"66","author":"Toldi","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"B631","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1161\/HYPERTENSIONAHA.113.01514","article-title":"Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy","volume":"62","author":"Cornelius","year":"2013","journal-title":"Hypertension"},{"key":"B632","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1189\/jlb.1112603","article-title":"A leading role for the immune system in the pathophysiology of preeclampsia","volume":"94","author":"Laresgoiti-Servitje","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B633","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2014.00244","article-title":"Innate immune system and preeclampsia","volume":"5","author":"Perez-Sepulveda","year":"2014","journal-title":"Front Immunol"},{"key":"B634","doi-asserted-by":"publisher","first-page":"316182","DOI":"10.1155\/2015\/316182","article-title":"The expression of notch\/notch ligand, IL-35, IL-17, and Th17\/Treg in preeclampsia","volume":"2015","author":"Cao","year":"2015","journal-title":"Dis Markers"},{"key":"B635","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jri.2015.05.007","article-title":"Increased circulating interleukin-17 levels in preeclampsia","volume":"112","author":"Molvarec","year":"2015","journal-title":"J Reprod Immunol"},{"key":"B636","doi-asserted-by":"publisher","first-page":"e0140118","DOI":"10.1371\/journal.pone.0140118","article-title":"Role of IL-17 variants in preeclampsia in Chinese Han women","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"B637","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3109\/14767058.2015.1057811","article-title":"Th1, Th2, Th17 and Treg levels in umbilical cord blood in preeclampsia","volume":"29","author":"Vargas-Rojas","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B638","first-page":"141","article-title":"The critical role of Th17 cells, Treg cells and co-stimulatory molecules in the development of pre-eclampsia","volume":"18","author":"Darmochwa\u0142-Kolarz","year":"2014","journal-title":"Dev Period Med"},{"key":"B639","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"B640","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","article-title":"The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome","volume":"26","author":"Wang","year":"2008","journal-title":"Am J Emerg Med"},{"key":"B641","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1172\/JCI44947","article-title":"Virulence determinants of pandemic influenza viruses","volume":"121","author":"Tscherne","year":"2011","journal-title":"J Clin Invest"},{"key":"B642","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u201ccytokine storm\u201d for therapeutic benefit","volume":"20","author":"D\u2019Elia","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B643","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B644","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N Engl J Med"},{"key":"B645","first-page":"33","article-title":"An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock","volume":"79","author":"Lai","year":"2013","journal-title":"Minerva Anestesiol"},{"key":"B646","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0192-0561(00)00026-6","article-title":"Deferoxamine reduces tissue injury and lethality in LPS-treated mice","volume":"22","author":"Vulcano","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"B647","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.intimp.2004.01.012","article-title":"Deferoxamine administration in septic animals: improved survival and altered apoptotic gene expression","volume":"4","author":"Messaris","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"B648","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jss.2015.07.001","article-title":"Anti-inflammatory and anti-bacterial effects of iron chelation in experimental sepsis","volume":"200","author":"Islam","year":"2016","journal-title":"J Surg Res"},{"key":"B649","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0022-3476(05)83294-9","article-title":"Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia","volume":"125","author":"Doron","year":"1994","journal-title":"J Pediatr"},{"key":"B650","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1542\/peds.102.5.1107","article-title":"Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia","volume":"102","author":"Kocherlakota","year":"1998","journal-title":"Pediatrics"},{"key":"B651","first-page":"775","article-title":"Risk of early onset neonatal septicemia in babies born to mothers with pre-eclampsia","volume":"37","author":"Bhaumik","year":"2000","journal-title":"Indian Pediatr"},{"key":"B652","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jpeds.2010.02.066","article-title":"Sepsis and neutropenia in very low birth weight infants delivered of mothers with preeclampsia","volume":"157","author":"Procianoy","year":"2010","journal-title":"J Pediatr"},{"key":"B653","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3109\/14767058.2013.860521","article-title":"Oxidative stress and antioxidant status among neonates born to mothers with pre-eclampsia and their early outcome","volume":"27","author":"Namdev","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B654","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11306-005-0003-1","article-title":"Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning","volume":"1","author":"Kenny","year":"2005","journal-title":"Metabolomics"},{"key":"B655","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1933719108316908","article-title":"Detection and identification of novel metabolomic biomarkers in preeclampsia","volume":"15","author":"Kenny","year":"2008","journal-title":"Reprod Sci"},{"key":"B656","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/pd.2822","article-title":"First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study","volume":"31","author":"Odibo","year":"2011","journal-title":"Prenat Diagn"},{"key":"B657","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.3109\/14767058.2012.680254","article-title":"Metabolomics and first-trimester prediction of early-onset preeclampsia","volume":"25","author":"Bahado-Singh","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B658","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11306-011-0348-6","article-title":"The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy","volume":"8","author":"Dunn","year":"2012","journal-title":"Metabolomics"},{"key":"B659","doi-asserted-by":"publisher","first-page":"S348","DOI":"10.1016\/j.ajog.2011.10.809","article-title":"Metabolomics to predict severe preeclampsia in early pregnancy","volume":"206","author":"Woodham","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"B660","doi-asserted-by":"publisher","first-page":"e98540","DOI":"10.1371\/journal.pone.0098540","article-title":"Metabolomics profiling for identification of novel potential markers in early prediction of preeclampsia","volume":"9","author":"Kuc","year":"2014","journal-title":"PLoS One"},{"key":"B661","doi-asserted-by":"publisher","first-page":"857108","DOI":"10.1155\/2015\/857108","article-title":"First-trimester serum acylcarnitine levels to predict preeclampsia: a metabolomics approach","volume":"2015","author":"Koster","year":"2015","journal-title":"Dis Markers"},{"issue":"266","key":"B662","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1016\/j.ajog.2006.10.875","article-title":"Evidence for multiple circulating factors in preeclampsia","volume":"196","author":"Myers","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"B663","doi-asserted-by":"publisher","first-page":"305964","DOI":"10.1155\/2012\/305964","article-title":"Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia","volume":"2012","author":"Kolla","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"B664","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1111\/1471-0528.12195","article-title":"Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study","volume":"120","author":"Myers","year":"2013","journal-title":"BJOG"},{"key":"B665","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1161\/HYPERTENSIONAHA.113.01168","article-title":"Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia","volume":"61","author":"Myers","year":"2013","journal-title":"Hypertension"},{"key":"B666","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1053\/j.ackd.2013.01.001","article-title":"Emerging new biomarkers of preeclampsia","volume":"20","author":"Polsani","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"B667","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1586\/14737159.2015.1025757","article-title":"Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?","volume":"15","author":"Hahn","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"B668","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/humrep\/deu268","article-title":"Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration","volume":"30","author":"Khan","year":"2015","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"B669","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3109\/1354750X.2011.587893","article-title":"Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?","volume":"16","author":"Paulus","year":"2011","journal-title":"Biomarkers"},{"key":"B670","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B671","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1471-0528.2002.01130.x","article-title":"Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia","volume":"109","author":"Savvidou","year":"2002","journal-title":"BJOG"},{"key":"B672","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/jog.12105","article-title":"Evaluation of the diagnostic value of the first-trimester maternal serum high-sensitivity C-reactive protein level for prediction of pre-eclampsia","volume":"39","author":"Kashanian","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"B673","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.mam.2007.02.006","article-title":"The role of the immune system in preeclampsia","volume":"28","author":"Saito","year":"2007","journal-title":"Mol Aspects Med"},{"key":"B674","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0002-9378(99)70325-X","article-title":"Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia","volume":"181","author":"Rinehart","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"B675","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0301-2115(01)00484-5","article-title":"Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia","author":"Serin","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B676","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejogrb.2005.03.014","article-title":"Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia","volume":"123","author":"Todros","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B677","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/00006454-200009000-00014","article-title":"Cytokines as markers of bacterial sepsis in newborn infants: a review","volume":"19","author":"Mehr","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"B678","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1179\/096805101101533089","article-title":"Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria","volume":"7","author":"Roger","year":"2001","journal-title":"J Endotoxin Res"},{"key":"B679","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/078538902321117841","article-title":"Markers of inflammation in sepsis","volume":"34","author":"Takala","year":"2002","journal-title":"Ann Med"},{"key":"B680","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1586\/14787210.2014.945431","article-title":"Prognostic markers of pediatric meningococcal sepsis","volume":"12","author":"Briassoulis","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B681","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/jp.2013.186","article-title":"Inflammatory markers in cord blood or maternal serum for early detection of neonatal sepsis-a systemic review and meta-analysis","volume":"34","author":"Su","year":"2014","journal-title":"J Perinatol"},{"key":"B682","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7551\/mitpress\/9780262195485.003.0001","article-title":"The role of modeling in systems biology","volume-title":"System Modeling in Cellular Biology: From Concepts to Nuts and Bolts","author":"Kell","year":"2006"},{"key":"B683","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511790515","volume-title":"Systems Biology: Properties of Reconstructed Networks","author":"Palsson","year":"2006"},{"key":"B684","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781139854610","volume-title":"Systems Biology: Constraint-Based Reconstruction and Analysis","author":"Palsson","year":"2015"},{"key":"B685","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/bioinformatics\/btg015","article-title":"The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models","volume":"19","author":"Hucka","year":"2003","journal-title":"Bioinformatics"},{"key":"B686","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1109\/JPROC.2008.925458","article-title":"CellDesigner 3.5: a versatile modeling tool for biochemical networks","volume":"96","author":"Funahashi","year":"2008","journal-title":"Proc IEEE"},{"key":"B687","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","article-title":"COPASI: a complex pathway simulator","volume":"22","author":"Hoops","year":"2006","journal-title":"Bioinformatics"},{"key":"B688","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/bioinformatics\/btq675","article-title":"Cytoscape 2.8: new features for data integration and network visualization","volume":"27","author":"Smoot","year":"2011","journal-title":"Bioinformatics"},{"key":"B689","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijgo.2005.02.008","article-title":"Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry","volume":"89","author":"Madazli","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"B690","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/pd.1606","article-title":"Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia","volume":"26","author":"Diesch","year":"2006","journal-title":"Prenat Diagn"},{"key":"B691","doi-asserted-by":"publisher","first-page":"e4453","DOI":"10.1371\/journal.pone.0004453","article-title":"Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia","volume":"4","author":"Reddy","year":"2009","journal-title":"PLoS One"},{"key":"B692","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0303-7207(01)00516-0","article-title":"Evidence for activin A and follistatin involvement in the systemic inflammatory response","volume":"180","author":"Phillips","year":"2001","journal-title":"Mol Cell Endocrinol"},{"key":"B693","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/jp.2009.109","article-title":"Activin A as a marker of intrauterine infection in women with preterm prelabour rupture of membranes","volume":"30","author":"Hodges","year":"2010","journal-title":"J Perinatol"},{"key":"B694","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1600-0897.2011.01074.x","article-title":"Modulation of amniotic fluid activin-A and inhibin-A in women with preterm premature rupture of the membranes and infection-induced preterm birth","volume":"67","author":"Rosenberg","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"B695","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/pr.2013.159","article-title":"Activin-A exerts a crucial anti-inflammatory role in neonatal infections","volume":"74","author":"Petrakou","year":"2013","journal-title":"Pediatr Res"},{"key":"B696","doi-asserted-by":"publisher","first-page":"e112890","DOI":"10.1371\/journal.pone.0112890","article-title":"Protein profiling of preeclampsia placental tissues","volume":"9","author":"Shu","year":"2014","journal-title":"PLoS One"},{"key":"B697","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1053\/S0046-8177(03)00339-3","article-title":"Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples","volume":"34","author":"Lugli","year":"2003","journal-title":"Hum Pathol"},{"key":"B698","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2436\/20.1501.01.221","article-title":"Transforming activities of Chlamydia pneumoniae in human mesothelial cells","volume":"17","author":"Rizzo","year":"2014","journal-title":"Int Microbiol"},{"key":"B699","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.peptides.2014.10.002","article-title":"The predictive value of the first-trimester maternal serum chemerin level for pre-eclampsia","volume":"62","author":"Xu","year":"2014","journal-title":"Peptides"},{"key":"B700","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.regpep.2011.03.005","article-title":"Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy","volume":"168","author":"Stepan","year":"2011","journal-title":"Regul Pept"},{"key":"B701","first-page":"5143","article-title":"Evaluation of serum levels of the adipokines chemerin and resistin in preeclampsia","volume":"9","author":"AL-Refai","year":"2012","journal-title":"Life Sci J"},{"key":"B702","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1515\/Jpm.2011.127","article-title":"Serum levels of the adipokine chemerin in preeclampsia","volume":"40","author":"Duan","year":"2012","journal-title":"J Perinat Med"},{"key":"B703","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12020-014-0286-y","article-title":"Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia","volume":"48","author":"Wang","year":"2015","journal-title":"Endocrine"},{"key":"B704","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11306-006-0037-z","article-title":"Statistical strategies for avoiding false discoveries in metabolomics and related experiments","volume":"2","author":"Broadhurst","year":"2006","journal-title":"Metabolomics"},{"key":"B705","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2893.2009.01224.x","article-title":"Chemerin, vaspin and insulin resistance in chronic hepatitis C","volume":"17","author":"Kukla","year":"2010","journal-title":"J Viral Hepat"},{"key":"B706","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2119\/molmed.2010.00105","article-title":"Potential role of leptin, adiponectin and three novel adipokines-visfatin, chemerin and vaspin-in chronic hepatitis","volume":"17","author":"Kukla","year":"2011","journal-title":"Mol Med"},{"key":"B707","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.4049\/jimmunol.1002352","article-title":"Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins","volume":"187","author":"Kulig","year":"2011","journal-title":"J Immunol"},{"key":"B708","doi-asserted-by":"publisher","first-page":"e58709","DOI":"10.1371\/journal.pone.0058709","article-title":"Chemerin is an antimicrobial agent in human epidermis","volume":"8","author":"Banas","year":"2013","journal-title":"PLoS One"},{"key":"B709","first-page":"1","article-title":"Chemerin regulation and role in host defense","volume":"3","author":"Zabel","year":"2014","journal-title":"Am J Clin Exp Immunol"},{"key":"B710","doi-asserted-by":"publisher","first-page":"e0117830","DOI":"10.1371\/journal.pone.0117830","article-title":"The expression and regulation of chemerin in the epidermis","volume":"10","author":"Banas","year":"2015","journal-title":"PLoS One"},{"key":"B711","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13054-016-12090-5","article-title":"Chemerin in peritoneal sepsis and its associations with glucose metabolism and prognosis: a translational cross-sectional study","volume":"20","author":"Horn","year":"2016","journal-title":"Crit Care"},{"key":"B712","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/HYPERTENSIONAHA.114.04255","article-title":"Copeptin: a new biomarker that is specific for preeclampsia?","volume":"64","author":"Cornelius","year":"2014","journal-title":"Hypertension"},{"key":"B713","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00404-015-3745-7","article-title":"Maternal serum copeptin, MR-proANP and procalcitonin levels at 11-13 weeks gestation in the prediction of preeclampsia","volume":"292","author":"Birdir","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"B714","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1210\/jc.2005-2830","article-title":"Copeptin and arginine vasopressin concentrations in critically ill patients","volume":"91","author":"Jochberger","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B715","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: clinical use of a new biomarker","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"B716","doi-asserted-by":"publisher","first-page":"w13101","DOI":"10.4414\/smw.2010.13101","article-title":"The stress hormone copeptin: a new prognostic biomarker in acute illness","volume":"140","author":"Katan","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"B717","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1741-7015-10-7","article-title":"The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department","volume":"10","author":"Nickel","year":"2012","journal-title":"BMC Med"},{"key":"B718","doi-asserted-by":"publisher","first-page":"172","DOI":"10.11613\/BM.2013.021","article-title":"Copeptin and its potential role in diagnosis and prognosis of various diseases","volume":"23","author":"Dob\u0161a","year":"2013","journal-title":"Biochem Med (Zagreb)"},{"key":"B719","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1515\/cclm-2016-0151","article-title":"Copeptin predicts 10-year all-cause mortality in community patients: a 10-year prospective cohort study","volume":"54","author":"Odermatt","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"B720","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0310057X0603400415","article-title":"Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock","volume":"34","author":"Jochberger","year":"2006","journal-title":"Anaesth Intensive Care"},{"key":"B721","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","article-title":"Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections","volume":"37","author":"M\u00fcller","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"B722","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/CCM.0b013e3181957532","article-title":"The vasopressin and copeptin response to infection, severe sepsis, and septic shock","volume":"37","author":"Jochberger","year":"2009","journal-title":"Crit Care Med"},{"key":"B723","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jac\/dkp148","article-title":"C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia \u2013 influence of antibiotic pre-treatment: results from the German competence network CAPNETZ","volume":"64","author":"Kr\u00fcger","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"B724","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jinf.2010.03.029","article-title":"Copeptin as a predictor of disease severity and survival in leptospirosis","volume":"61","author":"Limper","year":"2010","journal-title":"J Infect"},{"key":"B725","doi-asserted-by":"publisher","first-page":"e48309","DOI":"10.1371\/journal.pone.0048309","article-title":"Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke","volume":"7","author":"Fluri","year":"2012","journal-title":"PLoS One"},{"key":"B726","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.rmed.2012.06.008","article-title":"Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia","volume":"106","author":"Kolditz","year":"2012","journal-title":"Respir Med"},{"key":"B727","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.peptides.2013.04.015","article-title":"Relationship between plasma copeptin levels and complications of community-acquired pneumonia in preschool children","volume":"45","author":"Du","year":"2013","journal-title":"Peptides"},{"key":"B728","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12894-015-0061-2","article-title":"Utility of copeptin and standard inflammatory markers in the diagnostics of upper and lower urinary tract infections","volume":"15","author":"Masajtis-Zagajewska","year":"2015","journal-title":"BMC Urol"},{"key":"B729","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/5584_2014_41","article-title":"Sodium and copeptin levels in children with community acquired pneumonia","volume":"835","author":"Wrotek","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B730","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1471-0528.2003.02051.x","article-title":"Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies","volume":"110","author":"Strevens","year":"2003","journal-title":"BJOG"},{"key":"B731","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cca.2006.07.006","article-title":"Alteration and significance of serum cardiac troponin I and cystatin C in preeclampsia","volume":"374","author":"Yang","year":"2006","journal-title":"Clin Chim Acta"},{"key":"B732","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/00016340701318133","article-title":"Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia","volume":"86","author":"Kristensen","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B733","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/1933719111431001","article-title":"The application of serum cystatin C in estimating the renal function in women with preeclampsia","volume":"19","author":"Guo","year":"2012","journal-title":"Reprod Sci"},{"key":"B734","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3109\/14767058.2011.601366","article-title":"Cystatin C in pre-eclampsia","volume":"25","author":"Novakov Mikic","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B735","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/10641955.2013.827203","article-title":"Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia","volume":"32","author":"Xiao","year":"2013","journal-title":"Hypertens Pregnancy"},{"key":"B736","first-page":"118","article-title":"Relationship between oxidative stress parameters and cystatin C levels in patients with severe preeclampsia","volume":"49","author":"Yalcin","year":"2013","journal-title":"Medicina (Kaunas)"},{"key":"B737","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1001\/archinte.167.20.2213","article-title":"Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study","volume":"167","author":"Odden","year":"2007","journal-title":"Arch Intern Med"},{"key":"B738","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/00365510118007","article-title":"Cystatin C levels in sera of patients with acute infectious diseases with high C-reactive protein levels","volume":"61","author":"Randers","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"key":"B739","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/hiv.12268","article-title":"Markers of renal disease and function are associated with systemic inflammation in HIV infection","volume":"16","author":"Gupta","year":"2015","journal-title":"HIV Med"},{"key":"B740","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1074\/jbc.274.8.5201","article-title":"The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin","volume":"274","author":"Walker","year":"1999","journal-title":"J Biol Chem"},{"key":"B741","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/j.1471-0528.1999.tb08330.x","article-title":"Tissue factor levels and high ratio of fibrinopeptide A:d-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia","volume":"106","author":"Bellart","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"B742","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1600-0897.2012.01171.x","article-title":"An analysis of C-reactive protein, procalcitonin, and d-dimer in pre-eclamptic patients","volume":"68","author":"Gulec","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"B743","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cca.2012.08.003","article-title":"d-dimer in preeclampsia: systematic review and meta-analysis","volume":"414","author":"Pinheiro","year":"2012","journal-title":"Clin Chim Acta"},{"key":"B744","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12891\/ceog1949.2015","article-title":"Troponin I and d-dimer levels in preeclampsia and eclampsia: prospective study","volume":"42","author":"Bozkurt","year":"2015","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B745","first-page":"115","article-title":"Role of d-dimer in determining coagulability status in pre-eclamptic and normotensive pregnant women","volume":"24","author":"Rahman","year":"2015","journal-title":"Mymensingh Med J"},{"key":"B746","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3324\/haematol.2012.083410","article-title":"Association of d-dimer levels with all-cause mortality in a healthy adult population: findings from the MOLI-SANI study","volume":"98","author":"Di Castelnuovo","year":"2013","journal-title":"Haematologica"},{"key":"B747","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1160\/TH07-05-0377","article-title":"Laboratory d-dimer measurement: improved agreement between methods through calibration","volume":"98","author":"Jennings","year":"2007","journal-title":"Thromb Haemost"},{"key":"B748","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.thromres.2012.05.022","article-title":"d-dimer levels at different stages of pregnancy in Australian women: a single centre study using two different immunoturbidimetric assays","volume":"130","author":"Khalafallah","year":"2012","journal-title":"Thromb Res"},{"key":"B749","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/j.ajem.2012.04.033","article-title":"d-dimer is a significant prognostic factor in patients with suspected infection and sepsis","volume":"30","author":"Rodelo","year":"2012","journal-title":"Am J Emerg Med"},{"key":"B750","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1076029612454936","article-title":"Evaluation of the innovance d-dimer assay for the diagnosis of disseminated intravascular coagulopathy in different clinical settings","volume":"20","author":"Khalafallah","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"B751","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cyto.2015.04.013","article-title":"Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy","volume":"74","author":"Hentschke","year":"2015","journal-title":"Cytokine"},{"key":"B752","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10641963.2015.1060993","article-title":"Serum levels of endocan correlate with the presence and severity of pre-eclampsia","volume":"38","author":"Cakmak","year":"2016","journal-title":"Clin Exp Hypertens"},{"key":"B753","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/2193-1801-3-571","article-title":"Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosis","volume":"3","author":"Mosevoll","year":"2014","journal-title":"Springerplus"},{"key":"B754","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00404-014-3605-x","article-title":"Serum endocan concentration in women with pre-eclampsia","volume":"292","author":"Yuksel","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"B755","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","article-title":"Endocan: a novel inflammatory indicator in cardiovascular disease?","volume":"243","author":"Balta","year":"2015","journal-title":"Atherosclerosis"},{"key":"B756","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.clinbiochem.2015.01.006","article-title":"Endocan \u2013 the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease","volume":"48","author":"Pawlak","year":"2015","journal-title":"Clin Biochem"},{"key":"B757","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/01.CCM.0000199054.13823.A7","article-title":"Endocan or endothelial cell-specific molecule-1: a novel prognostic marker of sepsis?","volume":"34","author":"Filep","year":"2006","journal-title":"Crit Care Med"},{"key":"B758","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/01.CCM.0000198525.82124.74","article-title":"Endocan, a new endothelial marker in human sepsis","volume":"34","author":"Scherpereel","year":"2006","journal-title":"Crit Care Med"},{"key":"B759","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mvr.2014.04.004","article-title":"Endocan is useful biomarker of survival and severity in sepsis","volume":"93","author":"Mihajlovic","year":"2014","journal-title":"Microvasc Res"},{"key":"B760","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jcrc.2015.09.019","article-title":"Endothelial cell-specific molecule-1\/endocan: diagnostic and prognostic value in patients suffering from severe sepsis and septic shock","volume":"31","author":"Pauly","year":"2016","journal-title":"J Crit Care"},{"key":"B761","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1086\/513906","article-title":"Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia","volume":"61","author":"Shovlin","year":"1997","journal-title":"Am J Hum Genet"},{"key":"B762","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"issue":"Suppl","key":"B763","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.placenta.2013.10.020","article-title":"Review: the enigmatic role of endoglin in the placenta","volume":"35","author":"Gregory","year":"2014","journal-title":"Placenta"},{"key":"B764","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2393-13-82","article-title":"Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study","volume":"13","author":"Bell","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"B765","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1093\/ndt\/gfl439","article-title":"Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule","volume":"21","author":"Luft","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B766","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"B767","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.placenta.2014.04.013","article-title":"Soluble fms-like tyrosine kinase-1 in HIV infected pre-eclamptic South African Black women","volume":"35","author":"Govender","year":"2014","journal-title":"Placenta"},{"key":"B768","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10456-014-9452-3","article-title":"Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia","volume":"18","author":"Pratt","year":"2015","journal-title":"Angiogenesis"},{"key":"B769","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"BJOG"},{"key":"B770","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1083\/jcb.200412151","article-title":"CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells","volume":"170","author":"Muenzner","year":"2005","journal-title":"J Cell Biol"},{"key":"B771","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2893.2006.00733.x","article-title":"Increased intrahepatic and circulating levels of endoglin, a TGF-beta 1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis","volume":"13","author":"Clemente","year":"2006","journal-title":"J Viral Hepat"},{"key":"B772","doi-asserted-by":"publisher","first-page":"e24985","DOI":"10.1371\/journal.pone.0024985","article-title":"Circulating soluble endoglin levels in pregnant women in Cameroon and Malawi \u2013 associations with placental malaria and fetal growth restriction","volume":"6","author":"Silver","year":"2011","journal-title":"PLoS One"},{"key":"B773","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11594\/jtls.05.01.01","article-title":"Endoglin expression and the level of tgf-\u03b2 are increased in the placental tissue and correlated with low fetal weight in malaria infected mice","volume":"5","author":"Sasmito","year":"2015","journal-title":"J Trop Life Sci"},{"key":"B774","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1186\/2193-1801-3-561","article-title":"Endoglin (CD105) expression differentiates between aseptic loosening and periprosthetic joint infection after total joint arthroplasty","volume":"3","author":"Jansen","year":"2014","journal-title":"Springerplus"},{"key":"B775","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/15376510701556690","article-title":"Mammalian iron metabolism","volume":"17","author":"Valerio","year":"2007","journal-title":"Toxicol Mech Methods"},{"key":"B776","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1182\/blood-2007-12-077388","article-title":"Forging a field: the golden age of iron biology","volume":"112","author":"Andrews","year":"2008","journal-title":"Blood"},{"key":"B777","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1039\/b816714c","article-title":"A general map of iron metabolism and tissue-specific subnetworks","volume":"5","author":"Hower","year":"2009","journal-title":"Mol Biosyst"},{"key":"B778","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jtbi.2012.01.024","article-title":"The core control system of intracellular iron homeostasis: a mathematical model","volume":"300","author":"Chifman","year":"2012","journal-title":"J Theor Biol"},{"key":"B779","doi-asserted-by":"publisher","first-page":"e1003299","DOI":"10.1371\/journal.pcbi.1003299","article-title":"A computational model of liver iron metabolism","volume":"9","author":"Mitchell","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"B780","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/jcla.21668","article-title":"Iron metabolism: from health to disease","volume":"28","author":"Oliveira","year":"2014","journal-title":"J Clin Lab Anal"},{"key":"B781","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h3692","article-title":"Interpreting raised serum ferritin levels","volume":"351","author":"Kell","year":"2015","journal-title":"BMJ"},{"key":"B782","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1067\/mlc.2000.106456","article-title":"Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance","volume":"135","author":"Nielsen","year":"2000","journal-title":"J Lab Clin Med"},{"key":"B783","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1292\/Jvms.63.587","article-title":"Iron content of rat serum ferritin","volume":"63","author":"Watanabe","year":"2001","journal-title":"J Vet Med Sci"},{"key":"B784","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0009-9120(02)00380-6","article-title":"Relation between iron content of serum ferritin and clinical status factors extracted by factor analysis in patients with hyperferritinemia","volume":"35","author":"Yamanishi","year":"2002","journal-title":"Clin Biochem"},{"key":"B785","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.1021\/ac401692k","article-title":"Antibody labeling and elemental mass spectrometry (inductively coupled plasma-mass spectrometry) using isotope dilution for highly sensitive ferritin determination and iron-ferritin ratio measurements","volume":"85","author":"Konz","year":"2013","journal-title":"Anal Chem"},{"key":"B786","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/10641958309023469","article-title":"Altered ferrokinetics in toxemia of pregnancy \u2013 a possible indicator of decreased red cell survival","volume":"2","author":"Entman","year":"1983","journal-title":"Clin Exp Hypertens B"},{"key":"B787","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1373\/clinchem.2003.030932","article-title":"Nonglycosylated ferritin predominates in the circulation of women with preeclampsia but not intrauterine growth restriction","volume":"50","author":"Hubel","year":"2004","journal-title":"Clin Chem"},{"key":"B788","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/cid\/ciq126","article-title":"Severe hyperferritinemia in Mycobacteria tuberculosis infection","volume":"52","author":"Visser","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B789","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/sdi.12168","article-title":"Iron and infection in hemodialysis patients","volume":"27","author":"Ishida","year":"2014","journal-title":"Semin Dial"},{"key":"B790","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B791","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","article-title":"miRBase: annotating high confidence microRNAs using deep sequencing data","volume":"42","author":"Kozomara","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B792","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12864-015-1513-5","article-title":"microRNAs enrichment in GWAS of complex human phenotypes","volume":"16","author":"Goulart","year":"2015","journal-title":"BMC Genomics"},{"key":"B793","doi-asserted-by":"publisher","first-page":"E1106","DOI":"10.1073\/pnas.1420955112","article-title":"Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs","volume":"112","author":"Londin","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B794","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1095\/biolreprod.108.075481","article-title":"Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes","volume":"81","author":"Luo","year":"2009","journal-title":"Biol Reprod"},{"issue":"Suppl","key":"B795","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.placenta.2013.11.002","article-title":"Review: placenta-specific microRNAs in exosomes \u2013 good things come in nano-packages","volume":"35","author":"Ouyang","year":"2014","journal-title":"Placenta"},{"key":"B796","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.placenta.2014.02.009","article-title":"Intercellular communication by exosomes in placenta: a possible role in cell fusion?","volume":"35","author":"Record","year":"2014","journal-title":"Placenta"},{"key":"B797","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1373\/clinchem.2010.147660","article-title":"Identification of pregnancy-associated microRNAs in maternal plasma","volume":"56","author":"Miura","year":"2010","journal-title":"Clin Chem"},{"key":"B798","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jri.2011.01.004","article-title":"microRNAs in pregnancy","volume":"88","author":"Morales-Prieto","year":"2011","journal-title":"J Reprod Immunol"},{"key":"B799","doi-asserted-by":"publisher","first-page":"S163","DOI":"10.1016\/j.ajog.2015.05.057","article-title":"microRNAs in placental health and disease","volume":"213","author":"Mouillet","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B800","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3892\/mmr.2016.4846","article-title":"microRNA expression pattern in pre-eclampsia (review)","volume":"13","author":"Jairajpuri","year":"2016","journal-title":"Mol Med Rep"},{"key":"B801","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jri.2011.02.006","article-title":"Placental-specific microRNA in maternal circulation \u2013identification of appropriate pregnancy-associated microRNAs with diagnostic potential","volume":"89","author":"Kotlabova","year":"2011","journal-title":"J Reprod Immunol"},{"key":"B802","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.clinbiochem.2013.01.026","article-title":"Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases","volume":"46","author":"Zhao","year":"2013","journal-title":"Clin Biochem"},{"key":"B803","doi-asserted-by":"publisher","first-page":"294954","DOI":"10.1155\/2015\/294954","article-title":"Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications","volume":"2015","author":"Tsochandaridis","year":"2015","journal-title":"Biomed Res Int"},{"key":"B804","doi-asserted-by":"publisher","first-page":"661.e661","DOI":"10.1016\/j.ajog.2008.12.045","article-title":"Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies","volume":"200","author":"Zhu","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"B805","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1479-828X.2012.01481.x","article-title":"The emerging roles of placenta-specific microRNAs in regulating trophoblast proliferation during the first trimester","volume":"52","author":"Wang","year":"2012","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B806","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1095\/biolreprod.113.107805","article-title":"Human placental microRNAs and preeclampsia","volume":"88","author":"Chen","year":"2013","journal-title":"Biol Reprod"},{"key":"B807","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/REP-14-0095","article-title":"Genome-wide miRNA profiling of villus and decidua of recurrent spontaneous abortion patients","volume":"148","author":"Dong","year":"2014","journal-title":"Reproduction"},{"key":"B808","doi-asserted-by":"publisher","first-page":"e113735","DOI":"10.1371\/journal.pone.0113735","article-title":"First trimester screening of circulating C19MC microRNAs can predict subsequent onset of gestational hypertension","volume":"9","author":"Hromadnikova","year":"2014","journal-title":"PLoS One"},{"key":"B809","doi-asserted-by":"publisher","first-page":"e0122707","DOI":"10.1371\/journal.pone.0122707","article-title":"Placental expression of miR-517a\/b and miR-517c contributes to trophoblast dysfunction and preeclampsia","volume":"10","author":"Anton","year":"2015","journal-title":"PLoS One"},{"key":"B810","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3892\/mmr.2015.3414","article-title":"Deregulated microRNA species in the plasma and placenta of patients with preeclampsia","volume":"12","author":"Yang","year":"2015","journal-title":"Mol Med Rep"},{"key":"B811","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.tjog.2014.03.001","article-title":"Potential role of circulating microRNAs as early markers of preeclampsia","volume":"53","author":"Ura","year":"2014","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B812","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1093\/nar\/gkp205","article-title":"C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts","volume":"37","author":"Bortolin-Cavaill\u00e9","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B813","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jri.2012.11.001","article-title":"Pregnancy-associated miRNA-clusters","volume":"97","author":"Morales-Prieto","year":"2013","journal-title":"J Reprod Immunol"},{"key":"B814","doi-asserted-by":"publisher","first-page":"12048","DOI":"10.1073\/pnas.1304718110","article-title":"Human placental trophoblasts confer viral resistance to recipient cells","volume":"110","author":"Delorme-Axford","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"71","key":"B815","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/j.ajog.2014.07.060","article-title":"Human trophoblasts confer resistance to viruses implicated in perinatal infection","volume":"212","author":"Bayer","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B816","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1741-7007-11-19","article-title":"A functional genomics screen for microRNA regulators of NF-kappaB signaling","volume":"11","author":"Olarerin-George","year":"2013","journal-title":"BMC Biol"},{"key":"B817","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1017\/S204017441300024X","article-title":"Characterization of the role of microRNA-517a expression in low birth weight infants","volume":"4","author":"Song","year":"2013","journal-title":"J Dev Orig Health Dis"},{"key":"B818","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1387\/ijdb.130349ys","article-title":"The role of trophoblastic microRNAs in placental viral infection","volume":"58","author":"Mouillet","year":"2014","journal-title":"Int J Dev Biol"},{"key":"B819","doi-asserted-by":"publisher","first-page":"e0146361","DOI":"10.1371\/journal.pone.0146361","article-title":"Placental microparticles and microRNAs in pregnant women with Plasmodium falciparum or HIV infection","volume":"11","author":"Moro","year":"2016","journal-title":"PLoS One"},{"key":"B820","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0002-9378(00)70342-5","article-title":"Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia","volume":"182","author":"Khatun","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"B821","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0024-3205(95)00266-9","article-title":"Effect of neuropeptide Y on endotoxin-induced suppression of the response to various agonists in conscious rats","volume":"57","author":"Hauser","year":"1995","journal-title":"Life Sci"},{"key":"B822","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1525-1594.2010.01154.x","article-title":"Plasma and tissue levels of neuropeptide y in experimental septic shock: relation to hemodynamics, inflammation, oxidative stress, and hemofiltration","volume":"35","author":"Kuncov\u00e1","year":"2011","journal-title":"Artif Organs"},{"key":"B823","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol Cell"},{"key":"B824","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1128\/mBio.00224-11","article-title":"Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia","volume":"3","author":"Bachman","year":"2012","journal-title":"mBio"},{"key":"B825","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature"},{"key":"B826","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbcan.2012.03.008","article-title":"The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer","volume":"1826","author":"Chakraborty","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B827","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/14767058.2010.487138","article-title":"Plasma lipocalin-2 levels in pregnant women with pre-eclampsia, and their relation with severity of disease","volume":"24","author":"Cemgil Arikan","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B828","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1080\/00016340802464463","article-title":"Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia","volume":"87","author":"D\u2019Anna","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B829","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/pd.2339","article-title":"First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia","volume":"29","author":"D\u2019Anna","year":"2009","journal-title":"Prenat Diagn"},{"key":"B830","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/00016340903443676","article-title":"Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia","volume":"89","author":"D\u2019Anna","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B831","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3275\/6884","article-title":"Serum levels of the adipokine lipocalin-2 are increased in preeclampsia","volume":"33","author":"Stepan","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"B832","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1177\/1933719113477480","article-title":"Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia","volume":"20","author":"Kim","year":"2013","journal-title":"Reprod Sci"},{"key":"B833","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000356499","article-title":"Prognostic role of maternal neutrophil gelatinase-associated lipocalin in women with severe early-onset preeclampsia","volume":"35","author":"Scazzochio","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"B834","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pd.4337","article-title":"Maternal serum levels of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9\/NGAL in pregnancies with preeclampsia and those with a small for gestational age neonate. A longitudinal study","volume":"34","author":"Karampas","year":"2014","journal-title":"Prenat Diagn"},{"key":"B835","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4103\/2277-9175.145690","article-title":"Correlation of serum neutrophil gelatinase associated lipocalin with disease severity in hypertensive disorders of pregnancy","volume":"3","author":"Sachan","year":"2014","journal-title":"Adv Biomed Res"},{"key":"B836","first-page":"117","article-title":"Serum and urinary neutrophil gelatinase-associated lipocalin monitoring in normal pregnancy versus pregnancies complicated by pre-eclampsia","volume":"29","author":"Simonazzi","year":"2015","journal-title":"In Vivo"},{"key":"B837","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejogrb.2016.08.034","article-title":"Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and\/or second trimester of pregnancy. A pilot study","volume":"205","author":"Karampas","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B838","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"key":"B839","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11255-009-9608-z","article-title":"NGAL: a biomarker of acute kidney injury and other systemic conditions","volume":"42","author":"Soni","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"B840","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1515\/cclm-2011-0814","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences","volume":"50","author":"Clerico","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"B841","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/IJNRD.S45523","article-title":"Correlation of serum neutrophil gelatinase-associated lipocalin with acute kidney injury in hypertensive disorders of pregnancy","volume":"6","author":"Patel","year":"2013","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B842","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3233\/DMA-130966","article-title":"The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and cystatin C in early diagnosis of septic acute kidney injury in critically ill patients","volume":"34","author":"Aydo\u011fdu","year":"2013","journal-title":"Dis Markers"},{"key":"B843","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/1354750X.2013.787460","article-title":"Association of plasma neutrophil gelatinase-associated lipocalin (NGAL) with sepsis and acute kidney dysfunction","volume":"18","author":"M\u00e5rtensson","year":"2013","journal-title":"Biomarkers"},{"key":"B844","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/cc12540","article-title":"Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis","volume":"17","author":"Otto","year":"2013","journal-title":"Crit Care"},{"key":"B845","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.231\/JIM.0b013e31829cbd14","article-title":"Peripheral monocytes derived from patients with cystic fibrosis and healthy donors secrete NGAL in response to Pseudomonas aeruginosa infection","volume":"61","author":"Zughaier","year":"2013","journal-title":"J Investig Med"},{"key":"B846","doi-asserted-by":"publisher","first-page":"e110678","DOI":"10.1371\/journal.pone.0110678","article-title":"Sustained elevation of resistin, NGAL and IL-8 are associated with severe sepsis\/septic shock in the emergency department","volume":"9","author":"MacDonald","year":"2014","journal-title":"PLoS One"},{"key":"B847","doi-asserted-by":"publisher","first-page":"717318","DOI":"10.1155\/2014\/717318","article-title":"Serum and urinary NGAL in septic newborns","volume":"2014","author":"Smertka","year":"2014","journal-title":"Biomed Res Int"},{"key":"B848","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/aas.12427","article-title":"Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis","volume":"59","author":"Hjortrup","year":"2015","journal-title":"Acta Anaesthesiol Scand"},{"key":"B849","doi-asserted-by":"publisher","first-page":"413751","DOI":"10.1155\/2015\/413751","article-title":"Sepsis and AKI in clinical emergency room patients: the role of urinary NGAL","volume":"2015","author":"Nga","year":"2015","journal-title":"Biomed Res Int"},{"key":"B850","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/0886022X.2014.996109","article-title":"Factors limiting usefulness of serum and urinary NGAL as a marker of acute kidney injury in preterm newborns","volume":"37","author":"Suchojad","year":"2015","journal-title":"Ren Fail"},{"key":"B851","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10157-014-0952-7","article-title":"An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions","volume":"19","author":"Kanda","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"B852","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000364937","article-title":"The rise and fall of NGAL in acute kidney injury","volume":"37","author":"M\u00e5rtensson","year":"2014","journal-title":"Blood Purif"},{"key":"B853","doi-asserted-by":"publisher","first-page":"e0143367","DOI":"10.1371\/journal.pone.0143367","article-title":"Neutrophil gelatinase associated lipocalin (NGAL) in leptospirosis acute kidney injury: a multicenter study in Thailand","volume":"10","author":"Srisawat","year":"2015","journal-title":"PLoS One"},{"key":"B854","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/SHK.0000000000000530","article-title":"Serum neutrophil gelatinase associated lipocalin (NGAL) outperforms serum creatinine in detecting sepsis-induced acute kidney injury, experiments on bilateral nephrectomy and bilateral ureter obstruction mouse models","volume":"45","author":"Leelahavanichkul","year":"2016","journal-title":"Shock"},{"key":"B855","doi-asserted-by":"publisher","first-page":"a011056","DOI":"10.1101\/cshperspect.a011056","article-title":"PlGF: a multitasking cytokine with disease-restricted activity","volume":"2","author":"Dewerchin","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B856","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/00016340802253759","article-title":"Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia","volume":"87","author":"De Vivo","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B857","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/pd.3995","article-title":"Can detection of late-onset PE at triage by sflt-1 or PlGF be improved by the use of additional biomarkers?","volume":"32","author":"Kaufmann","year":"2012","journal-title":"Prenat Diagn"},{"key":"B858","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/uog.12400","article-title":"Uterine artery Doppler and sFlt-1\/PlGF ratio: usefulness in diagnosis of pre-eclampsia","volume":"41","author":"G\u00f3mez-Arriaga","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B859","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/hr.2013.95","article-title":"Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation","volume":"36","author":"Ohkuchi","year":"2013","journal-title":"Hypertens Res"},{"key":"B860","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/hr.2014.31","article-title":"A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation","volume":"37","author":"Hirashima","year":"2014","journal-title":"Hypertens Res"},{"key":"B861","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000359968","article-title":"Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks\u2019 gestation","volume":"35","author":"Lai","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"B862","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejogrb.2014.01.012","article-title":"Biomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case-control study","volume":"175","author":"Masoura","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B863","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.preghy.2014.04.024","article-title":"A trio of risk factors for the onset of preeclampsia in the second and early third trimesters","volume":"4","author":"Ohkuchi","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"B864","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/uog.14760","article-title":"Maternal serum sFlt-1\/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies","volume":"45","author":"Dr\u00f6ge","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B865","doi-asserted-by":"publisher","first-page":"127083","DOI":"10.1155\/2015\/127083","article-title":"Is it possible to differentiate chronic kidney disease and preeclampsia by means of new and old biomarkers? A prospective study","volume":"2015","author":"Rolfo","year":"2015","journal-title":"Dis Markers"},{"key":"B866","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B867","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/uog.15750","article-title":"Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia","volume":"47","author":"Khalil","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B868","doi-asserted-by":"publisher","first-page":"108.e101","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"B869","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"B870","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"JAMA"},{"key":"B871","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/Jp.2013.176","article-title":"Placental pathology, first-trimester biomarkers and adverse pregnancy outcomes","volume":"34","author":"Odibo","year":"2014","journal-title":"J Perinatol"},{"key":"B872","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.kint.2015.10.012","article-title":"Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease","volume":"89","author":"Bramham","year":"2016","journal-title":"Kidney Int"},{"key":"B873","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/AOG.0000000000001508","article-title":"Diagnostic biomarkers in women with suspected preeclampsia in a prospective multicenter study","volume":"128","author":"Duckworth","year":"2016","journal-title":"Obstet Gynecol"},{"key":"B874","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1084\/jem.20060375","article-title":"Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality","volume":"203","author":"Yano","year":"2006","journal-title":"J Exp Med"},{"key":"B875","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1084\/jem.20080398","article-title":"Elevated levels of placental growth factor represent an adaptive host response in sepsis","volume":"205","author":"Yano","year":"2008","journal-title":"J Exp Med"},{"key":"B876","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jri.2009.09.001","article-title":"Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia \u2013 a step forward but not the definitive answer","volume":"82","author":"Foidart","year":"2009","journal-title":"J Reprod Immunol"},{"key":"B877","doi-asserted-by":"publisher","first-page":"123717","DOI":"10.1155\/2011\/123717","article-title":"Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia","volume":"2011","author":"Furuya","year":"2011","journal-title":"J Pregnancy"},{"key":"B878","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejogrb.2011.04.049","article-title":"sFlt-1 and PlGF levels in a patient with mirror syndrome related to cytomegalovirus infection","volume":"158","author":"De Oliveira","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"163","key":"B879","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/j.ajog.2011.09.019","article-title":"Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction?","volume":"206","author":"Benton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"B880","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.kint.2016.01.008","article-title":"Promising biomarkers for superimposed pre-eclampsia in pregnant women with established hypertension and chronic kidney disease","volume":"89","author":"Acharya","year":"2016","journal-title":"Kidney Int"},{"key":"B881","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1515\/CCLM.2008.199","article-title":"Procalcitonin values in preeclamptic women are related to severity of disease","volume":"46","author":"Montagnana","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"B882","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1515\/CCLM.2011.232","article-title":"Inflammatory markers in preeclamptic patients","volume":"49","author":"Can","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"B883","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","volume":"39","author":"Simon","year":"2004","journal-title":"Clin Infect Dis"},{"key":"B884","doi-asserted-by":"publisher","first-page":"737141","DOI":"10.1155\/2008\/737141","article-title":"Serum amyloid A, procalcitonin, tumor necrosis factor-alpha, and interleukin-1beta levels in neonatal late-onset sepsis","volume":"2008","author":"Ucar","year":"2008","journal-title":"Mediators Inflamm"},{"key":"B885","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1309\/AJCP1MFYINQLECV2","article-title":"Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department","volume":"135","author":"Riedel","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"B886","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2012.05.002","article-title":"Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis","volume":"73","author":"Riedel","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B887","doi-asserted-by":"publisher","first-page":"CD007498","DOI":"10.1002\/14651858.CD007498.pub2","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"9","author":"Schuetz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B888","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1186\/cc12847","article-title":"Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study","volume":"17","author":"Ulla","year":"2013","journal-title":"Crit Care"},{"key":"B889","doi-asserted-by":"publisher","first-page":"547818","DOI":"10.1155\/2014\/547818","article-title":"Biomarkers for sepsis","volume":"2014","author":"Henriquez-Camacho","year":"2014","journal-title":"Biomed Res Int"},{"key":"B890","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jocn.2013.09.021","article-title":"Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit","volume":"21","author":"Tian","year":"2014","journal-title":"J \u2009Clin Neurosci"},{"key":"B891","doi-asserted-by":"publisher","first-page":"v","DOI":"10.3310\/hta19960","article-title":"Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis","volume":"19","author":"Westwood","year":"2015","journal-title":"Health Technol Assess"},{"key":"B892","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000100329","article-title":"Serum amyloid A levels are increased in pre-eclampsia","volume":"64","author":"Engin-\u00dcst\u00fcn","year":"2007","journal-title":"Gynecol Obstet Invest"},{"key":"B893","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000214081","article-title":"Serum amyloid A protein and C-reactive protein in normal pregnancy and preeclampsia","volume":"67","author":"Kristensen","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"B894","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2362.1996.159291.x","article-title":"Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice","volume":"26","author":"Malle","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"B895","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/00365540050165848","article-title":"C-reactive protein and serum amyloid A protein in neonatal infections","volume":"32","author":"Pizzini","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"B896","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/13506120009146815","article-title":"Serum amyloid A: from fibril to function. Current status","volume":"7","author":"Sipe","year":"2000","journal-title":"Amyloid"},{"key":"B897","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","article-title":"Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states","volume":"7","author":"Urieli-Shoval","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"B898","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1086\/319275","article-title":"Response of C-reactive protein and serum amyloid A to influenza A infection in older adults","volume":"183","author":"Falsey","year":"2001","journal-title":"J Infect Dis"},{"key":"B899","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/sj.jp.7211682","article-title":"Serum amyloid A: an early and accurate marker of neonatal early-onset sepsis","volume":"27","author":"Arnon","year":"2007","journal-title":"J Perinatol"},{"key":"B900","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1164\/rccm.200705-678OC","article-title":"Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease","volume":"177","author":"Bozinovski","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"B901","doi-asserted-by":"publisher","first-page":"631414","DOI":"10.1155\/2008\/631414","article-title":"Comparison of C-reactive protein and serum amyloid a protein in septic shock patients","volume":"2008","author":"Cicarelli","year":"2008","journal-title":"Mediators Inflamm"},{"key":"B902","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1572-0241.2007.01669.x","article-title":"Gastrointestinal manifestations of amyloidosis","volume":"103","author":"Ebert","year":"2008","journal-title":"Am J \u2009Gastroenterol"},{"key":"B903","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1651-2227.2008.00814.x","article-title":"Human serum amyloid A\u2009(SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections","volume":"97","author":"Lannerg\u00e5rd","year":"2008","journal-title":"Acta Paediatr"},{"key":"B904","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/jp.2008.207","article-title":"Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants","volume":"29","author":"\u00c7etinkaya","year":"2009","journal-title":"J Perinatol"},{"key":"B905","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/00365540903127417","article-title":"The time course of body temperature, serum amyloid A protein, C-reactive protein and interleukin-6 in patients with bacterial infection during the initial 3 days of antibiotic therapy","volume":"41","author":"Lannerg\u00e5rd","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"B906","doi-asserted-by":"publisher","first-page":"520294","DOI":"10.1155\/2013\/520294","article-title":"Diagnosis value of the serum amyloid A test in neonatal sepsis: a meta-analysis","volume":"2013","author":"Yuan","year":"2013","journal-title":"Biomed Res Int"},{"key":"B907","doi-asserted-by":"publisher","first-page":"e03206","DOI":"10.7554\/eLife.03206","article-title":"Serum amyloid A is a retinol binding protein that transports retinol during bacterial infection","volume":"3","author":"Derebe","year":"2014","journal-title":"Elife"},{"key":"B908","doi-asserted-by":"publisher","first-page":"245ra292","DOI":"10.1126\/scitranslmed.3008808","article-title":"Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia","volume":"6","author":"Buhimschi","year":"2014","journal-title":"Sci Transl Med"},{"key":"B909","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0197-4580(03)00127-1","article-title":"Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB\/c mice","volume":"25","author":"Little","year":"2004","journal-title":"Neurobiol Aging"},{"key":"B910","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","article-title":"Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation","volume":"429","author":"Wozniak","year":"2007","journal-title":"Neurosci Lett"},{"key":"B911","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3109\/14767058.2011.556204","article-title":"Fetal endothelium dysfunction is associated with circulating maternal levels of sE-selectin, sVCAM1, and sFlt-1 during pre-eclampsia","volume":"24","author":"Veas","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B912","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/j.1471-0528.2011.02962.x","article-title":"Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia","author":"Whitehead","year":"2011","journal-title":"BJOG"},{"key":"B913","doi-asserted-by":"publisher","first-page":"e0129117","DOI":"10.1371\/journal.pone.0129117","article-title":"Placental features of late-onset adverse pregnancy outcome","volume":"10","author":"Higgins","year":"2015","journal-title":"PLoS One"},{"key":"B914","doi-asserted-by":"publisher","first-page":"a023473","DOI":"10.1101\/cshperspect.a023473","article-title":"Molecular mechanisms of preeclampsia","volume":"5","author":"Hod","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B915","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"B916","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1681\/ASN.2011040369","article-title":"eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype","volume":"23","author":"Li","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B917","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrneph.2015.168","article-title":"Hypertension: sFlt-1 removal seems to be beneficial in women with pre-eclampsia","volume":"11","author":"Carney","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B918","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1681\/ASN.2015020157","article-title":"Removal of soluble fms-like tyrosine kinase-1 by dextran sulfate apheresis in preeclampsia","volume":"27","author":"Thadhani","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B919","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/SHK.0b013e31815072c1","article-title":"A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis","volume":"29","author":"Shapiro","year":"2008","journal-title":"Shock"},{"key":"B920","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/SHK.0b013e31821e4e04","article-title":"Endothelial cell activation in emergency department patients with sepsis-related and non-sepsis-related hypotension","volume":"36","author":"Schuetz","year":"2011","journal-title":"Shock"},{"key":"B921","doi-asserted-by":"publisher","first-page":"R182","DOI":"10.1186\/cc9290","article-title":"The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis","volume":"14","author":"Shapiro","year":"2010","journal-title":"Crit Care"},{"key":"B922","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1479-5876-9-23","article-title":"Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study","volume":"9","author":"Alves","year":"2011","journal-title":"J Transl Med"},{"key":"B923","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/cc11145","article-title":"Clinical utility of biomarkers of endothelial activation in sepsis \u2013 a systematic review","volume":"16","author":"Xing","year":"2012","journal-title":"Crit Care"},{"key":"B924","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-9378(93)90151-8","article-title":"Elevated circulating thrombomodulin in severe preeclampsia","volume":"169","author":"Hsu","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"B925","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000292631","article-title":"Increased levels of plasma thrombomodulin in preeclampsia","volume":"36","author":"Minakami","year":"1993","journal-title":"Gynecol Obstet Invest"},{"key":"B926","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0028-2243(95)02093-8","article-title":"Maternal plasma level of thrombomodulin is increased in mild preeclampsia","volume":"60","author":"Bontis","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B927","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0029-7844(95)00326-M","article-title":"Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension","volume":"86","author":"Hsu","year":"1995","journal-title":"Obstet Gynecol"},{"key":"B928","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0020-7292(96)02755-5","article-title":"Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia","volume":"55","author":"Shaarawy","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"key":"B929","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1055\/s-0037-1615021","article-title":"Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension","volume":"79","author":"Boffa","year":"1998","journal-title":"Thromb Haemost"},{"key":"B930","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0029-7844(98)00217-8","article-title":"Thrombomodulin release from umbilical endothelial cells initiated by preeclampsia plasma-induced neutrophil activation","volume":"92","author":"Kobayashi","year":"1998","journal-title":"Obstet Gynecol"},{"key":"B931","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"key":"B932","first-page":"1045","article-title":"Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE)","volume":"20","author":"Bosco","year":"2005","journal-title":"Histol Histopathol"},{"key":"B933","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1076029607303965","article-title":"Correlation between thrombomodulin and severe preeclampsia: a summary","volume":"14","author":"Wiwanitkit","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"B934","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/ATVBAHA.306780","article-title":"Loss of thrombomodulin in placental dysfunction in preeclampsia","volume":"36","author":"Turner","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B935","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B936","first-page":"294","article-title":"Thrombomodulin in sepsis","volume":"79","author":"Levi","year":"2013","journal-title":"Minerva Anestesiol"},{"key":"B937","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.thromres.2013.03.008","article-title":"Impact of recombinant soluble thrombomodulin (thrombomodulin alfa) on disseminated intravascular coagulation","volume":"131","author":"Mimuro","year":"2013","journal-title":"Thromb Res"},{"key":"B938","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit Care Med"},{"key":"B939","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00431-013-2155-8","article-title":"Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation","volume":"173","author":"Shirahata","year":"2014","journal-title":"Eur J Pediatr"},{"key":"B940","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/jth.12868","article-title":"Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality","volume":"13","author":"Levi","year":"2015","journal-title":"J Thromb Haemost"},{"key":"B941","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jth.12841","article-title":"Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis","volume":"13","author":"Yamakawa","year":"2015","journal-title":"J Thromb Haemost"},{"key":"B942","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13054-015-0810-3","article-title":"Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis","volume":"19","author":"Yoshimura","year":"2015","journal-title":"Crit Care"},{"key":"B943","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1160\/TH15-12-0987","article-title":"Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study","volume":"115","author":"Hayakawa","year":"2016","journal-title":"Thromb Haemost"},{"key":"B944","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.ajog.2005.06.053","article-title":"Toll-like receptor 4: a potential link between \u201cdanger signals,\u201d the innate immune system and preeclampsia?","volume":"193","author":"Kim","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"B945","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jri.2007.03.006","article-title":"Preeclampsia: a view through the danger model","volume":"76","author":"Bonney","year":"2007","journal-title":"J Reprod Immunol"},{"key":"B946","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2265.2007.03147.x","article-title":"Serum levels of the adipokine visfatin are increased in pre-eclampsia","volume":"69","author":"Fasshauer","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B947","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1080\/14767050902994622","article-title":"Increased visfatin and leptin in pregnancies complicated by pre-eclampsia","volume":"22","author":"Adali","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B948","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3109\/14767050903572190","article-title":"Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate","volume":"23","author":"Mazaki-Tovi","year":"2010","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B949","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/00016340801976012","article-title":"Serum visfatin levels in late pregnancy and pre-eclampsia","volume":"87","author":"Hu","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B950","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc13733","article-title":"Soluble adhesion molecules as markers for sepsis and the potential pathophysiological discrepancy in neonates, children and adults","volume":"18","author":"Zonneveld","year":"2014","journal-title":"Crit Care"},{"key":"B951","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejim.2012.10.009","article-title":"Circulating sICAM-1 and sE-selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome","volume":"24","author":"de Pablo","year":"2013","journal-title":"Eur J Intern Med"},{"issue":"Suppl 2","key":"B952","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/14767058.2011.601923","article-title":"Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers","volume":"24","author":"Mussap","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B953","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.cca.2011.07.024","article-title":"Development of a point-of-care assay system for measurement of presepsin (sCD14-ST)","volume":"412","author":"Okamura","year":"2011","journal-title":"Clin Chim Acta"},{"key":"B954","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10156-012-0435-2","article-title":"Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study","volume":"18","author":"Endo","year":"2012","journal-title":"J Infect Chemother"},{"key":"B955","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jiac.2013.07.005","article-title":"Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: a multicenter prospective study","volume":"20","author":"Endo","year":"2014","journal-title":"J Infect Chemother"},{"key":"B956","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2253-14-88","article-title":"Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury","volume":"14","author":"Nakamura","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"B957","doi-asserted-by":"publisher","first-page":"e0133057","DOI":"10.1371\/journal.pone.0133057","article-title":"Accuracy of presepsin in sepsis diagnosis: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"B958","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2016.06.030","article-title":"Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis","volume":"460","author":"Ali","year":"2016","journal-title":"Clin Chim Acta"},{"key":"B959","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13613-016-0160-6","article-title":"Diagnostic and prognostic value of soluble CD14 subtype (presepsin) for sepsis and community-acquired pneumonia in ICU patients","volume":"6","author":"Klouche","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"Pt A","key":"B960","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijsu.2016.07.070","article-title":"Prognostic value of presepsin for outcomes and complications in enterocutaneous fistula complicated by abdominal sepsis","volume":"33","author":"Song","year":"2016","journal-title":"Int J Surg"},{"key":"B961","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.diagmicrobio.2016.07.015","article-title":"Diagnostic accuracy of procalcitonin and presepsin for infectious disease in patients with acute kidney injury","volume":"86","author":"Takahashi","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B962","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1574-6968.1986.tb01863.x","article-title":"Metabolic control theory: its role in microbiology and biotechnology","volume":"39","author":"Kell","year":"1986","journal-title":"FEMS Microbiol Rev"},{"key":"B963","first-page":"1651","article-title":"Forces, fluxes and the control of microbial growth and metabolism. The twelfth Fleming lecture","volume":"133","author":"Kell","year":"1987","journal-title":"J Gen Microbiol"},{"key":"B964","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/bj2860313","article-title":"Metabolic control analysis \u2013 a survey of its theoretical and experimental development","volume":"286","author":"Fell","year":"1992","journal-title":"Biochem J"},{"key":"B965","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4613-1161-4","volume-title":"The Regulation of Cellular Systems","author":"Heinrich","year":"1996"},{"key":"B966","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11306-016-1108-4","article-title":"The metabolome 18 years on: a concept comes of age","volume":"12","author":"Kell","year":"2016","journal-title":"Metabolomics"},{"key":"B967","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0167-7799(98)01214-1","article-title":"Systematic functional analysis of the yeast genome","volume":"16","author":"Oliver","year":"1998","journal-title":"Trends Biotechnol"},{"key":"B968","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/35054646","article-title":"Silent genes given voice","volume":"409","author":"Cornish-Bowden","year":"2001","journal-title":"Nature"},{"key":"B969","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/83496","article-title":"A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations","volume":"19","author":"Raamsdonk","year":"2001","journal-title":"Nat Biotechnol"},{"key":"B970","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibtech.2004.03.007","article-title":"Metabolomics by numbers: acquiring and understanding global metabolite data","volume":"22","author":"Goodacre","year":"2004","journal-title":"Trends Biotechnol"},{"key":"B971","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mib.2004.04.012","article-title":"Metabolomics and systems biology: making sense of the soup","volume":"7","author":"Kell","year":"2004","journal-title":"Curr Opin Microbiol"},{"key":"B972","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/nrg1471","article-title":"Biological robustness","volume":"5","author":"Kitano","year":"2004","journal-title":"Nat Rev Genet"},{"issue":"Suppl 3","key":"B973","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.2337\/diabetes.53.suppl_3.S6","article-title":"Metabolic syndrome and robustness tradeoffs","volume":"53","author":"Kitano","year":"2004","journal-title":"Diabetes"},{"key":"B974","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1049\/sb:20045004","article-title":"Analysis of structural robustness of metabolic networks","volume":"1","author":"Wilhelm","year":"2004","journal-title":"Syst Biol (Stevenage)"},{"key":"B975","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/msb4100186","article-title":"The stability and robustness of metabolic states: identifying stabilizing sites in metabolic networks","volume":"3","author":"Grimbs","year":"2007","journal-title":"Mol Syst Biol"},{"key":"B976","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1111\/febs.12268","article-title":"Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening, and knowledge of transporters: where drug discovery went wrong and how to fix it","volume":"280","author":"Kell","year":"2013","journal-title":"FEBS J"},{"key":"B977","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/febs.12057","article-title":"Trade-off of dynamic fragility but not of robustness in metabolic pathways in silico","volume":"280","author":"Quinton-Tulloch","year":"2013","journal-title":"FEBS J"},{"key":"B978","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.drudis.2013.07.014","article-title":"Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery","volume":"19","author":"Kell","year":"2014","journal-title":"Drug Discov Today"},{"key":"B979","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1021\/ac9011599","article-title":"Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale non-targeted metabolomic studies of human serum","volume":"81","author":"Begley","year":"2009","journal-title":"Anal Chem"},{"key":"B980","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1021\/ac8019366","article-title":"Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum","volume":"81","author":"Zelena","year":"2009","journal-title":"Anal Chem"},{"key":"B981","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"Dunn","year":"2011","journal-title":"Nat Protoc"},{"key":"B982","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11306-014-0707-1","article-title":"Molecular phenotyping of a UK population: defining the human serum metabolome","volume":"11","author":"Dunn","year":"2015","journal-title":"Metabolomics"},{"key":"B983","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s11306-013-0564-3","article-title":"An analysis of a \u2018community-driven\u2019 reconstruction of the human metabolic network","volume":"9","author":"Swainston","year":"2013","journal-title":"Metabolomics"},{"key":"B984","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nbt.2488","article-title":"A community-driven global reconstruction of human metabolism","volume":"31","author":"Thiele","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B985","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11306-016-1051-4","article-title":"Recon 2.2: from reconstruction to model of human metabolism","volume":"12","author":"Swainston","year":"2016","journal-title":"Metabolomics"},{"key":"B986","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/nbt1492","article-title":"A consensus yeast metabolic network obtained from a community approach to systems biology","volume":"26","author":"Herrg\u00e5rd","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B987","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0301-2115(00)00367-5","article-title":"Pathophysiology of preeclampsia and the role of serotonin","volume":"95","author":"Bolte","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B988","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0169-5347(00)89013-8","article-title":"On pheromones, social behaviour and the functions of secondary metabolism in bacteria","volume":"10","author":"Kell","year":"1995","journal-title":"Trends Ecol Evol"},{"key":"B989","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.mib.2006.04.003","article-title":"Gamma-butyrolactones: Streptomyces signalling molecules regulating antibiotic production and differentiation","volume":"9","author":"Takano","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"B990","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000358338","article-title":"Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis","volume":"63","author":"Hypp\u00f6nen","year":"2013","journal-title":"Ann Nutr Metab"},{"key":"B991","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1210\/jc.2013-1257","article-title":"Maternal vitamin D status and risk of pre-eclampsia: a systematic review and meta-analysis","volume":"98","author":"Tabesh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B992","first-page":"16280","article-title":"Comparison of vitamin D levels in cases with preeclampsia, eclampsia and healthy pregnant women","volume":"8","author":"Bakacak","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B993","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.3390\/nu7085293","article-title":"Vitamin D and inflammatory cytokines in healthy and preeclamptic pregnancies","volume":"7","author":"Barrera","year":"2015","journal-title":"Nutrients"},{"key":"B994","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000441781","article-title":"Vitamin D status is related to oxidative stress but not high-sensitive C-reactive protein in women with pre-eclampsia","volume":"81","author":"Gargari","year":"2015","journal-title":"Gynecol Obstet Invest"},{"key":"B995","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18450","article-title":"Vitamin D supplementation in pregnancy: a systematic review","volume":"18","author":"Harvey","year":"2014","journal-title":"Health Technol Assess"},{"key":"B996","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3945\/ajcn.116.130419","article-title":"Vitamin D status is associated with utero-placental dysfunction in a large prospective pregnancy cohort with low 25(OH)D3 and ubiquitous 3-epi-25(OH)D3 and 25(OH)D2","volume":"102","author":"Kiely","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"B997","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2015.12.007","article-title":"Is first trimester vitamin D status in nulliparous women associated with pregnancy related hypertensive disorders?","volume":"34","author":"van Weert","year":"2016","journal-title":"Midwifery"},{"key":"B998","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jsbmb.2016.02.008","article-title":"Vitamin D supplementation during pregnancy: updated meta-analysis on maternal outcomes","volume":"164","author":"Palacios","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B999","doi-asserted-by":"publisher","first-page":"530.e1","DOI":"10.1016\/j.ajog.2015.06.044","article-title":"Validation of metabolomic models for prediction of early-onset preeclampsia","volume":"213","author":"Bahado-Singh","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"B1000","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/15548627.2015.1034414","article-title":"Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia","volume":"11","author":"Melland-Smith","year":"2015","journal-title":"Autophagy"},{"key":"B1001","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.neuint.2012.11.015","article-title":"Genetics and iron in the systems biology of Parkinson\u2019s disease and some related disorders","volume":"62","author":"Funke","year":"2013","journal-title":"Neurochem Int"},{"key":"B1002","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-0528.1998.tb10179.x","article-title":"A role for noradrenaline in pre-eclampsia: towards a unifying hypothesis for the pathophysiology","volume":"105","author":"Manyonda","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"B1003","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1471-0528.1998.tb09944.x","article-title":"Association of circulating endothelium and noradrenaline with increased calcium-channel binding sites in the placental bed in pre-eclampsia","volume":"105","author":"Ferreira-de-Almeida","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"B1004","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0024-3205(92)90273-R","article-title":"Catecholamine-induced growth of Gram-negative bacteria","volume":"50","author":"Lyte","year":"1992","journal-title":"Life Sci"},{"key":"B1005","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1574-6968.1999.tb13449.x","article-title":"Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers","volume":"172","author":"Freestone","year":"1999","journal-title":"FEMS Microbiol Lett"},{"key":"B1006","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1128\/AEM.68.10.4788-4794.2002","article-title":"Resuscitation of Salmonella enterica serovar typhimurium and enterohemorrhagic Escherichia coli from the viable but nonculturable state by heat-stable enterobacterial autoinducer","volume":"68","author":"Reissbrodt","year":"2002","journal-title":"Appl Environ Microbiol"},{"key":"B1007","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.tim.2003.11.004","article-title":"Microbial endocrinology and infectious disease in the 21st century","volume":"12","author":"Lyte","year":"2004","journal-title":"Trends Microbiol"},{"key":"B1008","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1017\/S146625231400019X","article-title":"The effect of stress on microbial growth","volume":"15","author":"Lyte","year":"2014","journal-title":"Anim Health Res Rev"},{"key":"B1009","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1128\/JB.182.21.6091-6098.2000","article-title":"The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin","volume":"182","author":"Freestone","year":"2000","journal-title":"J Bacteriol"},{"key":"B1010","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0378-1097(03)00243-X","article-title":"Involvement of enterobactin in norepinephrine-mediated iron supply from transferrin to enterohaemorrhagic Escherichia coli","volume":"222","author":"Freestone","year":"2003","journal-title":"FEMS Microbiol Lett"},{"key":"B1011","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1128\/AEM.00075-06","article-title":"Enhancement of in vitro growth of pathogenic bacteria by norepinephrine: importance of inoculum density and role of transferrin","volume":"72","author":"O\u2019Donnell","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"B1012","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1152\/physrev.00042.2006","article-title":"Catecholaminergic systems in stress: structural and molecular genetic approaches","volume":"89","author":"Kvetnansky","year":"2009","journal-title":"Physiol Rev"},{"key":"B1013","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1109\/EMBC.2015.7319876","article-title":"Metabolite analysis in sepsis through conditional independence maps","volume":"2015","author":"Ribas Ripoll","year":"2015","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"B1014","doi-asserted-by":"publisher","first-page":"e000056","DOI":"10.1136\/bmjresp-2014-000056","article-title":"Discrimination of sepsis stage metabolic profiles with an LC\/MS-MS-based metabolomics approach","volume":"1","author":"Su","year":"2014","journal-title":"BMJ Open Respir Res"},{"key":"B1015","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.mehy.2015.10.022","article-title":"A suggestion about the cause of inflammation in acute atherosis complicating poor placentation in preeclampsia","volume":"85","author":"Eggers","year":"2015","journal-title":"Med Hypotheses"},{"key":"B1016","first-page":"101","article-title":"The clinical utility of serum uric acid measurements in pre-eclampsia and transient hypertension in pregnancy","volume":"42","author":"D\u2019Anna","year":"2000","journal-title":"Panminerva Med"},{"key":"B1017","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S1701-2163(16)30193-1","article-title":"The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies","volume":"24","author":"Williams","year":"2002","journal-title":"J Obstet Gynaecol Can"},{"key":"B1018","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/01.HYP.0000188703.27002.14","article-title":"Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension","volume":"46","author":"Roberts","year":"2005","journal-title":"Hypertension"},{"key":"B1019","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1016\/j.placenta.2007.11.001","article-title":"Uric acid as a pathogenic factor in preeclampsia","volume":"29","author":"Bainbridge","year":"2008","journal-title":"Placenta"},{"key":"B1020","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejogrb.2009.05.014","article-title":"Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis","volume":"146","author":"Koopmans","year":"2009","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B1021","doi-asserted-by":"publisher","first-page":"CC04","DOI":"10.7860\/JCDR\/2014\/7901.4533","article-title":"Association of lipid profile and uric acid with pre-eclampsia of third trimester in nullipara women","volume":"8","author":"Agarwal","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"B1022","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7754\/Clin.Lab.2013.121228","article-title":"Association between uric acid and severity of pre-eclampsia","volume":"60","author":"Pereira","year":"2014","journal-title":"Clin Lab"},{"key":"B1023","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0002-9378(98)70549-6","article-title":"The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy","volume":"178","author":"Lim","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"B1024","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/00016340500342037","article-title":"Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review","volume":"85","author":"Cnossen","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B1025","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajog.2005.06.066","article-title":"Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery","volume":"194","author":"Powers","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"B1026","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1471-0528.2006.00908.x","article-title":"Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review","volume":"113","author":"Thangaratinam","year":"2006","journal-title":"BJOG"},{"key":"B1027","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/jhh.2015.47","article-title":"Serum uric acid may not be involved in the development of preeclampsia","volume":"30","author":"Chen","year":"2016","journal-title":"J Hum Hypertens"},{"key":"B1028","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2012","journal-title":"N Engl J Med"},{"key":"B1029","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1038\/tp.2013.18","article-title":"Alterations in metabolic pathways and networks in Alzheimer\u2019s disease","volume":"3","author":"Kaddurah-Daouk","year":"2013","journal-title":"Transl Psychiatry"},{"key":"B1030","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000346370","article-title":"Postmortem brain levels of urate and precursors in Parkinson\u2019s disease and related disorders","volume":"12","author":"McFarland","year":"2013","journal-title":"Neurodegener Dis"},{"key":"B1031","article-title":"Mass spectral imaging shows major derangements in neurogranin and in purine metabolism in the triple-knockout 3xTg Alzheimer-like mouse model","author":"Esteve","year":"Forthcoming 2016","journal-title":"Front Neurosci"},{"key":"B1032","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.0105-2896.2009.00860.x","article-title":"Mechanisms of uric acid crystal-mediated autoinflammation","volume":"233","author":"Martinon","year":"2010","journal-title":"Immunol Rev"},{"key":"B1033","doi-asserted-by":"publisher","first-page":"e39321","DOI":"10.1371\/journal.pone.0039321","article-title":"Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach","volume":"7","author":"Lyngdoh","year":"2012","journal-title":"PLoS One"},{"key":"B1034","doi-asserted-by":"publisher","first-page":"e5194","DOI":"10.1371\/Journal.Pone.0005194","article-title":"Uric acid is a mediator of the Plasmodium falciparum-induced inflammatory response","volume":"4","author":"Orengo","year":"2009","journal-title":"PLoS One"},{"key":"B1035","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"Kool","year":"2008","journal-title":"J Exp Med"},{"key":"B1036","volume-title":"Comprehensive Metabolomics Analysis of Peanut Allergy and Peanut-Induced Anaphylaxis [Ph.D. Thesis] Open Access Dissertations and Theses. Paper 7733","author":"Chalcraft","year":"2013"},{"key":"B1037","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s11306-013-0589-7","article-title":"Comprehensive metabolomic analysis of peanut-induced anaphylaxis in a murine model","volume":"10","author":"Chalcraft","year":"2014","journal-title":"Metabolomics"},{"key":"B1038","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/all.12579","article-title":"Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy","volume":"70","author":"Kong","year":"2015","journal-title":"Allergy"},{"key":"B1039","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V76.12.2520.2520","article-title":"Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways","volume":"76","author":"van Deventer","year":"1990","journal-title":"Blood"},{"key":"B1040","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1182\/blood.V87.12.5051.bloodjournal87125051","article-title":"The proinflammatory cytokine response to coagulation and endotoxin in whole blood","volume":"87","author":"Johnson","year":"1996","journal-title":"Blood"},{"key":"B1041","first-page":"744","article-title":"From the bench to the bedside: the future of sepsis research. Executive summary of an American College of Chest Physicians, National Institute of Allergy and Infectious Disease, and National Heart, Lung, and Blood Institute Workshop","volume":"111","author":"American College of Chest Physicians","year":"1997","journal-title":"Chest"},{"key":"B1042","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/01.ATV.19.10.2517","article-title":"Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen","volume":"19","author":"Pernerstorfer","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B1043","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1182\/blood.V95.5.1729.005k16_1729_1734","article-title":"Lepirudin blunts endotoxin-induced coagulation activation","volume":"95","author":"Pernerstorfer","year":"2000","journal-title":"Blood"},{"key":"B1044","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1086\/374835","article-title":"Inflammation and coagulation: implications for the septic patient","volume":"36","author":"Dellinger","year":"2003","journal-title":"Clin Infect Dis"},{"key":"B1045","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"Schouten","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B1046","first-page":"147","article-title":"Recent insights into the pathogenesis of bacterial sepsis","volume":"68","author":"Anas","year":"2010","journal-title":"Neth J Med"},{"key":"B1047","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.4081\/pr.2011.e30","article-title":"The coagulopathy in sepsis: significance and implications for treatment","volume":"3","author":"Saracco","year":"2011","journal-title":"Pediatr Rep"},{"key":"B1048","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.aat.2014.11.002","article-title":"Coagulation abnormalities in sepsis","volume":"53","author":"Tsao","year":"2015","journal-title":"Acta Anaesthesiol Taiwan"},{"key":"B1049","doi-asserted-by":"publisher","first-page":"e80192","DOI":"10.1371\/journal.pone.0080192","article-title":"Capture of lipopolysaccharide (endotoxin) by the blood clot: a comparative study","volume":"8","author":"Armstrong","year":"2013","journal-title":"PLoS One"},{"key":"B1050","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jri.2014.02.004","article-title":"Fibrinogen, an endogenous ligand of toll-like receptor 4, activates monocytes in pre-eclamptic patients","volume":"103","author":"Al-ofi","year":"2014","journal-title":"J Reprod Immunol"},{"key":"B1051","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/BF01936958","article-title":"Studies on plasma fibrinogen level in pre-eclampsia and eclampsia","volume":"34","author":"Chatterjee","year":"1978","journal-title":"Experientia"},{"key":"B1052","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.thromres.2003.08.025","article-title":"Increased high molecular weight fibrinogen in pre-eclampsia","volume":"111","author":"Manten","year":"2003","journal-title":"Thromb Res"},{"key":"B1053","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejogrb.2004.12.009","article-title":"Association of fibrinogen and C-reactive protein with severity of preeclampsia","volume":"121","author":"\u00dcst\u00fcn","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B1054","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijgo.2008.11.016","article-title":"Inflammatory markers in pre-eclampsia and related conditions","author":"Sersam","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"B1055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.58739\/jcbs\/v03i4.12","article-title":"Evaluation of plasma fibrinogen and plasma fibrin degradation product (FDP) in preeclampsia","volume":"3","author":"Sogani","year":"2013","journal-title":"J Clin Biomed Sci"},{"key":"B1056","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00003081-199235020-00015","article-title":"Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia","volume":"35","author":"Perry","year":"1992","journal-title":"Clin Obstet Gynecol"},{"key":"B1057","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0020-7292(94)90301-8","article-title":"Screening for consumptive coagulopathy in preeclampsia","volume":"46","author":"Metz","year":"1994","journal-title":"Int J Gynecol Obstet"},{"issue":"Suppl 2","key":"B1058","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/humrep\/10.suppl_2.121","article-title":"Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia","volume":"10","author":"Gilabert","year":"1995","journal-title":"Hum Reprod"},{"key":"B1059","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00001721-199706000-00004","article-title":"Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and\/or kidney in preeclampsia","volume":"8","author":"He","year":"1997","journal-title":"Blood Coagul Firbinolysis"},{"key":"B1060","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2215\/CJN.03761106","article-title":"Pathophysiology of the clinical manifestations of preeclampsia","volume":"2","author":"Hladunewich","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B1061","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1160\/TH06-10-0606","article-title":"The management of thrombosis in pregnancy: role of low-molecular-weight heparin","volume":"97","author":"Kher","year":"2007","journal-title":"Thromb Haemost"},{"key":"B1062","first-page":"321","article-title":"Coagulation factors in severe preeclampsia","volume":"11","author":"Jahromi","year":"2009","journal-title":"Iran Red Crescent Med J"},{"key":"B1063","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1016\/j.annfar.2010.03.012","article-title":"Clotting disorders and preeclampsia (in French)","volume":"29","author":"Ducloy-Bouthors","year":"2010","journal-title":"Ann Fr Anesth Reanim"},{"key":"B1064","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jri.2010.05.002","article-title":"Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies","volume":"86","author":"Mart\u00ednez-Zamora","year":"2010","journal-title":"J Reprod Immunol"},{"key":"B1065","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2010.09.030","article-title":"Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation","volume":"412","author":"Dusse","year":"2011","journal-title":"Clin Chim Acta"},{"key":"B1066","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11239-012-0708-8","article-title":"Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor","volume":"34","author":"Godoi","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"B1067","doi-asserted-by":"publisher","first-page":"516420","DOI":"10.1155\/2013\/516420","article-title":"The role of thrombophilia in pregnancy","volume":"2013","author":"Battinelli","year":"2013","journal-title":"Thrombosis"},{"key":"B1068","doi-asserted-by":"publisher","first-page":"e114488","DOI":"10.1371\/journal.pone.0114488","article-title":"Blood coagulation parameters and platelet indices: changes in normal and preeclamptic pregnancies and predictive values for preeclampsia","volume":"9","author":"Han","year":"2014","journal-title":"PLoS One"},{"key":"B1069","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000292703","article-title":"Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia","volume":"35","author":"Koh","year":"1993","journal-title":"Gynecol Obstet Invest"},{"key":"B1070","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3960\/jslrt.51.67","article-title":"Diagnostic criteria and laboratory tests for disseminated intravascular coagulation","volume":"51","author":"Kaneko","year":"2011","journal-title":"J Clin Exp Hematop"},{"key":"B1071","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11739-012-0859-9","article-title":"Disseminated intravascular coagulation: a review for the internist","volume":"8","author":"Levi","year":"2013","journal-title":"Int Emerg Med"},{"key":"B1072","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/2052-0492-2-20","article-title":"Classifying types of disseminated intravascular coagulation: clinical and animal models","volume":"2","author":"Asakura","year":"2014","journal-title":"J Intensive Care"},{"key":"B1073","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cca.2014.04.020","article-title":"Disseminated intravascular coagulation: testing and diagnosis","volume":"436","author":"Wada","year":"2014","journal-title":"Clin Chim Acta"},{"key":"B1074","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1378\/chest.128.4.2864","article-title":"Disseminated intravascular coagulation in sepsis","volume":"128","author":"Zeerleder","year":"2005","journal-title":"Chest"},{"key":"B1075","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejphar.2009.02.003","article-title":"Tanshinone IIA reduces lethality and acute lung injury in LPS-treated mice by inhibition of PLA2 activity","volume":"607","author":"Xu","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"B1076","doi-asserted-by":"publisher","first-page":"e2010024","DOI":"10.4084\/MJHID.2010.024","article-title":"Sepsis-associated disseminated intravascular coagulation and thromboembolic disease","volume":"2","author":"Semeraro","year":"2010","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"B1077","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2478\/v10011-011-0043-1","article-title":"Thrombocyte and erythrocyte indices in sepsis and disseminated intravascular coagulation","volume":"31","author":"Acikgoz","year":"2012","journal-title":"J Med Biochem"},{"key":"B1078","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/aps.2012.84","article-title":"Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC)","volume":"33","author":"Wu","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"B1079","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.blre.2015.10.002","article-title":"Potential diagnostic markers for disseminated intravascular coagulation of sepsis","volume":"30","author":"Iba","year":"2016","journal-title":"Blood Rev"},{"key":"B1080","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40560-016-0149-0","article-title":"Sepsis and disseminated intravascular coagulation","volume":"4","author":"Okamoto","year":"2016","journal-title":"J Intensive Care"},{"key":"B1081","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0030-1270334","article-title":"Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia","volume":"37","author":"D\u2019Elia","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"B1082","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/humupd\/dms060","article-title":"Genetic variants in pre-eclampsia: a meta-analysis","volume":"19","author":"Buurma","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B1083","doi-asserted-by":"publisher","first-page":"e56907","DOI":"10.1371\/journal.pone.0056907","article-title":"Association of plasminogen activator inhibitor-type 1 (-675 4G\/5G) polymorphism with pre-eclampsia: systematic review","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"B1084","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2016.08.006","article-title":"Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting","author":"Kell","year":"2016","journal-title":"Progr Biophys Mol Biol"},{"key":"B1085","doi-asserted-by":"publisher","first-page":"054734","DOI":"10.1101\/054734","article-title":"Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting. bioRxiv preprint","author":"Kell","year":"2016","journal-title":"bioRxiv"},{"key":"B1086","doi-asserted-by":"publisher","first-page":"6698","DOI":"10.1073\/pnas.0303859101","article-title":"Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis","volume":"101","author":"Akassoglou","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B1087","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"B1088","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1172\/JCI30134","article-title":"Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif","volume":"117","author":"Flick","year":"2007","journal-title":"J Clin Invest"},{"key":"B1089","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/ACO.0b013e3283489ac0","article-title":"Linking inflammation and coagulation: novel drug targets to treat organ ischemia","volume":"24","author":"Jennewein","year":"2011","journal-title":"Curr Opin Anaesthesiol"},{"key":"B1090","doi-asserted-by":"publisher","first-page":"568","DOI":"10.2119\/molmed.2010.00146","article-title":"Novel aspects of fibrin(ogen) fragments during inflammation","volume":"17","author":"Jennewein","year":"2011","journal-title":"Mol Med"},{"key":"B1091","doi-asserted-by":"publisher","first-page":"437695","DOI":"10.1155\/2015\/437695","article-title":"The inflammatory actions of coagulant and fibrinolytic proteases in disease","volume":"2015","author":"Schuliga","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B1092","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0301-0082(00)00015-0","article-title":"The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer\u2019s disease","volume":"62","author":"Miranda","year":"2000","journal-title":"Progr Neurobiol"},{"key":"B1093","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature06616","article-title":"Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer\u2019s disease","volume":"451","author":"Meyer-Luehmann","year":"2008","journal-title":"Nature"},{"key":"B1094","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/j.1460-9568.2009.06701.x","article-title":"Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer\u2019s disease","volume":"29","author":"Rival","year":"2009","journal-title":"Eur J Neurosci"},{"key":"B1095","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1074\/jbc.M110.158980","article-title":"Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation","volume":"286","author":"Liu","year":"2011","journal-title":"J Biol Chem"},{"key":"B1096","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease","volume":"136","author":"Minter","year":"2016","journal-title":"J Neurochem"},{"key":"B1097","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/08037051.2012.707336","article-title":"Red cell distribution width and inflammation in patients with non-dipper hypertension","volume":"22","author":"\u00d6zcan","year":"2013","journal-title":"Blood Press"},{"key":"B1098","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/Bf00667368","article-title":"Changes in blood rheology and their influence on oxygen diffusion in normal and pathological pregnancies","volume":"223","author":"Heilmann","year":"1977","journal-title":"Arch Gyn\u00e4kol"},{"key":"B1099","first-page":"95","article-title":"Quantitative utility assessment of some biophysical and rheological tests used in hypertension research. 1. Relevance analyses of the test parameters","volume":"56","author":"Stoeff","year":"2003","journal-title":"C R Acad Bulg Sci"},{"key":"B1100","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1076029613490827","article-title":"Relationship of red cell distribution width with the presence and severity of preeclampsia","volume":"21","author":"Kurt","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"B1101","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1746-1596-9-29","article-title":"Red blood cell distribution width is not correlated with preeclampsia among pregnant Sudanese women","volume":"9","author":"Abdullahi","year":"2014","journal-title":"Diagn Pathol"},{"key":"B1102","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1136\/neurintsurg-2012-010386","article-title":"Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage","volume":"5","author":"McMahon","year":"2013","journal-title":"J Neurointerv Surg"},{"key":"B1103","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1751-553X.2011.01379.x","article-title":"Scanning electron microscopy analysis of erythrocytes in thromboembolic ischemic stroke","volume":"34","author":"Swanepoel","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"B1104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1475-2840-12-25","article-title":"Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study","volume":"12","author":"Buys","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"B1105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2012-09-454793","article-title":"Iron alters red blood cell morphology","volume":"121","author":"Pretorius","year":"2013","journal-title":"Blood"},{"key":"B1106","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.carpath.2012.11.005","article-title":"Thromboembolic ischemic stroke changes red blood cell morphology","volume":"22","author":"Pretorius","year":"2013","journal-title":"Cardiovasc Pathol"},{"key":"B1107","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1089\/ars.2006.8.1183","article-title":"Mechanisms and significance of eryptosis","volume":"8","author":"Lang","year":"2006","journal-title":"Antioxid Redox Signal"},{"key":"B1108","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1159\/000185448","article-title":"Eryptosis, a window to systemic disease","volume":"22","author":"Lang","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"B1109","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000342534","article-title":"Physiology and pathophysiology of eryptosis","volume":"39","author":"Lang","year":"2012","journal-title":"Transfus Med Hemother"},{"key":"B1110","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000334163","article-title":"Mechanisms and significance of eryptosis, the suicidal death of erythrocytes","volume":"33","author":"Lang","year":"2012","journal-title":"Blood Purif"},{"key":"B1111","doi-asserted-by":"publisher","first-page":"513518","DOI":"10.1155\/2015\/513518","article-title":"Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death","volume":"2015","author":"Lang","year":"2015","journal-title":"Biomed Res Int"},{"key":"B1112","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1159\/000430241","article-title":"Impact of cyclin-dependent kinase CDK4 inhibition on eryptosis","volume":"37","author":"Lang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B1113","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/jcmm.12778","article-title":"Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin","volume":"20","author":"Qadri","year":"2016","journal-title":"J Cell Mol Med"},{"key":"B1114","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s10495-015-1094-4","article-title":"Ceramide in the regulation of eryptosis, the suicidal erythrocyte death","volume":"20","author":"Lang","year":"2015","journal-title":"Apoptosis"},{"key":"B1115","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fphys.2014.00516","article-title":"Oxidative stress in preeclampsia and the role of free fetal hemoglobin","volume":"5","author":"Hansson","year":"2014","journal-title":"Front Physiol"},{"key":"B1116","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"B1117","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(07)60713-2","article-title":"Aspirin for pre-eclampsia: compelling data on benefit and risk","volume":"369","author":"Roberts","year":"2007","journal-title":"Lancet"},{"key":"B1118","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejogrb.2011.04.010","article-title":"Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis","volume":"158","author":"Rossi","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B1119","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO trial and a meta-analysis of randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"key":"B1120","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S1701-2163(16)34300-6","article-title":"Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis","volume":"31","author":"Bujold","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"B1121","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1055\/s-0032-1310527","article-title":"Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis","volume":"29","author":"Roberge","year":"2012","journal-title":"Am J Perinatol"},{"key":"B1122","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/1471-0528.12170","article-title":"Initiation of aspirin in early gestation for the prevention of pre-eclampsia","volume":"120","author":"Roberge","year":"2013","journal-title":"BJOG"},{"key":"B1123","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1055\/s-0035-1570381","article-title":"Prevention of preeclampsia with aspirin in multiple gestations: a systematic review and meta-analysis","volume":"33","author":"Bergeron","year":"2016","journal-title":"Am J Perinatol"},{"key":"B1124","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1055\/s-0036-1572495","article-title":"Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: meta-analysis of large randomized trials","volume":"33","author":"Roberge","year":"2016","journal-title":"Am J Perinatol"},{"key":"B1125","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/1471-0528.12613","article-title":"Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary","volume":"121","author":"Hofmeyr","year":"2014","journal-title":"BJOG"},{"key":"B1126","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bpobgyn.2011.01.002","article-title":"Early prediction and prevention of pre-eclampsia","volume":"25","author":"Leslie","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B1127","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bpobgyn.2011.02.008","article-title":"Prediction and primary prevention of pre-eclampsia","volume":"25","author":"Thangaratinam","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B1128","doi-asserted-by":"publisher","first-page":"e113715","DOI":"10.1371\/journal.pone.0113715","article-title":"Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines","volume":"9","author":"Gillon","year":"2014","journal-title":"PLoS One"},{"key":"B1129","doi-asserted-by":"publisher","first-page":"12907","DOI":"10.3390\/ijms160612907","article-title":"From pre-clinical studies to clinical trials: generation of novel therapies for pregnancy complications","volume":"16","author":"Cottrell","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B1130","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The magpie trial: a randomised placebo-controlled trial","volume":"359","author":"Altman","year":"2002","journal-title":"Lancet"},{"key":"B1131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bpobgyn.2004.10.010","article-title":"Evidence and practice: the magnesium sulphate story","volume":"19","author":"Duley","year":"2005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B1132","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/aogs.12807","article-title":"Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies","volume":"95","author":"Pratt","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B1133","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2016.08.237","article-title":"Magnesium sulphate prevents lipopolysaccharide-induced cell death in an in vitro model of the human placenta","author":"Williamson","year":"2016","journal-title":"Pregnancy Hypertens"},{"key":"B1134","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJM199804163381607","article-title":"Drugs in pregnancy","volume":"338","author":"Koren","year":"1998","journal-title":"N Engl J Med"},{"key":"B1135","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/14767058.2011.557791","article-title":"Drug development in preeclampsia: a \u2018no go\u2019 area?","volume":"25","author":"Everett","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B1136","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.3390\/ijerph110807993","article-title":"Antibiotic use and misuse during pregnancy and delivery: benefits and risks","volume":"11","author":"Martinez de Tejada","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"B1137","doi-asserted-by":"publisher","first-page":"CD002250","DOI":"10.1002\/14651858.CD002250.pub2","article-title":"Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity","volume":"1","author":"Thinkhamrop","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B1138","doi-asserted-by":"publisher","first-page":"CD002256","DOI":"10.1002\/14651858.CD002256.pub2","article-title":"Treatments for symptomatic urinary tract infections during pregnancy","author":"Vazquez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B1139","doi-asserted-by":"publisher","first-page":"CD006841","DOI":"10.1002\/14651858.CD006841","article-title":"Antibiotics for preventing hypertensive diseases in pregnancy (protocol)","author":"Mathew","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B1140","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2710.2005.00631.x","article-title":"Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions","volume":"30","author":"Pound","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"B1141","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1345\/aph.1G308","article-title":"Penicillin-induced Jarisch-Herxheimer reaction","volume":"39","author":"See","year":"2005","journal-title":"Ann Pharmacother"},{"key":"B1142","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tmaid.2013.04.001","article-title":"The Jarisch-Herxheimer reaction: revisited","volume":"11","author":"Belum","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"B1143","doi-asserted-by":"publisher","first-page":"e59266","DOI":"10.1371\/journal.pone.0059266","article-title":"The Jarisch-Herxheimer reaction in leptospirosis: a systematic review","volume":"8","author":"Guerrier","year":"2013","journal-title":"PLoS One"},{"key":"B1144","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1128\/AAC.38.6.1211","article-title":"Clinical relevance of antibiotic-induced endotoxin release","volume":"38","author":"Prins","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"B1145","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1348-0421.1997.tb01203.x","article-title":"Antibiotic-induced endotoxin release from bacteria and its clinical significance","volume":"41","author":"Kirikae","year":"1997","journal-title":"Microbiol Immunol"},{"issue":"Spec No 1","key":"B1146","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1179\/joc.2001.13.Supplement-2.159","article-title":"Antibiotic induced endotoxin release and clinical sepsis: a review","volume":"13","author":"Holzheimer","year":"2001","journal-title":"J Chemother"},{"key":"B1147","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00134-002-1330-6","article-title":"Clinical implications of antibiotic-induced endotoxin release in septic shock","volume":"28","author":"Lepper","year":"2002","journal-title":"Intensive Care Med"},{"key":"B1148","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1128\/AAC.00326-16","article-title":"New role for FDA-approved drugs in combating antibiotic-resistant bacteria","volume":"60","author":"Andersson","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B1149","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(06)68433-X","article-title":"Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial","volume":"367","author":"Poston","year":"2006","journal-title":"Lancet"},{"key":"B1150","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/humupd\/dmu058","article-title":"The effects of dietary polyphenols on reproductive health and early development","volume":"21","author":"Ly","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B1151","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1471-0528.1985.tb01447.x","article-title":"Homozygous alpha-thalassaemia: clinical presentation, diagnosis and management. A review of 46 cases","volume":"92","author":"Liang","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"B1152","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1196\/annals.1368.013","article-title":"Development and application of a real-time quantitative PCR for prenatal detection of fetal alpha(0)-thalassemia from maternal plasma","volume":"1075","author":"Tungwiwat","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B1153","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1373\/clinchem.2004.031591","article-title":"Preeclampsia and the C282Y mutation in the hemochromatosis (HFE) gene","volume":"50","author":"Senden","year":"2004","journal-title":"Clin Chem"},{"key":"B1154","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12013-009-9043-x","article-title":"A review of the antioxidant mechanisms of polyphenol compounds related to iron binding","volume":"53","author":"Perron","year":"2009","journal-title":"Cell Biochem Biophys"},{"key":"B1155","doi-asserted-by":"publisher","first-page":"CD006780","DOI":"10.1002\/14651858.CD006780.pub2","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","author":"Dodd","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B1156","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1440-1797.2012.01657.x","article-title":"Low molecular weight heparin decreases the permeability of glomerular endothelial cells when exposed to pre-eclampsia serum in vitro","volume":"17","author":"Li","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"B1157","doi-asserted-by":"publisher","first-page":"CD006780","DOI":"10.1002\/14651858.CD006780.pub3","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"7","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B1158","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejogrb.2015.02.001","article-title":"Low-molecular-weight heparin protects kidney through an anti-apoptotic mechanism in a rat pre-eclamptic model","volume":"188","author":"Zhang","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B1159","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2174\/1389201017666160301103312","article-title":"A prevention of pre-eclampsia with the use of acetylsalicylic acid and low-molecular weight heparin \u2013 molecular mechanisms","volume":"17","author":"Darmochwa\u0142-Kolarz","year":"2016","journal-title":"Curr Pharm Biotechnol"},{"key":"B1160","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/uog.15789","article-title":"Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis","volume":"47","author":"Roberge","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B1161","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.mehy.2015.10.021","article-title":"A hypothesis about how to achieve anticoagulation without bleeding","volume":"85","author":"Eggers","year":"2015","journal-title":"Med Hypotheses"},{"key":"B1162","article-title":"How drugs pass through biological cell membranes \u2013 a paradigm shift in our understanding?","volume":"2","author":"Kell","year":"2016","journal-title":"Beilstein Mag"},{"key":"B1163","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1039\/b901356c","article-title":"Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity","volume":"5","author":"Park","year":"2009","journal-title":"Mol Biosyst"},{"key":"B1164","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1021\/ci3000979","article-title":"Detecting drug promiscuity using Gaussian ensemble screening","volume":"52","author":"P\u00e9rez-Nueno","year":"2012","journal-title":"J Chem Inf Model"},{"key":"B1165","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1021\/jm301514n","article-title":"Contributions of molecular properties to drug promiscuity","volume":"56","author":"Tarcsay","year":"2013","journal-title":"J Med Chem"},{"key":"B1166","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nchembio.1867","article-title":"The promise and peril of chemical probes","volume":"11","author":"Arrowsmith","year":"2015","journal-title":"Nat Chem Biol"},{"key":"B1167","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.cell.2015.05.045","article-title":"A global map of lipid-binding proteins and their ligandability in cells","volume":"161","author":"Niphakis","year":"2015","journal-title":"Cell"},{"key":"B1168","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1039\/b905821b","article-title":"The topology of drug-target interaction networks: implicit dependence on drug properties and target families","volume":"5","author":"Mestres","year":"2009","journal-title":"Mol Biosyst"},{"key":"B1169","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"key":"B1170","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/bioinformatics\/btp465","article-title":"Network analyses in systems pharmacology","volume":"25","author":"Berger","year":"2009","journal-title":"Bioinformatics"},{"key":"B1171","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1007\/s11095-011-0467-9","article-title":"Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development","volume":"28","author":"van der Graaf","year":"2011","journal-title":"Pharm Res"},{"key":"B1172","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.drudis.2012.01.015","article-title":"Relevance of systems pharmacology in drug discovery","volume":"17","author":"Cucurull-Sanchez","year":"2012","journal-title":"Drug Discov Today"},{"key":"B1173","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/aje\/kwj079","article-title":"Combined analysis of women\u2019s health initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease","volume":"163","author":"Prentice","year":"2006","journal-title":"Am J Epidemiol"},{"key":"B1174","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1126\/science.322.5899.220","article-title":"Cholesterol veers off script","volume":"322","author":"Couzin","year":"2008","journal-title":"Science"},{"key":"B1175","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nchembio1108-635","article-title":"Chemical biology and the limits of reductionism","volume":"4","author":"Peterson","year":"2008","journal-title":"Nat Chem Biol"},{"key":"B1176","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.amjcard.2007.11.060","article-title":"Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk","volume":"101","author":"Robinson","year":"2008","journal-title":"Am J Cardiol"},{"key":"B1177","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2183\/pjab.86.484","article-title":"A historical perspective on the discovery of statins","volume":"86","author":"Endo","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"B1178","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nbt1387","article-title":"Large-scale chemical dissection of mitochondrial function","volume":"26","author":"Wagner","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B1179","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets","volume":"8","author":"Libby","year":"2002","journal-title":"Nat Med"},{"key":"B1180","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0167-5273(02)00195-X","article-title":"Beyond lipid lowering: the role of statins in vascular protection","volume":"86","author":"Liao","year":"2002","journal-title":"Int J Cardiol"},{"key":"B1181","first-page":"287","article-title":"Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease","volume":"48","author":"Undas","year":"2002","journal-title":"Clin Lab"},{"key":"B1182","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","article-title":"Statins as anti-inflammatory agents","volume":"23","author":"Weitz-Schmidt","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"B1183","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1046\/j.1523-1755.2003.00744.x","article-title":"Anti-inflammatory and immunomodulatory effects of statins","volume":"63","author":"Blanco-Colio","year":"2003","journal-title":"Kidney Int"},{"key":"B1184","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","article-title":"Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins","volume":"2","author":"Kwak","year":"2003","journal-title":"Autoimmun Rev"},{"key":"B1185","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1055\/s-2004-869599","article-title":"Anti-inflammatory properties of statins","volume":"4","author":"Steffens","year":"2004","journal-title":"Semin Vasc Med"},{"key":"B1186","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"B1187","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/art.21521","article-title":"Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy?","volume":"54","author":"Abeles","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B1188","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosissup.2006.01.005","article-title":"Statins: potential new indications in inflammatory conditions","volume":"7","author":"Endres","year":"2006","journal-title":"Atheroscler Suppl"},{"key":"B1189","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mehy.2006.09.070","article-title":"Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property","volume":"69","author":"Li","year":"2007","journal-title":"Med Hypotheses"},{"key":"B1190","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/187153009789044383","article-title":"Immunomodulatory and anti-inflammatory activities of statins","volume":"9","author":"Mira","year":"2009","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B1191","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory agents: present and future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"key":"B1192","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MOL.0b013e3283453e41","article-title":"Mechanisms for the anti-inflammatory effects of statins","volume":"22","author":"Bu","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"B1193","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161212799504803","article-title":"Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials","volume":"18","author":"Antonopoulos","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B1194","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1086\/323334","article-title":"The effect of statins on mortality in patients with bacteremia","volume":"33","author":"Liappis","year":"2001","journal-title":"Clin Infect Dis"},{"key":"B1195","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1473-3099(06)70439-X","article-title":"Statins: panacea for sepsis?","volume":"6","author":"Terblanche","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"B1196","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/jac\/dkn019","article-title":"Statins for infection and sepsis: a systematic review of the clinical evidence","volume":"61","author":"Falagas","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"B1197","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/597039","article-title":"Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"B1198","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/cvr\/cvu058","article-title":"View of statins as antimicrobials in cardiovascular risk modification","volume":"102","author":"Kozarov","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B1199","first-page":"S81","article-title":"The endotoxin-lipoprotein hypothesis\u2009\u2013 an update","volume":"3","author":"Sandek","year":"2007","journal-title":"Arch Med Sci"},{"key":"B1200","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s12020-009-9157-3","article-title":"Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients","volume":"35","author":"Ukinc","year":"2009","journal-title":"Endocrine"},{"key":"B1201","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/qjmed\/hcs204","article-title":"Might the beneficial effects of statin drugs be related to their action on iron metabolism?","volume":"105","author":"Mascitelli","year":"2012","journal-title":"QJM"},{"key":"B1202","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1111\/febs.12893","article-title":"Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms","volume":"281","author":"Kanugula","year":"2014","journal-title":"FEBS J"},{"key":"B1203","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2165\/11632010-000000000-00000","article-title":"Statins and pregnancy: between supposed risks and theoretical benefits","volume":"72","author":"Lecarpentier","year":"2012","journal-title":"Drugs"},{"key":"B1204","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/AOG.0b013e31827d8ad5","article-title":"Pravastatin for the prevention of preeclampsia in high-risk pregnant women","volume":"121","author":"Costantine","year":"2013","journal-title":"Obstet Gynecol"},{"key":"B1205","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.preghy.2013.04.120","article-title":"Review: potential druggable targets for the treatment of early onset preeclampsia","volume":"3","author":"Downing","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"B1206","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ijdevneu.2013.11.004","article-title":"The effect of maternal pravastatin therapy on adverse sensorimotor outcomes of the offspring in a murine model of preeclampsia","volume":"33","author":"Carver","year":"2014","journal-title":"Int J Dev Neurosci"},{"key":"B1207","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fphar.2014.00119","article-title":"The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia","volume":"5","author":"Cindrova-Davies","year":"2014","journal-title":"Front Pharmacol"},{"issue":"1\u2013102","key":"B1208","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jri.2013.07.005","article-title":"Can statins prevent pregnancy complications?","volume":"10","author":"Girardi","year":"2014","journal-title":"J Reprod Immunol"},{"issue":"542","key":"B1209","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1016\/j.ajog.2014.01.010","article-title":"The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model","volume":"210","author":"McDonnold","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"1\u2013102","key":"B1210","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jri.2013.12.120","article-title":"Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia","volume":"10","author":"Ramma","year":"2014","journal-title":"J Reprod Immunol"},{"key":"B1211","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1933719113492207","article-title":"Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia","volume":"21","author":"Saad","year":"2014","journal-title":"Reprod Sci"},{"issue":"1\u2013102","key":"B1212","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jri.2013.09.001","article-title":"Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors","volume":"10","author":"Staff","year":"2014","journal-title":"J Reprod Immunol"},{"key":"B1213","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1111\/bph.12977","article-title":"Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?","volume":"172","author":"Ahmed","year":"2015","journal-title":"Br J Pharmacol"},{"key":"B1214","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.111.00226","article-title":"Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension","volume":"61","author":"Bauer","year":"2013","journal-title":"Hypertension"},{"key":"B1215","doi-asserted-by":"publisher","first-page":"e100873","DOI":"10.1371\/journal.pone.0100873","article-title":"Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model","volume":"9","author":"Carver","year":"2014","journal-title":"PLoS One"},{"key":"B1216","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1161\/HYPERTENSIONAHA.114.03115","article-title":"Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin","volume":"63","author":"Lefkou","year":"2014","journal-title":"Hypertension"},{"key":"B1217","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.115.05445","article-title":"Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia","volume":"66","author":"Brownfoot","year":"2015","journal-title":"Hypertension"},{"key":"B1218","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3109\/14767058.2015.1022864","article-title":"Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD)","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B1219","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3109\/10641951003634766","article-title":"Sildenafil for the treatment of preeclampsia","volume":"29","author":"Downing","year":"2010","journal-title":"Hypertens Pregnancy"},{"key":"B1220","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1177\/1933719115574340","article-title":"Drug repositioning for preeclampsia therapeutics by in vitro screening: phosphodiesterase-5 inhibitor vardenafil restores endothelial dysfunction via induction of placental growth factor","volume":"22","author":"Kakigano","year":"2015","journal-title":"Reprod Sci"},{"key":"B1221","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejogrb.2011.03.005","article-title":"Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats","volume":"157","author":"Ramesar","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B1222","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/j.1471-0528.2012.03430.x","article-title":"Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats","volume":"119","author":"Herraiz","year":"2012","journal-title":"BJOG"},{"key":"B1223","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1055\/s-0032-1304823","article-title":"Effects of sildenafil in Nomega-nitro-L-arginine methyl ester-induced intrauterine growth restriction in a rat model","volume":"29","author":"Nassar","year":"2012","journal-title":"Am J Perinatol"},{"key":"B1224","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.111.186270","article-title":"Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model","volume":"59","author":"Stanley","year":"2012","journal-title":"Hypertension"},{"key":"B1225","doi-asserted-by":"publisher","first-page":"R397","DOI":"10.1152\/ajpregu.00216.2013","article-title":"Sildenafil attenuates placental ischemia-induced hypertension","volume":"305","author":"George","year":"2013","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B1226","doi-asserted-by":"publisher","first-page":"18241","DOI":"10.1038\/srep18241","article-title":"Sildenafil therapy normalizes the aberrant metabolomic profile in the comt(-\/-) mouse model of preeclampsia\/fetal growth restriction","volume":"5","author":"Stanley","year":"2015","journal-title":"Sci Rep"},{"key":"B1227","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.preghy.2011.04.002","article-title":"Different effects of different phosphodiesterase type-5 inhibitors in pre-eclampsia","volume":"1","author":"Karasu","year":"2011","journal-title":"Pregnancy Hypertens"},{"key":"B1228","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/10641963.2011.628730","article-title":"Endothelial dysfunction in the human umbilical artery due to preeclampsia can be prevented by sildenafil","volume":"34","author":"Karasu","year":"2012","journal-title":"Clin Exp Hypertens"},{"key":"B1229","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2046-4053-3-23","article-title":"STRIDER: sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction \u2013 a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis","volume":"3","author":"Ganzevoort","year":"2014","journal-title":"Syst Rev"},{"key":"B1230","doi-asserted-by":"publisher","first-page":"CD002252","DOI":"10.1002\/14651858.CD002252.pub3","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2","author":"Abalos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B1231","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000153250","article-title":"Stimulation of erythrocyte cell membrane scrambling by methyldopa","volume":"31","author":"Mahmud","year":"2008","journal-title":"Kidney Blood Press Res"},{"key":"B1232","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/1471-0528.12737","article-title":"Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review","volume":"121","author":"Firoz","year":"2014","journal-title":"BJOG"},{"key":"B1233","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1517\/14740338.2015.998197","article-title":"Labetalol for hypertension in pregnancy","volume":"14","author":"Magee","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"B1234","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3892\/mmr.2012.886","article-title":"Short-term suppression of the renin-angiotensin system in mice associated with hypertension during pregnancy","volume":"6","author":"Ishimaru","year":"2012","journal-title":"Mol Med Rep"},{"key":"B1235","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4682-3-1","article-title":"Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b","volume":"3","author":"Marshall","year":"2006","journal-title":"Theor Biol Med Model"},{"key":"B1236","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJM199102143240701","article-title":"Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group","volume":"324","author":"Ziegler","year":"1991","journal-title":"N Engl J Med"},{"key":"B1237","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0171-2985(11)80357-8","article-title":"Immunotherapy of endotoxemia and septicemia","volume":"187","author":"Baumgartner","year":"1993","journal-title":"Immunobiology"},{"key":"B1238","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/515184","article-title":"Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group","volume":"28","author":"Derkx","year":"1999","journal-title":"Clin Infect Dis"},{"key":"B1239","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/bja\/73.6.805","article-title":"In vitro effects of HA-1A (centoxin) on cytokine production in whole blood from intensive care unit patients","volume":"73","author":"Yentis","year":"1994","journal-title":"Br J Anaesth"},{"key":"B1240","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4161\/mabs.19909","article-title":"The birth pangs of monoclonal antibody therapeutics: the failure and legacy of centoxin","volume":"4","author":"Marks","year":"2012","journal-title":"MAbs"},{"key":"B1241","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/IAI.66.2.870-873.1998","article-title":"Anti-lipid A monoclonal antibody centoxin (HA-1A) binds to a wide variety of hydrophobic ligands","volume":"66","author":"Helmerhorst","year":"1998","journal-title":"Infect Immun"},{"key":"B1242","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1096\/fj.1530-6860","article-title":"High-affinity LPS binding domain(s) in recombinant factor C of a horseshoe crab neutralizes LPS-induced lethality","volume":"14","author":"Tan","year":"2000","journal-title":"FASEB J"},{"key":"B1243","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1096\/fj.99-0866com","article-title":"Definition of endotoxin binding sites in horseshoe crab factor C recombinant sushi proteins and neutralization of endotoxin by sushi peptides","volume":"14","author":"Tan","year":"2000","journal-title":"FASEB J"},{"key":"B1244","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1128\/AAC.45.10.2820-2825.2001","article-title":"High therapeutic index of factor C sushi peptides: potent antimicrobials against Pseudomonas aeruginosa","volume":"45","author":"Yau","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"B1245","first-page":"21","article-title":"The molecular mechanism of interaction between sushi peptide and Pseudomonas endotoxin","volume":"3","author":"Li","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"B1246","doi-asserted-by":"publisher","first-page":"10554","DOI":"10.1021\/bi0602765","article-title":"Molecular mechanisms that govern the specificity of sushi peptides for Gram-negative bacterial membrane lipids","volume":"45","author":"Li","year":"2006","journal-title":"Biochemistry"},{"key":"B1247","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s00018-008-7456-0","article-title":"The sushi peptides: structural characterization and mode of action against Gram-negative bacteria","volume":"65","author":"Ding","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B1248","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1741-7007-7-22","article-title":"Single molecule resolution of the antimicrobial action of quantum dot-labeled sushi peptide on live bacteria","volume":"7","author":"Leptihn","year":"2009","journal-title":"BMC Biol"},{"key":"B1249","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4161\/viru.1.1.10229","article-title":"One step at a time: action mechanism of sushi 1 antimicrobial peptide and derived molecules","volume":"1","author":"Leptihn","year":"2010","journal-title":"Virulence"},{"key":"B1250","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1128\/AAC.48.9.3349-3357.2004","article-title":"De novo design of potent antimicrobial peptides","volume":"48","author":"Frecer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"B1251","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.2174\/092986710791959756","article-title":"De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs","volume":"17","author":"Bhattacharjya","year":"2010","journal-title":"Curr Med Chem"},{"key":"B1252","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/aje\/kwr168","article-title":"Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study","volume":"174","author":"Brantsaeter","year":"2011","journal-title":"Am J Epidemiol"},{"key":"B1253","volume-title":"Principles of Evolutionary Medicine","author":"Gluckman","year":"2009"},{"key":"B1254","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00210-006-0046-5","article-title":"Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine","volume":"373","author":"Hemmings","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B1255","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1095\/biolreprod.105.043034","article-title":"Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone","volume":"74","author":"Hemmings","year":"2006","journal-title":"Biol Reprod"},{"key":"B1256","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"key":"B1257","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.virol.2012.09.039","article-title":"Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection","volume":"435","author":"Oldstone","year":"2013","journal-title":"Virology"},{"key":"B1258","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"key":"B1259","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-319-05879-5_6","article-title":"Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule","volume":"378","author":"Oldstone","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"B1260","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1128\/JVI.00464-14","article-title":"Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy","volume":"88","author":"Walsh","year":"2014","journal-title":"J Virol"},{"key":"B1261","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.drudis.2015.09.013","article-title":"Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases","volume":"21","author":"Arish","year":"2016","journal-title":"Drug Discov Today"},{"key":"B1262","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1093\/humrep\/det339","article-title":"Sphingosine signalling regulates decidual NK cell angiogenic phenotype and trophoblast migration","volume":"28","author":"Zhang","year":"2013","journal-title":"Hum Reprod"},{"key":"B1263","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/aji.12239","article-title":"Emerging roles for lysophospholipid mediators in pregnancy","volume":"72","author":"Nagamatsu","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B1264","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000278289","article-title":"Altered sphingolipid composition in Wharton\u2019s jelly of pre-eclamptic newborns","volume":"77","author":"Romanowicz","year":"2010","journal-title":"Pathobiology"},{"key":"B1265","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2613.2009.00675.x","article-title":"Lipid compounds of human Wharton\u2019s jelly and their alterations in preeclampsia","volume":"91","author":"Romanowicz","year":"2010","journal-title":"Int J Exp Pathol"},{"key":"B1266","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11010-010-0403-z","article-title":"Sphingolipids of human umbilical cord vein and their alteration in preeclampsia","volume":"340","author":"Romanowicz","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"B1267","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.placenta.2013.02.004","article-title":"Lipidomic analysis of human placental syncytiotrophoblast microvesicles in adverse pregnancy outcomes","volume":"34","author":"Baig","year":"2013","journal-title":"Placenta"},{"key":"B1268","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2014.09.059","article-title":"miR-125b-1-3p inhibits trophoblast cell invasion by targeting sphingosine-1-phosphate receptor 1 in preeclampsia","volume":"453","author":"Li","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B1269","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/j.1600-079X.2005.00265.x","article-title":"Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-\/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects","volume":"39","author":"Carrillo-Vico","year":"2005","journal-title":"J Pineal Res"},{"key":"B1270","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1600-079X.2008.00649.x","article-title":"Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin","volume":"46","author":"Gitto","year":"2009","journal-title":"J Pineal Res"},{"key":"B1271","doi-asserted-by":"publisher","first-page":"e003788","DOI":"10.1136\/bmjopen-2013-003788","article-title":"Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol","volume":"3","author":"Hobson","year":"2013","journal-title":"BMJ Open"},{"key":"B1272","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1469-0691.2009.02736.x","article-title":"Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis","volume":"15","author":"Westh","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"B1273","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12859-016-0992-y","article-title":"Sensitivity and correlation of hypervariable regions in 16S rRNA genes in phylogenetic analysis","volume":"17","author":"Yang","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"B1274","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1128\/JCM.43.4.1934-1936.2005","article-title":"Comparison between rpoB and 16S rRNA gene sequencing for molecular identification of 168 clinical isolates of Corynebacterium","volume":"43","author":"Khamis","year":"2005","journal-title":"J Clin Microbiol"},{"key":"B1275","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tim.2008.09.008","article-title":"The rpoB gene as a tool for clinical microbiologists","volume":"17","author":"Ad\u00e9kambi","year":"2009","journal-title":"Trends Microbiol"},{"key":"B1276","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1574-6941.2011.01190.x","article-title":"Comparison of 16S rRNA and protein-coding genes as molecular markers for assessing microbial diversity (bacteria and archaea) in ecosystems","volume":"78","author":"Roux","year":"2011","journal-title":"FEMS Microbiol Ecol"},{"issue":"3","key":"B1277","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3103\/S0891416812030056","article-title":"Popular molecular markers in bacteria","volume":"27","author":"Liu","year":"2012","journal-title":"Mol Gen Microbiol Virol"},{"key":"B1278","doi-asserted-by":"publisher","first-page":"e57923","DOI":"10.1371\/journal.pone.0057923","article-title":"The variability of the 16S rRNA gene in bacterial genomes and its consequences for bacterial community analyses","volume":"8","author":"V\u011btrovsk\u00fd","year":"2013","journal-title":"PLoS One"},{"key":"B1279","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mimet.2014.05.013","article-title":"Understanding molecular identification and polyphasic taxonomic approaches for genetic relatedness and phylogenetic relationships of microorganisms","volume":"103","author":"Das","year":"2014","journal-title":"J Microbiol Methods"},{"key":"B1280","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1128\/JCM.00066-13","article-title":"Real-time genomic epidemiological evaluation of human Campylobacter isolates by use of whole-genome multilocus sequence typing","volume":"51","author":"Cody","year":"2013","journal-title":"J Clin Microbiol"},{"key":"B1281","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2350-10-120","article-title":"Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia","volume":"10","author":"Lazar","year":"2009","journal-title":"BMC Med Genet"},{"key":"B1282","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1515\/CCLM.2010.160","article-title":"Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy","volume":"48","author":"Galbiati","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"B1283","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/ajh\/hpt187","article-title":"Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome","volume":"26","author":"Miranda","year":"2013","journal-title":"Am J Hypertens"},{"key":"B1284","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.clinbiochem.2015.03.004","article-title":"Maternal plasma RNA sequencing","volume":"48","author":"Oudejans","year":"2015","journal-title":"Clin Biochem"},{"key":"B1285","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.clinbiochem.2015.03.015","article-title":"Digital PCR analysis of circulating nucleic acids","volume":"48","author":"Hudecova","year":"2015","journal-title":"Clin Biochem"},{"key":"B1286","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/00126839-200607030-00001","article-title":"New strategies for antibacterial drug design: targeting non-multiplying latent bacteria","volume":"7","author":"Coates","year":"2006","journal-title":"Drugs R D"},{"key":"B1287","doi-asserted-by":"publisher","first-page":"e11818","DOI":"10.1371\/journal.pone.0011818","article-title":"A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections","volume":"5","author":"Hu","year":"2010","journal-title":"PLoS One"},{"key":"B1288","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1476-5381.2011.01250.x","article-title":"Novel classes of antibiotics or more of the same?","volume":"163","author":"Coates","year":"2011","journal-title":"Br J Pharmacol"},{"key":"B1289","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance \u2013 the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"B1290","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fmicb.2015.00641","article-title":"High-dose rifampicin kills persisters, shortens treatment duration, and reduces relapse rate in vitro and in vivo","volume":"6","author":"Hu","year":"2015","journal-title":"Front Microbiol"},{"key":"B1291","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/j.1538-7836.2004.00993.x","article-title":"Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation","volume":"2","author":"Barber","year":"2004","journal-title":"J Thromb Haemost"},{"key":"B1292","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1532-5415.2009.02284.x","article-title":"The apolipoprotein 2 allele in Alzheimer\u2019s disease: suggestions for a judicious use of antiplatelet and anticoagulant medications","volume":"57","author":"Murthy","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"B1293","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1084\/jem.20131751","article-title":"A novel abeta-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer\u2019s disease mice","volume":"211","author":"Ahn","year":"2014","journal-title":"J Exp Med"},{"key":"B1294","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.jmb.2014.04.015","article-title":"A bacteriophage capsid protein provides a general amyloid interaction motif (GAIM) that binds and remodels misfolded protein assemblies","volume":"426","author":"Krishnan","year":"2014","journal-title":"J Mol Biol"},{"key":"B1295","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/joim.12506","article-title":"Current and future treatment of amyloid diseases","volume":"280","author":"Ankarcrona","year":"2016","journal-title":"J Intern Med"},{"key":"B1296","first-page":"S116","article-title":"Helicobacter pylori","volume":"89","author":"Marshall","year":"1994","journal-title":"Am J Gastroenterol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2016.00060\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T20:30:09Z","timestamp":1718915409000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2016.00060\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,29]]},"references-count":1296,"URL":"https:\/\/doi.org\/10.3389\/fmed.2016.00060","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/057356","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,29]]}}}